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Abstract 
Mild cognitive impairment (MCI) is a common condition which lies between normal cognition 
and dementia. Relatively little is known about the experiences of people with MCI (PWMCI) 
and their caregivers (‘advocates’), particularly regarding healthcare services. No measures 
developed specifically to evaluate health related quality of life in PWMCI or their advocates 
exist. Therefore the aim of this work was to gather information about these groups’ 
experiences of living with MCI, with particular reference to their contact with healthcare 
services, to use this information to develop a patient reported outcome measure (PROM) for 
PWMCI and equivalent measure for advocates and to suggest improvements to healthcare 
services in light of the findings. Initial, in-depth information was gathered during semi-
structured interviews with 23 PWMCI and 20 linked advocates, the resulting data was 
analysed using grounded theory methods. Commonly recurring and salient themes from 
analysis of the interview data were used as a basis for initial drafts of the outcome measures 
and patient and advocate surveys regarding healthcare experiences. The outcome 
measures and healthcare surveys were combined into two questionnaires (one for PWMCI 
and one for advocates). These initial drafts were discussed with a focus group and refined in 
light of their feedback, the resulting questionnaires were administered (by post) to 280 
PWMCI (recruited from research databases and memory clinics) and their linked advocates. 
The response rate was 54% for PWMCI and 36% for advocates. Data from the outcome 
measure section of the questionnaire was analysed using factor analysis producing a 
measure for PWMCI (the MCQ) and one for advocates (the MCQ-Carer); both had good 
psychometric properties. Descriptive analysis of the healthcare experiences survey data 
revealed that both the PWMCI and advocates reported a range of unmet needs for help, 
support and information related to MCI; appropriate suggested improvements to healthcare 
services are made. 
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A Note on Terminology 
The term ‘person with mild cognitive impairment’ (PWMCI), rather than patient, has been 
used in this thesis as many PWMCI are not patients i.e. are not engaged with healthcare 
services. An exception to this is in cases where the PWMCI is being discussed specifically 
as a user of healthcare services.  
The term ‘advocate’ has been used in this study to denote a relative or friend that the 
PWMCI felt had been affected by their cognitive problems. This term was used in preference 
to ‘carer’ or ‘care-giver’ as, by definition, most people with MCI do not have significant 
difficulty with standard ADLs and therefore do not require ‘care’ in the usual sense of the 
word. However, in the introduction (Chapter 1) and literature review (Chapter 2) the term 
‘carer’ or ‘caregiver’ was used throughout to reflect the terminology used in the literature 
cited. In the interests of clarity, in the literature given to participants in the study the term 
‘relative or friend’ was used rather than advocate. The patient reported outcome measure 
(PROM) developed for use with advocates of people with MCI was named the MCQ-Carer 
so that population in whom the measure is intended for use is unambiguous. 
  
14 
 
 
 
Chapter 1: Introduction 
1.1 Thesis Structure 
Mild cognitive impairment (MCI) is a state between normal cognition and dementia; it is 
common and associated with an increased risk of dementia. It is increasingly recognised that 
people with MCI (PWMCI) and their caregivers experience a range of practical and 
emotional difficulties which health and social care services often fail to address adequately, 
although evidence regarding many aspects of this topic is limited at best. Therefore the aim 
of this work was to gather detailed information about the experiences of PWMCI and their 
caregivers, with particular reference to their involvement with healthcare services, to use this 
information to develop a patient reported outcome measure (PROM) and equivalent 
measure for caregivers and to suggest potential improvements to services. The PROM for 
the PWMCI is to be designated the Mild Cognitive impairment Questionnaire (MCQ) and that 
for caregivers as the MCQ-carer. 
In Chapter 2 the current literature regarding patient and caregiver experience in MCI is 
reviewed, with particular emphasis on experiences of healthcare and existing measures of 
outcome in these groups. 
In the first stage of the study in-depth, semi-structured interviews with PWMCI and their 
caregivers were conducted in order to gain a detailed picture of the experiences of these 
groups – both in everyday life and in their contact with healthcare services. In the first part of 
Chapter 3 the methodology for conducting the interviews and analysing the resulting data is 
described, including a discussion of the justification for, and limitations of, this methodology. 
In the second and third part of this chapter respectively the results of the interviews are 
described and discussed (with reference to the existing literature). 
In the second stage of the study the results of the interviews were used to generate items for 
initial versions of the outcome measures for PWMCI and caregivers and to design surveys of 
experiences of healthcare for the two groups. The initial outcome measures and surveys 
were incorporated into two questionnaires (one for patients and one for caregivers); these 
were refined after review by a focus group and then administered to PWMCI and their 
caregivers by post. In the first part of Chapter 4 the methods used to develop the outcome 
measures and surveys and to administer the questionnaires are described. In the second 
part of the chapter the results of administration of the initial versions of the outcome 
measures and the surveys are presented and analysed. In the final part of this chapter the 
results of the analysis of the initial versions of the outcome measures are discussed and final 
versions (the MCQ and MCQ-Carer) are presented; the results of the patient and caregiver 
15 
 
 
 
surveys are also discussed and some potential improvements to healthcare services 
suggested.  
In Chapter 5 the overall results of the study and their implications are briefly discussed 
together with potential avenues for further work. 
1.2 Background 
1.2.1 Introduction to Mild Cognitive Impairment 
The defining criteria for MCI most commonly used in research are those first proposed by 
Petersen et al. in 1999 (Petersen et al., 1999)  i.e. for a diagnosis of MCI there should be: 
memory complaint from the patient (preferably corroborated by an informant), evidence of 
objective memory impairment (for age and education) on testing but preserved general 
cognitive function, intact activities of daily living (ADLs) and an absence of dementia. In 
2011, a working group from the National Institute on Aging and the Alzheimer’s Association 
published revised ‘core clinical’ criteria for the diagnosis of ‘MCI due to Alzheimer’s disease 
(AD)’; these altered Petersen’s original criteria to include cognitive changes in domains other 
than memory, to emphasise the importance of a decline in cognitive abilities and to specify 
that, although independence in functional abilities should be preserved, complex ADLs may 
affected (Albert et al., 2011) . The revised criteria state that MCI may be diagnosed if there 
is: evidence of concern (from the patient, an informant or a clinician) about a change in 
cognition, impairment in one or more cognitive domain(s) on examination (greater than 
expected for age and education), preservation of independence in functional activities (with 
minimal aid or assistance) and an absence of dementia. The working group also published 
‘research criteria’ which included the use of biomarkers (such as markers of amyloid beta 
deposition) to establish the likelihood that MCI is due to a symptomatic, pre-dementia phase 
of AD.  MCI can be divided into four subtypes depending on which cognitive domains are 
affected (Petersen et al., 2009): amnestic single domain (in which there is impairment of 
memory only), amnestic multiple domain (in which there is impairment of memory and 
(an)other cognitive domain(s)), non-amnestic single domain (in which there is impairment of 
a single, non-memory cognitive domain) and non-amnestic multiple domain (in which there is 
impairment of multiple, non-memory cognitive domains).  
The reported prevalence of MCI varies depending on the definition used and population 
studied. Prevalence in general older populations where strict research definitions (such as 
the Petersen criteria given above) are used seems to be approximately 3% (Gauthier et al., 
2006, Anstey et al., 2008, Palmer et al., 2008, Wright, 2009) . Where more inclusive 
definitions are used (such as “cognitive impairment, no dementia”) prevalence estimates 
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may be as high as 25%. Similarly, the incidence of MCI quoted in the literature is dependent 
on the definition used and ranges from 1 to 5% per year (Gauthier et al., 2006, Chertkow et 
al., 2008). Current estimates are that approximately 1.5 million people in the UK have MCI 
(Smith et al., 2010). 
The majority of interest in MCI has been as a result of the associated increased risk of 
dementia. Like prevalence, the quoted conversion rate from MCI to dementia is dependent 
on the definitions used and the populations studied (Ganguli et al., 2011). Annual incidence 
of dementia is around 3% in those with MCI in the general population (Farias et al., 2009, 
Mitchell and Shiri-Feshki, 2009, Ganguli et al., 2011) compared to approximately 0.5% in all 
people over 60 in the UK (National Institute for Clinical Excellence and Social Care Institute 
for Excellence (England and Wales), 2006). In clinic based research populations the rate of 
progression from MCI to dementia is higher than in community based populations: estimates 
for clinic based population vary widely and have been quoted as anything between 10 and 
41% per year, although most studies suggest a figure of between 10 and 15% (Gauthier et 
al., 2006, Chertkow et al., 2008, Farias et al., 2009, Mitchell and Shiri-Feshki, 2009, Adams, 
2006). It is commonly reported that subjects with amnestic MCI (aMCI) have a higher rate of 
conversion to AD than those with other subtypes who more frequently progress to other 
disorders such as vascular dementia (Petersen et al., 2001a). It is also known that a 
significant proportion of people meeting criteria for MCI show at least some improvement in 
cognition over time; studies have shown this to be in the case in 11 – 44% of those 
diagnosed with MCI at baseline (Wright, 2009, Gauthier et al., 2006, Wahlund et al., 2003, 
Matthews et al., 2008). 
1.2.2 Relevant Policies 
It is likely that the rate of diagnosis of MCI will increase in the UK over the coming years due 
both to the ageing population and to various government and health service strategies 
relating to the early diagnosis of dementia which will probably have the secondary effect of 
increasing the rate of diagnosis of MCI: 
The National Institute for Clinical Excellence (NICE) guideline on dementia published in 2006 
(National Institute for Clinical Excellence and Social Care Institute for Excellence (England 
and Wales), 2006) states that ‘primary healthcare staff should consider referring people who 
show signs of MCI for assessment by memory assessment services’. 
The National Dementia Strategy (NDS) published by the UK Department of Health (DoH) in 
2009 sets out 17 key objectives to improve the quality of services for people with dementia, 
focussing on improved awareness, earlier diagnosis and intervention and a higher quality of 
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care (Department of Health, 2009b). The strategy is being coordinated nationally with 
implementation beginning at a local level over the five years from 2009 onwards. MCI is not 
specifically mentioned in the strategy, however some of the objectives are likely to have an 
effect on the rate of diagnosis of MCI as consultation and referral rates to secondary care 
increase amongst patients with memory problems. Objectives which are particularly relevant 
include: Objective 1: ‘improving public and professional awareness and understanding of 
dementia’ and Objective 2: ‘good quality early diagnosis and intervention for all’. In 
September 2010 the DoH decided to focus on five main priorities – one of which was early 
diagnosis and intervention in primary care (Department of Health, 2010). To complement the 
NDS the DoH national campaign to raise public awareness of the early features of dementia 
was launched in November 2011 (Department of Health (England), 2011). This incorporated 
a media campaign to raise public awareness of the fact that many cases of dementia go 
undiagnosed. The campaign was particularly aimed at the friends and family of those at risk 
of dementia and emphasised the importance of consulting a health professional for 
assessment where they had concerns about a person’s memory. There is some evidence 
that referrals to memory clinics from primary care has increased since the NDS was 
published (Menon and Larner, 2011). 
In April 2012 the British Prime Minister, David Cameron, launched his ‘dementia challenge’ 
which ‘aims to deliver major improvements in dementia care and research by 2015’ and 
‘build on the achievements of the NDS (Department of Health, 2012)’. This DoH guidance set 
out a number of commitments relating to improving awareness, quality of care and research 
in dementia; these included two which are particularly likely to increase the rate of MCI 
diagnosis as a by-product of cognitive screening programs: The first of these was the 
commitment to increase diagnosis rates through regular checks for over-65s: General 
Practitioners (GPs) and other health professionals are to make patients aged 65 and 
older aware of memory clinics and refer those in need of assessment; this commitment 
includes targets for rates of diagnosis. The second important pledge was the commitment 
to financial rewards for hospitals offering quality dementia care: From April 2012, £54m 
has been made available through the Dementia Commissioning for Quality and 
Innovation (CQUIN) to hospitals offering dementia risk assessments to all over-75s 
admitted to their care.  
Other bodies aside from the DoH encourage early diagnosis in dementia, for example The 
World Alzheimer Report 2011 emphasised the importance of early diagnosis and 
intervention – both on an individual level for patients and carers and in terms of financial 
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benefits for society (Alzheimer's Disease International, 2011). The meaning of ‘early 
diagnosis’ was discussed, acknowledging that for some, this means ‘timely diagnosis’, at the 
point at which the individual or carer first become concerned rather than screening the 
general population to detect disease early. Clearly ‘timely diagnosis’ in this context can apply 
to individuals with MCI as well as those with dementia. 
Several recent reports have highlighted the need for more research in this field: The Medical 
Research Council (MRC) and DoH convened a Ministerial Summit on Dementia Research in 
2009, the independent report of which stated:  ‘There is a need for more clinical studies of 
people with mild cognitive impairment’(Department of Health and Medical Research 
Council, 2009). Both the National Institute for Health Research (NIHR), in their 2011 call for 
research, and the Prime Minister’s Challenge mentioned above (Department of Health, 
2012), emphasized the importance of research into the social impact of living with cognitive 
impairment.  
1.2.3 Current Support and Information for People Affected by Mild 
Cognitive Impairment 
As discussed in the review of current literature in Chapter 2, there is relatively little published 
evidence about the experience of living with MCI or caring for people with the condition. The 
work which has been done is observational in nature and there are few interventional studies 
to provide evidence about the most effective way to support these groups; this is in contrast 
to dementia where there is quite a large body of evidence on these topics. 
Overall, the evidence which does exist suggests that both PWMCI and their advocates 
experience more difficulties than might be expected when considering Petersen’s research 
definition of MCI which states that, despite a degree of cognitive impairment, these 
individuals have intact general cognition and are able to function independently in terms of 
ADLs (Petersen et al., 2001b). The evidence also suggests that PWMCI are a 
heterogeneous group with regards to their experiences and support needs which further 
underlines the need to develop standardised assessment tools for this group. 
In keeping with the paucity of published evidence on the topic, and in stark contrast to 
dementia, there are few national or international guidelines regarding the management of 
MCI (Palmer et al., 2010). The only published guidelines which specifically relate to the 
management of MCI were published in North America: The American Academy of 
Neurology’s ‘practice parameter’ (Petersen et al., 2001b) and The American Academy for 
Physicians’ Assistants (AAPA) guidelines on the management of dementia and MCI 
(Boissonneault, 2010). These documents make recommendations about the management 
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options for MCI, including, in the AAPA’s guidance, that ‘clinicians should consider the 
social and familial impact of MCI’. In the UK, the NICE guidance on dementia (National 
Institute for Clinical Excellence and Social Care Institute for Excellence (England and 
Wales), 2006) states that ‘memory assessment services that identify people with MCI …. 
should offer follow-up to monitor cognitive decline and other signs of possible dementia in 
order to plan care at an early stage’. 
1.2.4 Patient Reported Outcome Measures in Mild Cognitive 
Impairment 
As discussed in the literature review in Chapter 2, and confirmed by published reviews of the 
topic (Weiner et al., 2012, Frank et al., 2011), there are very few assessment tools designed 
specifically for use in MCI – either for cognitive or comprehensive needs assessment.  
One of the objectives of this project is to develop a patient reported outcome measure 
(PROM) and equivalent measure for advocates in MCI (which, for the sake of simplicity, will 
also be referred to as a PROM in this document). PROMs are defined by the UK 
Department of Health as ‘measures of a patient’s health status or health-related quality of 
life. They are typically short, self-completed questionnaires, which measure the patients’ 
health status or health related quality of life at a single point in time’. They are being used 
with increasing frequency - to provide information on the impact of disease in clinical practice 
and to measure outcomes both in clinical practice and clinical trials (Revicki, 2002, Leidy et 
al., 1999). Their increasing popularity is reflected by the fact that the UK Department of 
Health made it mandatory for PROMs data to be collected for all patients undergoing hip or 
knee replacement, varicose vein or groin hernia repair surgery within the NHS from 2009 
(Department of Health, 2009a). The European Medicines Agency (EMA) issued guidance for 
industry regarding the use of PROMs in medical product development in 2005 (European 
Medicines Agency, 2005) as did the US Food and Drug Administration (FDA) in 2009 (US 
Department of Health and Human Services et al., 2009). The importance of measuring 
health related quality of life (HRQL) as an outcome measure in clinical trials in cognitive 
impairment has been commented on by several authors (Winblad et al., 2001, Rockwood et 
al., 2006). 
A PROM for carers specific to MCI is also likely to be a useful tool; many carers of PWMCI 
have already taken on caring responsibilities but these are likely to be different from those 
involved in caring for someone with physical health problems or dementia (Gallagher et al., 
2011) – therefore existing measures developed for these groups of carers may well not be 
applicable to those of PWMCI. In addition, some of the studies described in Chapter 2 found 
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that carers’ subjective assessments of factors such as burden or severity of the PWMCI’s 
cognitive impairment were correlated with adverse effects (such as decreased marital 
quality) whereas objective measures of the same factors were not (Garand et al., 2007, 
Bruce et al., 2008). This suggests that a PROM may be a more accurate reflection of true 
carer experience than existing, objective measures. 
The review of the literature identified only one PROM developed for use in MCI and this was, 
in fact, developed based on interviews with both PWMCI and AD and has only been 
validated for use in North America (Frank et al., 2006a). No PROMs designed for use in 
carers of PWMCI were identified. Discussing the lack of MCI-specific HRQL scales in their 
review of PROMs for MCI, Frank et al stated: 
‘..the value of disease-specific HRQL assessment for treatment evaluation in MCI and 
prodromal AD is limited by lack of consensus on domains to include and lack of clarity about 
how to weight domains for scoring. The HRQL impact of MCI, as distinct from that of later 
disease, remains to be defined’. 
They concluded: 
‘…the time is right for development of new patient-reported measures for MCI. Although 
measurement from the perspective of patients with MCI and prodromal AD is still at an early 
stage, the development of new measures…should be pursued to increase the tools available to 
expand our understanding of mild levels of cognitive impairment’. 
Consequently, this thesis aims to develop such measures for PWMCI and carers. In the next 
chapter a review of the relevant published literature will be set out; in subsequent chapters 
the development of the measures will be described and then discussed in the context of this 
literature. 
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Chapter 2: A Critical Review of The Literature 
 
The concept of mild cognitive impairment (MCI), as it is recognised today,  was first 
‘formalised’ when Petersen published his definition in 1999 (Petersen et al., 1999). Most of 
the literature relevant to this work has therefore been published since this time, with an 
exponentially increasing volume of publications between the late 1990s and the current time, 
for example 20 articles with the phrase ‘mild cognitive impairment’ in the title were published 
in 1999 compared to 633 in 2011. Consequently, there is a large volume of published 
literature on the subject of MCI and a careful literature search, as described below, was 
carried out in order to identify those articles relevant to this work i.e. those relating to: the 
experiences living with MCI for those with the condition and their carers (with particular 
reference to healthcare), potentially helpful interventions for these groups and the tools 
available to measure patient (and carer) experience and the outcomes of interventions. 
2.1 Methods 
The Embase, Medline and PsychINFO databases were searched via the NHS Evidence 
Health Information Resources website (formerly the National Electronic Library for Health’) in 
August 2010, the search was repeated at regular intervals during the course of the research 
up to October 2012. The titles of all papers to October 2012 were searched for the following 
keywords (without explosion): 
• ‘mild cognitive impairment’ OR MCI,  combined in turn (using AND) with: 
o symptoms (limited to papers from 2008 – current) 
o ‘subjective complaint*’ 
o care* 
o experience* 
o clinic* (limited to papers from 2008 – current) 
o ‘primary health care’ OR ‘general pract*’ OR GP 
o consult* OR attend* OR ‘seeking help’ OR ‘help seeking’ 
o ‘patient perception*’ 
o future 
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• ‘memory clinic*’ combined in turn (using AND) with: 
o experience* 
o perception* 
 
• ‘cognitive impairment’ OR MCI OR dementia combined in turn (using AND) with: 
o ‘patient reported outcome*’ 
o ‘outcome measure*’ 
o PRO OR PROs 
o PROM or PROMs 
o ‘care* outcome*’ 
No limits were applied except as specified in the list above. In addition, a search of the 
Cochrane Library was performed using the ‘advanced search’ facility to search ‘the tile, 
abstract and keywords of articles using the terms ‘Mild Cognitive Impairment’ and ‘MCI’ - 
Cochrane and ‘other’ reviews were considered. The ‘Topics’ section on the NHS Evidence 
website was searched for the term ‘mild cognitive impairment’, the results were filtered by 
‘type of information’ and articles in the sections ‘Guidelines’, ‘Patient Information’, ‘Policy and 
Service Development’ and ‘Quality Measures’ were reviewed.  
The titles and abstracts of the papers identified using this strategy were screened for 
relevance using the following criteria: Papers were included in the review if they were 
primarily concerned with aspects of MCI relating to everyday experiences of patients or 
carers, their experiences of health or social care or outcome measures for use in these 
groups. Articles published in languages other than English were excluded. Abstracts were 
included if they contained sufficient information, unpublished studies were not. 
Citations were excluded from the review if, on examination of the title and / or abstract, they 
were clearly not relevant to the topic being reviewed. The full text versions of papers which 
appeared to be relevant following initial screening were obtained and reviewed further.  
The search strategy yielded 1020 articles, 243 of which were duplicates. After review of the 
title and / or abstract of the 777 unique articles, the full versions of 105 papers were obtained 
and reviewed. 56 of these papers obtained met the inclusion criteria. The reference lists of 
all relevant articles were examined for any additional articles of interest, this yielded 6 further 
articles, therefore in total 62 articles were included in this review.  
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2.2 Patients’ Experience of Mild Cognitive Impairment 
2.2.1 General Experiences of Living with Mild Cognitive Impairment 
2.2.1.1 Cognitive Changes 
Given the definition of MCI, which mandates cognitive complaints from the person with MCI 
(PWMCI) or informant, it is to be expected that people living with MCI should report noticing 
cognitive changes in various domains – and this is indeed the case. Qualitative studies have 
provided useful in-depth information about the experiences of people living with MCI, 
including their perceptions of cognitive changes: Guided interviews of eight very recently 
diagnosed patients in Holland identified four common themes (Joosten-Weyn Banningh et 
al., 2008) one of which was ‘changes noticed by the patient’ – these were often cognitive in 
nature, for example ‘forgetfulness’ and ‘poor concentration’. Frank et al. carried out focus 
group interviews of 20 people with MCI and 11 ‘informants’, as well as similar numbers of 
people with mild probable AD (Alzheimer’s disease) (Frank et al., 2006b). They also found 
that PWMCI commonly reported cognitive changes affecting recall, verbal fluency and 
processing skills. As linked PWMCI and informants were interviewed in this study in many 
cases it was possible to compare their reported experiences.  
Lu et al. carried out open ended interviews with eleven PWMCI in order to 
identify ‘commonalities of the lived experience of being diagnosed and living with MCI’ (Lu 
et al., 2007a). They described a longitudinal ‘journey’ experienced by PWMCI beginning with 
the gradual awareness of their problems, followed by efforts to maintain a sense of ‘being 
able’ and finally development of strategies to maintain ‘a sense of self’. The first of these 
elements incorporated an awareness of worsening memory. Although this study provided 
detailed information about people’s current experiences of living with MCI the mean time 
from diagnosis to interview was 2.5 years which may have limited subject recall of issues 
which were particularly relevant at the time of diagnosis.  
In a study in which questionnaires about health, beliefs about their diagnosis and coping 
were administered to 63 PWMCI the symptoms endorsed by more than half of the 
respondents were cognitive in nature (Lin and Heidrich, 2012).  
2.2.1.2 Function 
Despite the stipulation in the original Petersen definition of MCI that basic activities of daily 
living (ADLs) should be intact it has been increasingly recognized that more complex (or 
‘instrumental’) ADLs (IADLs), such as managing medications or finances, may be affected 
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by MCI and, in fact, it is this ‘minimal impairment’ which helps differentiate MCI from normal 
aging (Winblad et al., 2004).  
Difficulties with IADLs in MCI have been identified in quite a number of studies, often at a 
rate between those experienced by people with dementia and normal controls: In a 
questionnaire based study of 46 people recently diagnosed with MCI subjects reported a 
need for assistance with complex ADLs, although to a lesser degree than the levels of 
assistance that their carers reported they required (McIlvane et al., 2008). In a large study 
based on data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) informant 
reports of function (as measured with the quantitative Pfeffer Functional Activities 
Questionnaire) for nearly 400 PWMCI were compared with those for controls and subjects 
with mild AD (Brown et al., 2011). The authors found that functional impairment in one or 
more of the domains covered by the questionnaire was present in 72% of the PWMCI 
compared to 8% controls and 95% subjects with mild AD and that, perhaps unsurprisingly, 
greater functional impairment was associated with poorer performance on various 
neuropsychological tests. A prospective case control study of 107 PWMCI also showed that 
they were more likely to report deficits in complex functions, such as managing finances and 
preparing food, than were cognitively normal controls (Tabert et al., 2002). The authors 
found that a subset of people overestimated their functional abilities when compared with 
informant reports (indicating either a diminished awareness of their functional limitations or 
an underestimation of their abilities by the informant) and that this subset had a greater risk 
of developing Alzheimer’s disease. A case control study in Korea also found that PWMCI 
had significantly more difficulty with IADLs than did controls (Ahn et al., 2009); IADLS where 
significant differences in ability were identified included telephone use, meal preparation, 
management of medication, participation in leisure activities and keeping of appointments. In 
this study PWMCI’s ability to perform IADLs was assessed from caregiver reports therefore 
the results were unaffected by any decreased insight on the part of the PWMCI. A study of 
functional ability in approximately 300 French people with cognitive impairment insufficient to 
meet the criteria for dementia also found rates of difficulty with various ADLs to be 
significantly greater than in cognitively intact subjects in the same age group (30.8% vs. 
3.3%) (Artero et al., 2001). Interestingly, some of the ADLs with which subjects in this study 
most commonly reported difficulty (e.g. independent toileting, mobility and bathing) were 
much more basic than the IADLs in the studies described above. The subjects included in 
this study underwent extensive neuropsychiatric, clinical and imaging investigations; the 
criteria used to diagnose MCI were: having subjective cognitive complaint plus a reported a 
cognitive change over the preceding year plus having cognitive scores greater than one 
standard deviation below the mean expected score for age and education but who not 
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meeting the criteria for dementia. However, by the Petersen criteria, those subjects with 
limitations of basic ADLs, cannot be diagnosed with MCI which means that the results of this 
study should be interpreted with caution. 
One recent study specifically examined social function in PWMCI and mild dementia (Henry 
et al., 2012): it concluded that there was no difference in informant ratings of socially 
insensitive behaviour between the control and MCI groups (whereas the group with mild 
dementia was rated as displaying elevated levels of such behaviour). However, this study 
used the quantitative ‘Peer-Report Social Functioning Scale’ which may be less sensitive in 
detecting subtle effects on social function than qualitative methods, such as those used in de 
Vriendt’s study of PWMCI (described in detail below) which did detect effects on subjects’ 
ability to socialize (De Vriendt et al., 2012). 
There is some evidence that PWMCI may not always spontaneously report problems with 
function, even where they are present: A qualitative study involving interviews with 37 
patients newly diagnosed with aMCI and 22 informants found that, although participants did 
not explicitly report functional problems resulting from cognitive problems, descriptions of 
their typical day-to-day activities did reveal subtle difficulties with advanced ADLS such as 
the use of electronic equipment, cooking complex meals, complex economic activities and 
socializing (De Vriendt et al., 2012) It is also likely that the problems with function 
experienced depend on MCI subtype: In a study of nearly 500 subjects with MCI carried out 
in California functional deficits were found to vary by MCI subtype – those with aMCI were 
more likely to have difficulty with recall (e.g. for names) and less likely to have difficulty with 
basic ADLs (such as eating as continence) than those with non-amnestic MCI (Weston et al., 
2011) 
2.2.1.3 Emotional Consequences and Neuropsychiatric Symptoms 
Neuropsychiatric symptoms (NPS) are known to be a common feature of MCI:  In a 
population based cohort study of PWMCI, carried out as part of the Cardiovascular Health 
Study in the United States, Neuropsychiatric Inventory (NPI) scores were examined for 320 
people classified as having MCI. 43% were found to have had at least one NPS in the 
preceding month with the commonest symptoms being of depression (20%), apathy (15%) 
and irritability (15%) (Lyketsos et al., 2002) This has subsequently been confirmed in 
another quantitative study where similar rates of NPS were identified (Feldman et al., 2004). 
However, there has been some disagreement as to the psychological impact of living with 
MCI, for example the questionnaire based study of recently diagnosed patients found 
measures of psychological wellbeing (such as depression and life satisfaction) to be within 
normal limits (McIlvane et al., 2008).  
26 
 
 
 
Results of some of the qualitative studies, however, appear to confirm that negative 
emotional reactions are common in PWMCI. For example, one of the major themes identified 
in Joosten-Weyn’s interview based study was ‘consequences’ which were commonly 
negative emotions experienced by PWMCI regarding their cognitive problems (Joosten-
Weyn Banningh et al., 2008). The subjects in Lu et al.’s study also described a range of 
negative emotional reactions to their memory problems (Lu et al., 2007a). Frank et al.’s 
study identified a theme of embarrassment / shame about their problems resulting in a 
tendency to attempt to conceal them (to a greater extent than the patients with mild AD 
included in the study did) (Frank et al., 2006b). DeVriendt et al., in their study of function in 
MCI, also commented that the combination of impaired function and impaired coping they 
identified led, in many cases, to negative emotional consequences (De Vriendt et al., 2012). 
In a study involving semi-structured interviews with 25 people diagnosed with MCI at 
specialist memory clinics ‘fear and uncertainty’ were found to be a major theme (Roberts and 
Clare, 2012).  
Lin and Heidrich, in their questionnaire based study, found that PWMCI within their study 
population described a diverse range of emotional responses and often disagreed with one 
another about the consequences, for example 46% participants agreed with the statement 
‘MCI makes me feel uncertain about the future’, while 38% disagreed (Lin and Heidrich, 
2012). This is in keeping with the fact that PWMCI are a heterogeneous group who are likely 
to differ widely in their responses to the diagnosis. 
2.2.1.4 Coping 
The coping mechanisms employed by PWMCI have also been examined in several studies. 
One of the themes identified in Joosten-Weyn’s study was ‘coping’ and they identified three 
types of coping mechanism in their subjects:  
• Emotion orientated e.g. resignation  
• Problem solving orientated e.g. developing strategies to aid memory  
• Avoidance orientated e.g. disguising their memory difficulties (Joosten-Weyn 
Banningh et al., 2008) 
Beard and Neary also identified use of the first two of these strategies in the PWMCI 
interviewed for their study (Beard and Neary, 2012) as did Lin and Heidrich in their 
questionnaire based study (Lin and Heidrich, 2012). In a qualitative study of ‘self-initiated 
health behaviours’ following a diagnosis of MCI, 53 people were interviewed about changes 
they had made as a result of their diagnosis. ‘Symptom driven’ changes, such as the use of 
compensatory strategies or cognitive exercises, were reported most commonly and the 
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authors comment that these strategies broadly equate to the ‘problem focused’ coping 
strategies described above (Morgan et al., 2012). 
The final theme identified in Lu et al.’s qualitative study concerned coping mechanisms – 
some similar to those described above (e.g. acceptance and strategies to aid memory) and 
some not identified in Joosten-Weyn’s study (for example information seeking, careful 
communication in order to maintain relationships and efforts to maintain hope) (Lu et al., 
2007a). 
A study of 56 ‘triads’ consisting of an ‘elder’ with MCI plus a primary and a secondary ‘care 
partner’ used semi-structured interviews to assess the subjects’ perceptions of MCI and their 
associated coping mechanisms. The authors concluded that coping style appeared to differ 
with the degree of acknowledgement of problems: subjects who  displayed ‘passive’ 
acknowledgement (where memory problems were acknowledged but attributed to causes 
other than MCI)  tended to rely on others for assistance and those in other groups were 
more likely to seek active strategies such as using reminder lists (Roberto et al., 2011) 
2.2.1.5 Attributions 
The causes to which PWMCI attribute their symptoms have been discussed in several 
studies. Attributions vary widely but there are several which recur across the literature 
including: normal aging, physical health problems and personality. ‘Normal aging’ was by far 
the commonest attribution in that it was mentioned by PWMCI in almost every relevant study 
and, in addition, was often the most frequently described attribution within each study. For 
example, in one qualitative study 11 people who were aware of the term ‘Mild Cognitive 
Impairment’ relating to their cognitive problems were interviewed about their perceptions of 
their diagnosis (Lingler et al., 2006), they cited ‘normal ageing’ as the most common 
explanation for their symptoms. This was also the case in the study involving semi-structured 
interviews with 25 PWMCI, all of whom had had their diagnosis disclosed to them at the 
memory clinic (Roberts and Clare, 2012). Other qualitative and questionnaire based studies 
have had similar results (McIlvane et al., 2008, Lin and Heidrich, 2012, Beard and Neary, 
2012). 
One of the themes identified in Joosten-Weyn’s study was ‘Attributions’ described by the 
PWMCI and these included normal ageing, personality, dementia and ‘somatic’ origins 
(Joosten-Weyn Banningh et al., 2008). In Lu et al.’s interview based study the theme of 
‘gradual awareness of problems’ also incorporated a discussion of attributions. Many 
subjects in this study, in common with those in Joosten-Weyn’s, attributed their symptoms to 
physical health problems including medication side effects.  Others blamed an episode of 
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significant personal loss (such as bereavement) and, again, normal ageing (Lu et al., 
2007a).  
Beard and Neary noted that the people they interviewed were particularly keen to deny any 
association between their experiences and AD, stating that their awareness of their own 
limitations distinguished their condition from dementia (Beard and Neary, 2012). In contrast, 
Roberts and Clare found that concern about memory difficulties representing the beginnings 
of dementia was heightened by personal experience of others with dementia or by depictions 
in the media (Roberts and Clare, 2012). 
In the qualitative study of the degree of ‘acknowledgement’ of memory impairment described 
above the authors categorised the degree of acknowledgement into (Roberto et al., 2011): 
• ‘Complete’ – where all members of the triad fully acknowledged the PWMCI’s 
limitations and attributed them to MCI 
• ‘Passive’ – where memory problems were acknowledged but attributed to other 
causes, often physical health problems. PWMCI in this group often had reduced 
insight into their difficulties 
• ‘Partial’ – where memory problems were acknowledged but ‘personalised’ i.e. 
attributed to something over which members of the triad had control – such as the 
degree of effort applied to remembering on the PWMCI’s part or the way in which 
care partners interacted with them 
• ‘No acknowledgement’ – where all members of the triad denied major memory 
problems. 
Approximately one third of the triads fell into each of the first of these three categories with 
only 2 families in the ‘no acknowledgement’ group. The authors found that the degree of 
acknowledgement was influenced most strongly by families’ prior experiences of other 
people with dementia: triads where a member had professional experience of dementia (e.g. 
was a healthcare worker) tended to have a higher degree of acknowledgement whereas 
those with prior personal experience (e.g. another family member with dementia) were 
under-represented in the ‘complete acknowledgers’ group, seemingly because they 
minimised the PWMCI’s difficulties in comparison with that of the person they had known 
with dementia.  
2.2.1.6 Insight and Mild Cognitive Impairment 
The issue of whether PWMCI have reduced insight into their condition is key to the 
interpretation of the literature described here, for example the findings of studies where there 
were no informant reports may have been inaccurate if the PWMCI in these studies had 
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reduced insight. It is well recognised that impaired insight for deficits (‘anosognosia’) is a 
common feature of dementia (Starkstein et al., 1997), however the degree to which insight is 
impaired in MCI is more controversial. 
Some studies in this area have concluded that PWMCI do under-report cognitive and 
functional limitations: A study in which individuals with aMCI were compared to those with 
mild AD and controls found that the subjects with aMCI and mild AD had a similar degree of 
impaired insight into their memory problems and that this was greater than in controls (Vogel 
et al., 2004). Frank et al. commented that the PWMCI in their qualitative study appeared to 
have reduced insight into their difficulties when compared to informant reports, although this 
was less marked than in their mild AD group (Frank et al., 2006b). In contrast, one study 
comparing self and informant reports of everyday functional abilities (where a discrepancy 
was taken to indicate decreased insight on the part of the PWMCI) found no difference in 
insight between controls and PWMCI (Farias et al., 2005).  
The conflicting results described above may be, at least in part, due to the difficulties 
inherent in measuring insight in this group. A method commonly used is the comparison of 
the reports of informants and PWMCI – with a discrepancy taken to indicate decreased 
insight on the part of the PWMCI. As several authors have commented, where the informant 
is a caregiver the assumption that their reports are accurate may be erroneous as they may 
be influenced by a number of factors such as caregiver burden, neuropsychiatric symptoms 
or their own cognitive problems (Vogel et al., 2004, Frank et al., 2011). Indeed, in a study 
where assessment of the cognitive function of 119 PWMCI using standardised 
neuropsychological testing was compared to assessment using informant reports, it was 
found that there were significant differences in the prevalence of impairment in 7 of the 8 
cognitive domains examined as rated by informants compared to formal testing (Abbate et 
al., 2011). It may also be that insight changes as MCI progresses (Lu et al., 2007a) or varies 
between subtypes of MCI: Tabert’s longitudinal cohort study of just over 100 PWMCI found 
that, although there was no overall difference between self- and informant-reported ratings of 
IADLS between the MCI and control group, in the subgroup of PWMCI who under-reported 
functional deficits when compared with their informant’s report there was an increased risk of 
conversion to AD (Tabert et al., 2002) – this may indicate that insight is reduced only where 
MCI represents a pre-AD stage of dementia.  
In an effort to address some of the difficulties in measuring insight described above, Roberts 
and Clare used a qualitative approach (using interpretative phenomenological analysis) to 
gain a more in-depth understanding of ‘meta-representational’ awareness of symptoms and 
their impact in PWMCI (Roberts and Clare, 2012). They defined ‘meta-representational 
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awareness’ as the most complex expression of awareness - which ‘encompasses aspects of 
self-identity and the environment’. They concluded that all the PWMCI they interviewed did 
display awareness of their cognitive difficulties at this level but that various psychological 
and social factors influenced how this awareness was expressed. This finding was illustrated 
by the fact that, despite the conclusion that these subjects displayed awareness of their 
difficulties and the fact that they had been given the name of their diagnosis at their memory 
clinic appointment, none of them used the term ‘MCI’ during the semi-structured interviews. 
Due to the poor comparability of studies in this area the authors of a systematic review of 
this topic were unable to draw any firmer conclusions than ‘there is variability in awareness 
(of deficits) in PWMCI’ (Roberts et al., 2009). They mentioned many of the points made 
above as possible explanations for the conflicting results of the studies they reviewed and, in 
addition, pointed out that insight may vary depending on the domain to which it pertains (i.e. 
cognitive, behavioural or functional). 
2.2.2 Patient’s Experiences of Healthcare and Support Services 
Diagnosis 
Patient experience of diagnosis with MCI appears to vary widely. As part of the multi-centre 
European Descripa study 124 clinicians were surveyed about their practice of diagnostic 
disclosure in MCI. The results revealed that the diagnostic terms used to describe MCI were 
variable but that almost 80% of patients were given information about prognosis (Derksen et 
al., 2009). A survey of members of the American Academy of Neurology (most of whom 
reported assessing PWMCI at least monthly) revealed high rates of recognition of MCI as a 
clinical diagnostic term and of provision of information about physical and mental exercise to 
the patients they diagnosed. However, only 27% and 15% respectively reported providing 
information on support services or information in a written format (Roberts et al., 2010).  A 
survey of over 1,200 UK psychiatrists with a special interest in older patients found that 91% 
reported making the diagnosis of MCI in clinical practice and that about two thirds felt that 
they were ‘very’ or ‘extremely’ familiar with the concept (Rodda et al., 2012). Some studies 
suggest a problem with recognition of MCI in primary care: A meta-analysis of studies 
(conducted in various countries) of GPs’ ability to diagnose MCI found that only about 45% 
of cases of MCI (as defined by a validated cognitive severity scale) were recognised by GPs 
and that, where a diagnosis was made, it was recorded in the notes in only about 10% of 
cases (Mitchell et al., 2011). 
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Reasons for Presentation to Healthcare Services 
Some work has been done on the reasons for presentation to health services among people 
with memory complaints. A study of nearly 300 non-demented subjects seeking assessment 
for memory problems in secondary care found that they reported higher total levels of 
subjective memory complaints (SMCs) than community based controls, 
particularly ‘forgetting names of family members or friends’ (Pires et al., 2012). The authors 
did note, however, that the people seeking memory assessments had higher levels of 
depressive symptoms than the controls which may have been a confounder. Despite the 
findings of this study, which suggest (unsurprisingly) that memory concerns are the main 
driver for consultation, it is known that only a small proportion of those with SMC seek 
memory assessment (Waldorff et al., 2008). In a study of nearly 100 people with SMC (and 
Mini-Mental State Examination Scores (MMSEs) of 24 or greater) Hurt et al. aimed to 
establish which factors were associated with help seeking in this group; they identified social 
comparison (i.e. perceiving memory as being worse than others’), particular causal 
attributions (e.g. ‘lack of blood supply to the brain’) and having a close relative with dementia 
as being associated with seeking a memory assessment (Hurt et al., 2012). A study of 126 
community dwelling people aged over 65 found that 31% reported significant SMC and that 
this group viewed their symptoms with comparable degrees of concern to other health 
problems such as hypertension (Begum et al., 2012). However only one participant with 
SMC had consulted their GP about their cognitive symptoms, a far lower proportion than 
those with physical health concerns (e.g. 80% of those with skin complaints had sought 
medical help despite the fact that this group displayed lower levels of concern about their 
symptoms than those with SMC). The authors commented that it was difficult to explain the 
low levels of help seeking in people with SMC, despite their relatively high levels of concern, 
based on their quantitative data.  
Experiences at Memory Clinics 
A number of authors have examined the experiences of patients and caregivers attending 
memory clinics – although these patients are heterogeneous in terms of eventual diagnosis 
and many of the studies have focused on patients receiving a diagnosis of dementia rather 
than MCI: 
In a study of memory clinic users mixed methods were used to explore the experiences of 28 
patients (most  of whom received a diagnosis of dementia) and their caregivers on attending 
their first memory clinic assessment (Cahill et al., 2008). The authors found that the wait 
between referral to memory clinic and the appointment itself was often a distressing and 
unsettling time for patients and that, on arrival at the clinic appointment, over 50% of patients 
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reported feeling nervous about the forthcoming assessment. Patients in the study tended to 
have a general expectation of being provided with ‘help’ by the clinic. Immediately after the 
clinic appointment most patients reported feeling content with the assessment process – 
although a number did state that they found some aspects of it upsetting. They also reported 
feeling satisfied with the information they had been given, although many stated that they 
would have liked to have received information in written form in addition to verbally. In a 
study carried out in Holland, questionnaire based interviews of 31 patients attending memory 
clinics and 81 carers were used to assess satisfaction with five aspects of their experiences 
at the clinic (van Hout et al., 2001). Levels of satisfaction with communication of results, the 
usefulness of assessment and the clinician’s attitude were generally high with 70-80% 
patients giving positive responses in these areas. However, patients reported being less 
satisfied with the clarity of information provided to them with only ~40% giving this a positive 
rating. Unfortunately, details of the diagnoses of patients included in this study were not 
reported. 
A cross-sectional study of the participation preferences and decision-making capacity of 29 
people with aMCI, which involved interviews with patients, relatives and referring physicians, 
was carried out in a German memory clinic (Hamann et al., 2011). Unfortunately the results 
for these patients were pooled with the 71 patients with mild AD also interviewed for the 
study and therefore results for the aMCI group alone were not available. In the combined 
group patients indicated a wish to be routinely involved in decision making, particularly that 
related to social decisions such as relocation to a nursing home, with their relatives playing a 
secondary role. Relatives’ preferences, however, were that patients should have significantly 
lower participation than the patients stated they wanted, particularly in social decisions. The 
study included a quantitative assessment of decision making capacity which identified 
deficits in patients’ capacity relating to ‘understanding’ – which the authors commented may 
‘restrict involvement of patients…..in social and medical decisions’. By definition, people with 
aMCI should retain decision making capacity on these matters but unfortunately the data for 
decision making capacity scores for the aMCI group alone was not given in the paper 
therefore it is not possible to be certain whether the study’s findings were driven by the 
patients with mild AD rather than MCI. 
Only one of the qualitative studies of the experience of living with MCI included specific 
questions about subjects’ experiences at memory clinic in their topic guide (Roberts and 
Clare, 2012). In this study PWMCI most commonly described their visit to the memory clinic 
as ‘routine’; some subjects displayed confusion regarding the reason for referral to the clinic 
and some reported that they had received little information at the appointment. 
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Diagnosis Disclosure 
Only one study of the effect of disclosing a diagnosis of MCI was identified in the literature 
review: Carpenter et al. evaluated symptoms of depression and anxiety in patients (and their 
advocates) before and after receiving a diagnosis of MCI (41 patients) or mild dementia (21 
patients) in a research setting (Carpenter et al., 2008). They found no clinically significant 
changes in these symptoms in either group following diagnosis. On a more general level, 
Beard’s qualitative study identified themes of uncertainty and misinformation regarding the 
diagnosis and prognosis of MCI coupled with a dread of developing Alzheimer’s disease 
(Beard and Neary, 2012). Clinicians may be reluctant to disclose a diagnosis of MCI for fear 
of causing the patient anxiety about the risk of dementia conferred by the diagnosis, 
particularly in light of the current lack of effective treatments for MCI. However, a study of the 
effect of disclosing AD risk based on ApoE genotype to family members of patients with AD 
identified no differences in NPS between individuals who were told their risk of AD and those 
who were not, even in those with genotypes associated with a greater risk of dementia 
(Green et al., 2009). This suggests that informing patients that they have an increased risk of 
dementia does not necessarily increase levels of anxiety. 
The general consensus in the current literature is that early diagnosis is important in 
dementia and some authors argue that those who undergo assessment and receive another 
diagnosis, such as MCI, may also benefit. As Alastair Burns, the national clinical director for 
dementia in the UK, wrote in a letter to the BMJ in 2012 (Burns, 2012): 
‘An early and timely diagnosis is important because it gives people a definitive answer to 
complaints that might be causing distress and anxiety (and reassures those who have memory 
problems but do not have dementia). This is what people with dementia want, and it means 
interventions can take place to avoid crises.’ 
The most common reaction to their diagnosis reported by patients in the studies reviewed 
was uncertainty  – this was identified, for example, in Lingler’s study of PWMCI’s perceptions 
of their diagnosis (Lingler et al., 2006), in Frank et al.’s study of the impact of living with MCI 
(Frank et al., 2006b) and in Beard’s study of PWMCI’s opinions about their diagnosis (Beard 
and Neary, 2012).  
Information Provision 
There is currently a lack of educational and support materials aimed at specifically at 
PWMCI and their advocates (Austrom and Lu, 2009) making it difficult for clinicians to 
provide appropriate written information. Only three short fact sheets were identified, all 
entitled ’Mild Cognitive Impairment’ published in The Neurologist in 2009 (Kernich, 2009), by 
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the Alzheimer’s Society in 2005 (Alzheimer's Society, 2005) and in the Journal of the 
American Medical Association in 2009 (Torpy et al., 2008). Although the internet is an 
increasingly popular source of health-related information there are some limitations to its use 
in MCI: Given the increasing prevalence with age many PWMCI and advocates are  in older 
age groups, these groups have been shown to be less likely to use the internet to search for 
information (Denizard-Thompson et al., 2011, Macfarlane et al., 2012). In addition, PWMCI’s 
cognitive impairment may itself create a barrier to learning or retaining the skills required to 
use the internet effectively for this purpose.  
2.2.3 Suggested Interventions and Support 
The potential interventions for MCI which have received the most attention in the literature 
come under the umbrella of ‘cognitive interventions’, these are also known by other terms 
such as ‘cognitive training’, ‘cognitive rehabilitation’ and ‘cognitive stimulation’. In their review 
of the subject Simon et al. define cognitive training as ‘an approach which teaches 
theoretically supported strategies and skills to optimize specific cognitive functions’ and 
cognitive rehabilitation as ‘an individualised approach using tailored programs centred on 
specific activities of daily life (in which) personally relevant goals are identified and the 
therapist, patient and family work together to achieve these goals’ (Simon et al., 2012). 
Examples of strategies taught in cognitive training include the use of memory aids, specific 
memory strategies and reminiscence therapy. Many studies and several reviews have 
reported that cognitive interventions appear to have beneficial effects in MCI, particularly in 
improving memory. The authors of the review mentioned above concluded that cognitive 
interventions appear to improve learning in aMCI but that it is difficult to be sure which 
aspects of the ‘black box’ interventions used in many studies, which were often multi-
component, were responsible for this effect. They also commented that the effects observed 
in many studies related to the specific domain in which cognitive training had occurred rather 
than improving global cognition. A Cochrane review of the subject published in 2011 found 
that there was a significant improvement in recall in PWMCI who had undergone memory 
training but that this was only evident when they were compared to a ‘no treatment’ control 
group – there was no difference in recall when compared with an ‘active’ control group 
suggesting that the observed differences may not have been directly attributable to the 
memory training (Martin et al., 2011). 
Another intervention which has been studied is the use of physical training. Studies in this 
area have shown some modest benefit on cognition but the results are somewhat clouded 
by the fact that positive results have frequently been gender-specific or only found when 
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physical training was used as part of an intervention package including cognitive training 
(Lautenschlager et al., 2010). A Cochrane review of this topic is currently underway. 
Other studies have examined the effect of multicomponent interventions including aspects 
such as cognitive rehabilitation, psychoeducation, physical training and social activities. For 
example, Joosten-Weyn Banningh et al. carried out a study of a group based intervention in 
PWMCI and their carers which incorporated several of those features (Joosten-Weyn 
Banningh et al., 2011). They found no difference in measures of distress or general well-
being in the intervention group compared to controls, although those receiving the 
intervention did show higher levels of acceptance. A Japanese study of 112 PWMCI 
attending ‘dementia prevention classes’, which involved ‘exercise, recreation, creative 
activities or local excursions’ identified modest overall improvements in cognitive function in 
at the end of the 3 months over which the classes were held (Ito and Urakami, 2012). 
However, as the authors pointed out, although there was an overall effect, when examined 
by geographical district not all classes resulted in cognitive improvements so it is not clear 
whether these results are widely generalizable or sustainable.  
As part of the study of lived experiences of MCI described earlier, Lu and Haase carried out 
a qualitative exploration of the experience of spousal caregivers of people with MCI in which 
they interviewed ten people caring for spouses with MCI (at which point data saturation was 
reached). Based on the results of this and their other qualitative work on the subject (Lu et 
al., 2007a), Lu and Haase developed the ‘Daily Enhancement of Meaningful Activity’ (DEMA) 
programme for PWMCI and their caregivers (Lu and Haase, 2011). The programme has 
three main components:  
• Six ‘face-to-face’ sessions for PWMCI and their caregiver with an advanced practice 
nurse, focussing on ‘self-management’ (i.e. provision of information about MCI, 
planning, management of negative emotions, available resources and strategies for 
minimising the effects of MCI) 
• ‘Homework’ – completion of ‘meaningful activities’ and goals set in the face-to-face 
sessions 
• Provision of a ‘self-management toolkit’ i.e. written educational material covering a 
similar range of topics to those in the face-to-face sessions 
They assessed the validity, usefulness and acceptability of the programme using qualitative 
analysis of focus group discussions with 9 PWMCI and their spouses who had taken part in 
it; overall findings were positive. Participants stated that they wanted the programme to 
focus on self-management skills to help the PWMCI maintain independence (e.g. systems 
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for managing their own medication safely), communication skills (both between PWMCI and 
carers and with others), management of negative emotions and training in technology skills 
such as the use of mobile telephones and ‘satnav’ systems for navigating when driving. 
Participants supported the idea that such a programme should be accessed via physician 
referral. 
2.2.4 Patient Reported Outcome Measures for Mild Cognitive 
Impairment 
There is currently no consensus on the best way to assess needs or outcomes in MCI. A 
recent review of needs assessment instruments for use in mental and cognitive disorders 
concluded that ‘there is a lack of instruments to assess the needs in individuals with 
subjective cognitive impairment (SCI), MCI or dementia comprehensively’ (Schmid et al., 
2011). The authors identified and reviewed 17 instruments, most of which took the form of 
structured interviews or questionnaires; the majority were designed to assess the needs of 
patients with dementia or long term mental illness, none were designed specifically for use in 
MCI. The authors noted that, as patient reported unmet needs have been shown to correlate 
negatively with quality of life outcomes (QoL), tools designed to assess specific needs and 
hence guide appropriate interventions should be developed. They recommended that any 
needs assessment instruments developed should be based on a theoretical framework.  
A review of patient self-reported measures for use in MCI identified a small number of 
patient-reported outcome measures (PROMs) used for the assessment of everyday function 
/ ADLs, executive functioning, neuropsychiatric symptoms and health related quality of life 
(HRQL) (Frank et al., 2011). With the exception of the ‘Patient Reported Outcomes in 
Cognitive Impairment’ (PROCOG) tool (which is discussed in detail below) all other 
instruments identified were developed for use in other conditions (usually dementia) and 
adapted / validated to varying degrees for use in MCI. The authors noted that many of these 
tests fail to capture the subtle deficits which may be present in MCI and concluded that ‘the 
time is right for the development of new patient-reported measures for MCI’.  
The PROCOG is a 55 item symptom impact questionnaire which was developed by Frank et 
al. (Frank et al., 2006a) for use in people with MCI and AD. The questionnaire was designed 
to assess basic symptoms and their impact on PWMCI’s’ lives. The process of development 
involved drafting an initial version of the questionnaire based on a review of the existing 
literature, the results of focus group discussions with patients and caregivers (Frank et al., 
2006b) and discussion with an expert panel. The draft questionnaire was then reviewed by a 
small representative group of patients before further review by the expert panel and 
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modification to produce a final draft version of the questionnaire. The draft PROCOG was 
then field tested:  It was validated against various neuropsychological measures in 78 
PWMCI, 75 with mild probable AD and 33 cognitively intact controls and found to have good 
psychometric properties (Frank et al., 2006a). The stated aim of the PROCOG is ‘assessing 
symptoms and patient rating of their impact on function, behaviour and HRQL’ and the 
authors suggested that the PROGOG might be used both as part of the neuropsychological 
diagnostic assessment process and in the assessment of needs for PWMCI and their carers. 
The questionnaire has subscales which measure affect, skill loss, semantic memory, recent 
memory, cognitive function, social impairment and long term memory.  There are some 
limitations to the use of the PROCOG to assess outcomes in MCI in the UK: As described 
above the focus groups interviewed in the initial development of the measure and the patient 
panel who reviewed the first draft were comprised of both people with dementia and with 
MCI; as mentioned previously in this literature review the challenges faced by PWMCI and 
people with dementia have often been shown to differ significantly and therefore the use of a 
single instrument to assess outcomes in both these groups is questionable. The PROCOG 
was designed for patient use only, no assessment tool was designed for use by caregivers -  
a potential limitation given the finding in Frank’s own study (and other studies) that PWMCI 
tend to under-report their problems when compared with informant reports. Although the 
focus group interviews with PWMCI were carried out at centres in both the United States of 
America (USA) and UK, no UK based informants were interviewed and validation of the 
PROCOG was carried out only in the USA. As there are important differences in the health 
and social care arrangements between these two countries it is unclear whether the 
PROCOG would be an appropriate tool for use assessment of PWMCI in the UK. 
As mentioned above quite a number of scales to assess outcomes in dementia exist and 
these have been commented on in various arenas: A European consensus on outcome 
measures for psychosocial intervention research in dementia care, published in 2008, 
concluded that the most appropriate outcome measures for patients covered, between them, 
the domains of quality of life (QoL), mood, global function, behaviour and ADLs (Moniz-Cook 
et al., 2008). The authors identified the Quality of Life Alzheimer’s Disease Scale (QOL-AD) 
(Logsdon et al., 2002) and the Dementia Quality of Life Instrument (DQOL) (Brod et al., 
1999) as the measures of choice for the QoL domain. Some work has been done to 
establish whether these measures might be useful in MCI, for example, a group in Japan 
examined whether the QOL-AD, might be clinically useful in MCI (Tatsumi et al., 2011). They 
concluded that the scale did appear to be valid and reliable in this group. However, the study 
was small (involving 47 PWMCI and advocates) and conducted using the Japanese version 
of the QOL-AD, no similar studies have been conducted using the English language version. 
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The Alzheimer’s Association (AA) published a report on PROs in dementia research in 2007 
in which the use of such measures was discussed in light of the draft Food and Drug 
Administration (USA) (FDA) guidance on the subject which had been published the previous 
year (Frank, 2007). In the report the authors discussed the fact that, aside from 
recommending that proxy measures be used in cognitively impaired patients, the guidance 
made little reference to this patient group; recommendations were made about the future 
development of measures for use in this area. No similar reports on the use of PROMs in 
MCI have been published. 
2.3 Caregivers’ Experience of Mild Cognitive Impairment 
2.3.1 General Experience of Caregiving in Mild Cognitive 
Impairment 
2.3.1.1 Changes Noticed 
Several qualitative studies of caregiving in MCI have been carried out and provide a 
description of the changes that such caregivers notice in the person for whom they are 
caring; those described most frequently across the literature were: behavioural changes, 
evidence of memory deficits and changes in the emotions expressed by PWMCI. 
As part of the study of  lived experiences described earlier, Lu and Haase carried out a 
qualitative exploration of the experience of spousal caregivers of people with MCI in which 
they interviewed ten people caring for spouses with MCI (at which point data saturation was 
reached) (Lu and Haase, 2009). They identified four major themes one of which was ‘putting 
the puzzle pieces together: there really is something wrong’. This theme covered the 
changes caregivers noticed in their spouses such as short term memory loss, difficulty with 
familiar tasks and changes in behaviour, emotions and social activity. Behavioural change 
was also reported by informants in a mixed methods study of care partner responses to the 
onset of MCI (Blieszner and Roberto, 2010),  Bleiszner et al.’s study of spousal caregivers 
(Blieszner et al., 2007) and Frank et al.’s qualitative study of PWMCI and mild AD (Frank et 
al., 2006b)  
Changes in personality and expressed emotion were also noted in a qualitative study of the 
experience of 10 family caregivers of PWMCI in Taiwan (Kuo and Shyu, 2010) and in Frank 
et al.’s study (where informants particularly reported increased expressions of anger by the 
PWMCI) (Frank et al., 2006b). 
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2.3.1.2 Effects on Relationships 
Several studies of caregiver experiences in MCI mention the effect on relationships with 
spouses, other family members and friends. For example, in Adams’ study of carers in MCI 
and mild AD one of the main themes was ‘changes in the relationship’, such as increased 
protectiveness towards the PWMCI (Adams, 2006). On a positive note many spousal 
caregivers in this study noted that they had maintained a loving relationship with the PWMCI 
despite their cognitive changes. 
Guided interviews with 67 married couples where one partner had a diagnosis of MCI were 
used to assess the impact on marital family life in study carried out in 2007 (Blieszner et al., 
2007). The authors identified three key themes which were consistent with the theory of 
‘ambiguous loss’ and noted that a diagnosis of MCI has far reaching effects for couples’ 
relationships. The spousal caregivers interviewed reported changed roles within the home 
and relationship and increased relationship tensions (particularly where there had been pre-
existing difficulties) – although the authors noted that most couples demonstrated a degree 
of ‘resiliency’ as they renegotiated their roles and relationships.  
Another study focusing on the experiences of spouses of PWMCI examined self-reported 
measures of perception of marital quality, MCI related behaviour and caregiver burden in the 
spouses of 27 people recently diagnosed with MCI (Garand et al., 2007). Behaviours 
exhibited by PWMCI which resulted in the highest frequency-distress rating in caregiving 
spouses were: repetitive questioning, losing items and poor recall of recent events; these 
behaviours were all associated with lower marital satisfaction. Items reflecting disrupted 
communication between couples, such as ‘decreased talk’, were shown to be negatively 
associated with marital cohesion. Interestingly, marital quality was shown to be adversely 
affected by carer burden as described subjectively but not as assessed objectively. 
Tellingly, the feelings about changes in their marital relationships that many of the caregivers 
in Lu and Haase’s study described were summarised by the statement ’my best friend is 
gone’ (Lu and Haase, 2009). The subjects in Adams’ study also described a sense of loss of 
important elements of their relationship with the PWMCI – for example loss of a confidant or 
a parental figure (Adams, 2006). 
2.3.1.3 Carer Burden 
Some of the qualitative studies in this area have provided useful information on carer burden 
in MCI. The most commonly described elements of burden relate to increased carer 
responsibility for practical, everyday matters (such as driving and handling finances), 
increased supervision of the PWMCI and a resulting decrease in the carer’s QoL. 
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One of the themes identified in Lu and Haase’s qualitative study was ‘the consequences to 
caregivers of living in a world of silence’. This incorporated the new responsibilities taken on 
by caregivers and their effects, for example: practical assistance with everyday function (e.g. 
providing supervision), increased decision making responsibilities and resulting detrimental 
effects on the caregiver’s QoL (Lu and Haase, 2009). Frank et al.’s study also found that 
informants reported that PWMCI’s roles within the family had changed and that they had 
become increasingly dependent. This resulted in substantial practical burdens on informants 
such as dealing with finances, driving and providing increased supervision (Frank et al., 
2006b).  In keeping with these findings Adams’ study of caregiving in early dementia and 
MCI also identified practical burdens on carers which included taking on new household 
tasks, managing finances and driving (Adams, 2006). The author noted that many of the 
interviewees described a ‘struggle to decide how much to do for the person with memory 
loss’ and, particularly in the MCI group, difficulties with negotiating these decisions with the 
PWMCI. Blieszner et al. also noted that many spouses worried about whether the strategies 
they used to cope were the right ones (Blieszner et al., 2007). In addition, these caregivers 
reported detrimental effects on their own social lives resulting from their increased caring 
responsibilities. 
Other studies have examined caregiver burden more quantitatively: McIlvane et al, as part of 
their questionnaire based study of people recently diagnosed with MCI, also surveyed 29 
care partners about their experiences. They found that these care partners spent an average 
of 24 hours / week assisting the PWMCI (McIlvane et al., 2008). A retrospective, notes 
based study of carers of 51 PWMCI found that about one third reported clinically significant 
perceived levels of burden and that increased burden was associated with a greater degree 
of cognitive impairment as perceived by both the PWMCI and carer and a with greater 
degree of depressed mood in the PWMCI as perceived by the carer (Bruce et al., 2008). 
However, there was no association between carer burden and cognition as objectively 
assessed on neuropsychological testing suggesting that the perceived severity of the 
PWMCI’s cognitive impairment has more effect on carer burden than the actual degree of 
cognitive impairment. Garand et al. also examined caregiver burden in their cohort of 
spousal caregivers of PWMCI (Garand et al., 2005). They identified burden resulting from a 
wide range of areas such as household and nursing tasks in addition to perceived lifestyle 
constraints at levels greater than those reported by non-caregivers but less than reported by 
carers of people with dementia.   
The results described above suggest that the subjects were caring for PWMCI with a 
relatively high level of dependency, something which might call the accuracy of their 
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diagnoses into question. However, in most of the studies cited above, MCI was diagnosed 
using the either Petersen, International Statistical Classification of Diseases and Related 
Health Problems 10th Edition (ICD-10) (World Health Organisation, 1992) or Clinical 
Dementia Rating (CDR) (Morris, 1993) criteria, usually following extensive neuropsychiatric 
and clinical evaluation in either a clinical or research setting. In the only study not to specify 
using one of these criteria (Bleiszner’s study of couples coping with MCI (Blieszner et al., 
2007)) it was specifically stated that a diagnosis of dementia in their subjects had been ruled 
out. Therefore it seems likely that the subjects in these studies were indeed caring for people 
with MCI, rather than dementia or other disorders, despite the high level of dependency they 
displayed 
2.3.1.4 Strategies and Coping 
The final theme identified in Lu and Haase’s study was ‘taking charge of care’. This included 
a description of the coping strategies caregivers developed in the course of caregiving, such 
as practical approaches (e.g. use of reminder systems) and managing their own emotional 
distress (Lu and Haase, 2009). The strategies described in other studies can also be broadly 
divided into practical / problem focused and emotion focused: Practical coping strategies 
were identified in Blieszner et al.’s study where carers described creative approaches such 
as the use of reminder systems, redefinition of roles within the relationship and adaptation of 
the their daily routine (Blieszner et al., 2007). In McIlvane et al.’s questionnaire based study 
some carers also reported problem focused strategies (such planning for the future and 
seeking support) whereas others reported emotion focused coping (e.g. acceptance, 
humour) (McIlvane et al., 2008). 
2.3.1.5 Emotional Consequences 
Unsurprisingly, given the burdens on caregivers of PWMCI and the negative effects on their 
relationships described thus far, many studies have identified negative emotional 
consequences in this group. 
One of the themes identified in Lu and Haase’s study was  ‘a downward spiral into a world of 
silence’ – this incorporated a description of intermittent periods of distress – both in response 
to the PWMCI’s functional decline and as a result of family and friends’ inability to 
understand the situation (Lu and Haase, 2009). Adams’ study also identified negative 
emotional effects on carers, particularly frustration, impatience and anger (Adams, 2006). In 
both Kuo’s and Blieszner et al.’s studies caregivers described uncertainty about the future 
coupled with anxiety about the possibility of the PWMCI developing dementia (Kuo and 
Shyu, 2010, Blieszner et al., 2007).  
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There has been some disagreement about the psychological impact on carers with MCI. 
Whereas the studies described above suggest an increased rate of NPS in MCI carers, a 
questionnaire based study found levels of depression and life satisfaction to be within normal 
limits (McIlvane et al., 2008). However, this study was small (29 carers were included) and 
secondary analysis of data for a much larger number of caregivers (769) from the 
Alzheimer’s Disease Cooperative Study MCI trial identified depressed mood in nearly a 
quarter of all MCI care givers (Lu et al., 2007b) – a prevalence that was greater than in non-
carers of a similar age (~13%) but less than in caregivers of people with AD (~ 40%). 
Factors associated with a greater risk of depressed mood were: fewer years of education in 
the carer and greater ‘relational deprivation’. Younger, non-spousal caregivers were also at 
greater risk for depression. 
Blieszner and Roberto’s mixed methods study examined the relationship between 
depressive symptoms in carers of PWMCI and various demographic factors and other 
characteristics (Blieszner and Roberto, 2010). They identified clinically significant depressive 
symptoms in 12.5% of the study population (compared with 9% in the general population) 
and found that there was an association between depressive symptoms and poorer 
knowledge of dementia, being more bothered by the memory loss of the PWMCI, having a 
greater perceived level of burden and, interestingly, having a greater level of social support. 
Areas of stress identified included the PWMCI being less likely to initiate activities, changes 
in their sleep pattern, perseveration of ‘unpleasant’ behaviour such as repetitive questioning 
and memory problems compounding pre-exiting issues such as physical ill-health. This was 
a relatively large study (with 86 subjects) which covered a wide range of issues using the 
mixed method approach; however, it is unclear whether depressive symptoms in isolation 
are a valid measure of carer experience. Garand’s study also examined levels of depression 
as well as anxiety in carers of PWMCI; these were found to be at a level between those 
reported by non-carers and carers of people with dementia. Carer depression was 
associated with a greater responsibility for nursing tasks (such as administering medication) 
and anxiety with a greater perceived lifestyle constraint (for example carers reporting having 
a lack of time for themselves) (Garand et al., 2005). 
The fact that the behaviour exhibited by PWMCI can negatively influence caregiver affect 
was confirmed in another study of spousal caregivers (Savla et al., 2011). In this study 30 
spouses living with PWMCI were assessed over a seven day period using a checklist based 
telephone interview to assess daily stressors and affect as well as salivary cortisol levels as 
a marker of physiological stress. Negative affect in caregivers was found to be associated 
with behavioural problems occurring in the evening, unpleasant interactions with the PWMCI 
and decreased participation in scheduled activities on the part of caregivers.  The authors 
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noted that it was these stressors which had the most impact rather than those related to 
caregiving per-se and as a result hypothesised that non-care related stressors affecting 
martial and social relationships may be the most significant in early cognitive decline. 
Caregivers who reported greater degrees of behavioural disturbance in their spouses were 
found to have higher levels of cortisol with less diurnal variation, consistent with a 
physiological stress reaction. 
A fourth study (Roberto’s study of family triads) also examined factors influencing the level of 
distress experienced by care partners of PWMCI (Roberto et al., 2011). The authors found 
that ‘primary stressors’ (such as witnessing changes in memory) and ‘secondary stressors 
(such as having to provide repeated reminders) were experienced by most care-partners 
regardless of the degree of acknowledgement of memory problems that they displayed. 
However, in families exhibiting a greater degree of acknowledgement care-partners were 
more able to assist the PWMCI in maintaining their previous activities and social contacts 
and seemed to cope with less distress. In families where acknowledgement was ‘complete’ 
or ‘passive’ care-partners were able to take on new responsibilities in a timely fashion 
whereas when acknowledgement was ‘partial’ or ‘absent’ the PWMCI often appeared 
reluctant to accept their changing role and care-partners reported feeling overwhelmed by 
trying to manage new responsibilities in this context. Moreover, the degree of discrepancy 
between acknowledgement in the PWMCI and their care-partner was important: where 
discrepancy existed it was most commonly due to a lack of acknowledgement on the 
PWMCI’s part and this often resulted in a degree of resistance to accepting support from 
‘outside’ sources thus resulting in increased care-partner distress. 
2.3.1.6 Attributions 
Like PWMCI, carers’ attributions for the changes they observed varied widely in the studies 
reviewed; they included many of the same explanations described by PWMCI, although 
carers described being uncertain as to the cause of such changes more frequently than the 
PWMCI did. For example, Blieszner et al., in their interviews with married couples, found that 
many experienced a period of uncertainty during which they were unsure whether there was 
a significant problem or not. During this period spouses attributed the changes they had 
noticed to a variety of causes – both ’external, uncontrollable’ (such as ‘getting older’ and 
physical health problems) and ‘internal, controllable’ (such as laziness or poor concentration) 
(Blieszner et al., 2007). Frank et al. also identified diagnostic uncertainty in the MCI 
informant group (Frank et al., 2006b).  
Aside from uncertainty, carers described a variety of attributions including ‘normal ageing’ – 
as in Beliszner et al’s study and the study of Taiwanese caregivers which concluded that 
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they tended to use a process of ‘ambivalent normalisation’ to adjust to the changes observed 
in PWMCI. As part of this process many compared the PWMCI’s condition with that of their 
peers (or even themselves) and concluded that the changes observed were part of normal 
ageing (Kuo and Shyu, 2010). 
Physical health problems were also commonly cited as an explanation for cognitive 
symptoms – for example in Bleiszner et al’s study and that of the ‘family triads’, where 
subjects were roughly equally split between those who attributed the changes in the PWMCI 
to a physical health problem, those who attributed it to a primary cognitive problem and 
those who attributed it to aspects under the PWMCI’s control e.g. concentration (Roberto et 
al., 2011).  
Finally, as mentioned above, it was not uncommon for informants to attribute the changes 
they had observed to factors under the PWMCI’s control – such as the amount of effort or 
concentration a person out into remembering something (Blieszner et al., 2007, Roberto et 
al., 2011). 
2.3.1.7 Comparison With Caregiving in Early Dementia 
The burdens associated with caring in dementia have been extensively studied. A review of 
the literature published in 2000 described the varied patient and carer factors that have been 
shown in different studies to be associated with carer burden and stress (Burns and Rabins, 
2000). The most consistent of these, identified in several studies, appeared to be personality 
change and behavioural disturbance in the patient and level of expressed emotion in the 
carer. The commonest manifestation of carer stress was found to be depression which was 
identified in up to 70% of carers. 
It is far from clear, however, whether the findings of studies of caregiving in dementia are 
applicable to caregiving in MCI. In fact, it is likely that carers of PWMCI face a number of 
different issues from dementia caregivers, for example the fact that a diagnosis of MCI 
carries a much greater degree of prognostic uncertainty than one of dementia and that these 
carers are at a much earlier stage in their caregiving career so may not yet have adapted to 
their new role. It is also likely that the different manifestations of MCI and dementia result in 
different challenges for caregivers. For example, in a study of dependence and caregiver 
burden in AD and MCI functional impairment was found to predict caregiver burden in the 
MCI group whereas the severity of NPS was the only predictor of burden in the AD group 
(Gallagher et al., 2011). In contrast, a study involving semi-structured interviews with twenty 
carers of PWMCI and dementia identified no significant differences in the experiences of 
carers in each group (Adams, 2006). However, as the study sample included only 3 subjects 
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with MCI it is difficult to be sure that data saturation would truly have been reached for this 
group and consequently there may have been issues relevant to the MCI carer group not 
identified by this study.  A review of published literature on the subject of caregiver burden in 
MCI noted that the studies reviewed had, on the whole, used the same concepts and 
theoretical constructs as studies of caregiving in dementia and that this approach may well 
be flawed due to the fact there are many aspects of caregiving in MCI which are unique 
(Werner, 2012). The conclusion to the review included the recommendation that further 
qualitative or mixed-method studies should be carried out in this area to gain a better 
understanding of the issues which are specific to MCI carers. 
Finally, it is important to remember that the extensive network of formal and informal support 
available for people with dementia and their carers is not available to most PWMCI or their 
carers and that this may increase levels of perceived burden amongst caregivers. 
2.3.2 Caregivers Experiences of Healthcare and Support Services 
Much less work has been done on the topic of caregivers’ experiences of healthcare than on 
the experiences of the PWMCI themselves. However, some of the studies of PWMCI’s 
experiences of healthcare have also examined those of their carers: In the study of patients 
and caregivers attending their first memory clinic assessment the carers, like the patients, 
reported that they found the wait between referral to memory clinic and the appointment a 
distressing and unsettling time (Cahill et al., 2008). Unlike the patients (who reported a 
general desire to be ‘helped’ by the clinic), carers in this study reported that they hoped for 
specific outcomes as a result of the assessment process, most commonly identification of 
the cause of memory problems or provision of treatment. In the Dutch study of patients and 
carers attending memory clinic the levels of satisfaction with communication of results, the 
usefulness of assessment and the clinician’s attitude were equally high in the carers and the 
patients (70-80% of both groups reported satisfaction with these aspects of their care), 
however carers reported being less satisfied with the advice and support that they received 
(with only ~20% giving a positive rating on this topic) (van Hout et al., 2001). 
In Blieszner et al.’s study of married couples many reported receiving ‘vague’ information 
about MCI from their physicians and consequently some had sought information from other 
sources such as the internet or public libraries (Blieszner et al., 2007). Those who did so 
reported finding very little information specific to MCI aimed at the general public. In the 
study of family caregivers in Taiwan many reported ‘unintentional helpseeking’ i.e. learning 
the diagnosis of MCI via a process of assessment begun when the person sought medical 
care for another (usually physical) condition (Kuo and Shyu, 2010). 
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2.3.3 Suggested Interventions 
Increased Support Needs 
Several studies have identified a need for additional support for carers of PWMCI: In a study 
comparing the support service needs of carers of PWMCI with those of cognitively normal 
controls and people with probable AD a similar need for support services was identified in 
the carers of PWMCI and those of people with probable AD, this was greater than the 
support needs of carers of normal controls (Ryan et al., 2010). The term ‘support services’ 
encompassed medical, social, community and mental health support. Assessment of support 
needs and the attributes of the PWMCI was achieved by the use of several quantitative 
scales, such as the NPI, meaning that the analysis of the reasons for the elevated support 
needs in the MCI care group was limited. However, a correlation was found between the 
support needs of carers in the MCI group and the degree of frailty of the PWMCI as well as 
with the number and frequency of NPS they displayed.  
The theme ‘taking charge of care’ identified in Lu and Haase’s study included a description 
of the needs reported by carers (Lu and Haase, 2009). The major categories of needs 
described were: information about MCI and development of skills in communication, 
caregiving skills and managing distress in the PWMCI and themselves. Adams’ interviews of 
caregivers revealed ambivalence in some about seeking both formal and informal support – 
often due to concerns about placing burden on other family members  or the opinion that it 
was ‘too early’ in the course of the disease to seek formal help (Adams, 2006). 
Relevant Studies in Dementia 
A great deal of research into caregiver interventions in dementia has been published and 
forms a useful backdrop for designing potential guidance for services managing PWMCI and 
their carers. For example, Burns and Rabin’s review of carer burden in dementia (Burns and 
Rabins, 2000) (which included outcomes other than burden rating scales) concluded that 
there is evidence that interventions aimed at both patients and carers can reduce 
behavioural problems, improve mood in both patients and carers and decrease rates of 
nursing home placement in dementia. The most effective interventions reviewed appeared to 
be those directed at behaviour, often in the form of family or individual counseling or support 
groups. A meta-analysis of 127 controlled intervention studies in dementia caregivers also 
identified small but significant effects on burden, depression, subjective well-being, ability 
and knowledge ratings following caregiver interventions (Pinquart and Sorensen, 2006). 
Active participation in psycho-educational programmes in which information about dementia 
and caregiver support was provided seemed to be the most effective intervention. A reduced 
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risk of admission to long term care was also identified, but only following multicomponent 
interventions (i.e. those combining at least two types of intervention). The authors caution, 
however, that the effect sizes where identified were small and tended to diminish with time 
(particularly in the case of subjective well-being). As discussed above, however, the 
applicability of the finding of these studies to caregivers of PWMCI may well be limited. 
Suggested Interventions 
Few studies have assessed the efficacy of interventions specifically for caregivers for people 
with MCI. However, several of the observational studies which have focused on the 
difficulties faced by PWMCI and their carers have included recommendations for 
interventions that might prove effective in light of the study’s findings – a number of which 
recur across the literature: 
A common recommendation was the provision of information about various aspects of MCI, 
for example as recommended by Joosten-Weyn, Adams and Kuo and Shyu following their 
studies of PWMCI (Joosten-Weyn Banningh et al., 2008, Adams, 2006, Kuo and Shyu, 
2010). Austom and Lu conducted a review of the literature about caregiving in MCI and 
relevant work on assisting carers of people with early dementia (Austrom and Lu, 2009) in 
2009. They noted that the evidence for effectiveness of educational and psychological 
interventions in people caring for patients with AD had been mixed. Nonetheless, they made 
several recommendations regarding interventions in MCI including that information about 
sources of legal and financial advice should be offered and that carers should be educated 
about the nature of MCI. Blieszner et al. also advocated the provision of information specific 
to MCI, both in print and on the internet, covering topics such as the cause, helpful 
interventions for symptoms and techniques which might be employed to allow PWMCI to live 
as full a life as possible (Blieszner et al., 2007). The authors of the study of family triads 
suggested that, in light of their findings, information and support might be tailored to the type 
of acknowledgement displayed by the family: Where acknowledgement is limited they 
postulated that the provision of detailed information about the pathogenesis of MCI and 
guidance on management and sources of support would be helpful (Roberto et al., 2011). 
Like Blieszner et al., several authors recommended that, in addition to basic information 
about MCI, caregivers should be provided with strategies to assist the PWMCI and enhance 
coping in everyday life. For example, both Austom and Lu and Lu et al.’s papers 
recommended that family caregivers should be advised on how best to assist PWMCI in 
remaining independently engaged in their usual activities and social networks (Lu et al., 
2007a, Austrom and Lu, 2009) and the authors of the Taiwanese study recommended that 
caregivers should be helped to develop strategies to avoid conflict with the PWMCI. The 
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conclusions of the study on daily stressors, psychological well-being and cortisol levels in 
spouses of people with MCI suggested that, in light of their findings (which suggested a 
physiological stress reaction in this group of caregivers), efforts should be made to teach 
effective stress management to this group (Savla et al., 2011). The authors of the study of 
family triads suggested that advice on the development of useful strategies might be helpful 
for caregivers where there is full acknowledgement of MCI (Roberto et al., 2011). 
Another common recommendation in the literature was the provision of psychosocial training 
or support to caregivers (Joosten-Weyn Banningh et al., 2008, Adams, 2006). In their review 
Austrom and Lu recommended that attention should be paid to psychological health via the 
provision of family therapy and / or support groups and that education of both carers and 
PWMCI should include information about the features of depression with encouragement to 
seek assessment should they develop symptoms (Austrom and Lu, 2009). The authors of 
the study of couples coping with MCI also recommended group and individual interventions 
such as family therapy, counseling and MCI specific support groups (Blieszner et al., 2007).  
Many authors emphasised the importance of early assessment and intervention for 
caregivers. For example Austrom and Lu recommended that information should be offered to 
caregivers early on as part of an emphasis on planning for the future (Austrom and Lu, 
2009), Blieszner et al.’s and Adams’ papers both recommended that psychosocial 
interventions should be offered early (Blieszner et al., 2007, Adams, 2006) and Savla 
recommended that stress management skills be taught at the beginning of the caregiving 
career (Savla et al., 2011). Lu and Haase also recommended that any interventions should 
be offered early in order to capitalise on the period when the insight of the PWMCI is 
preserved (Lu et al., 2007a). 
In their study of spousal caregivers of PWMCI Lu and Haase noted the lack of proven 
interventions for this group and concluded that ‘there is a critical need to develop an early 
intervention that can help MCI patient-carer dyads modify behaviour, compensate for 
deficits, and minimize negative outcomes from conflicts associated with those deficits (Lu and 
Haase, 2009). The resulting DEMA programme designed for use in both PWMCI and their 
caregivers is described in the section on ‘Patient Experiences of Healthcare and Support 
Services - Suggested Interventions and Support’ (Lu and Haase, 2011). In the study 
examining validity of the DEMA, in addition to the general comments on content, the 
caregiver focus group made specific recommendations about the format of educational 
material provided (e.g. the avoidance of abbreviations in material designed for the PWMCI) 
and requested that they be provided with separate information to the PWMCI with more 
advanced content. The authors concluded that their findings ‘support the importance of 
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integrating family members into interventions designed for PWMCI, because it provides a 
foundation of support as family members move to a greater caregiving role.’ 
2.3.4 ‘Self-Reported’ Outcome Measures for Carers of People with 
Mild Cognitive Impairment 
No articles on self-reported outcome measures for use in caregivers of PWMCI were 
identified by the literature review. Some work has been done on this topic in dementia 
caregivers, for example the authors of the ‘European consensus on outcome measures for 
psychosocial intervention research in dementia care’, as well as examining the most 
appropriate outcome measures for patients, also commented on the best scales to use for 
their caregivers (Moniz-Cook et al., 2008). The measures they identified for use in family 
caregivers covered the domains of mood and burden (incorporating coping and QoL) with 
those measuring QoL falling into two categories: ‘generic’ health-related QoL scales such as 
the Short Form Health Survey (SF) scales (Ware and Sherbourne, 1992) and disease 
specific measures. They commented that, while many of the health related QoL scales had 
good psychometric properties they had not been validated specifically for use in caregivers 
of people with dementia. Disease specific scales were also mentioned, such as that 
developed in the French PIXEL study (Thomas et al., 2006), but it was noted that these 
required further validation before their use could be recommended.  Whilst it may be that 
general health related QoL scales could be used as a valid measure of QoL in carers of 
PWMCI there is no published literature to support this, nor have any disease specific, self–
reported scales for measuring outcomes in this group been published. 
2.4 Limitations of the Studies Discussed 
Most studies reviewed here examined the experiences of spousal caregivers which limits the 
information available on issues relevant to non-spousal caregivers such as grown-up 
children. Non-spousal caregivers are likely to experience a different set of concerns given 
that their circumstances tend to be different from spousal caregivers e.g. they usually live 
separately from the PWMCI and often have additional responsibilities such as childcare and 
employment. The Alzheimer’s Disease Cooperative Study (Lu et al., 2007b) did find that that 
younger, non-spousal carers had greater rates of depression which supports the hypothesis 
that the experience of caregiving is different in some way for non-spousal carers. 
Another limitation common to most of the studies reviewed is that subjects were almost 
exclusively Caucasian - there is very little information about carer experiences in ethnic 
minorities. Although several of the studies were carried out in countries other than the UK or 
USA (e.g. Holland and Taiwan) no subjects in these studies were ‘ethnic minorities’ in this 
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context as all interviewees were living in their country of origin. Most of the themes identified 
in studies conducted in the various countries were similar or identical with only occasional 
exceptions – such as the phenomenon of ‘unintentional help seeking’ which was only 
identified in the study conducted in Taiwan. This may reflect cultural differences in attitudes 
to illness and interaction with health services. 
All these studies, including those employing quantitative research methods, had relatively 
small sample sizes and most were observational, meaning that limited conclusions about 
causality are possible. Most studies were cross sectional in design therefore little is known 
about how the experiences and support needs of PWMCI and their carers change over time. 
2.5 Summary 
Evidence regarding the experiences of PWMCI and their carers is limited and evidence for 
successful interventions in this group almost non-existent (although some studies in patients 
with early dementia may be relevant). 
The studies which have been done suggest that PWMCI experience a range of cognitive, 
neuropsychiatric and practical issues (such as difficulty completing complex ADLs). They 
face uncertainty about their condition and about the future and, in the face of this, often 
attribute their symptoms to ‘normal ageing’. It may be that PWMCI under-report their 
problems due to reduced insight secondary to their MCI. Carers experience a range of 
emotions (mainly negative) and new responsibilities for which they are obliged to develop 
practical solutions. Relationships between PWMCI and carers often change as they adapt to 
their new roles and carers face significant uncertainty about the future. 
Few studies of cognitive or psychosocial interventions have been carried out in MCI; those 
which have been done have found that psychoeducational and multicomponent programmes 
have been most successful in improving outcomes for patients. Various strategies have 
been suggested by the authors of the observational studies of MCI reviewed here. The most 
commonly suggested interventions include provision of information about MCI and practical 
matters such as sources of legal and financial support, psychosocial training (via individual 
counseling or support groups) and the teaching of strategies to enhance communication 
skills and coping. Most authors emphasise the importance of early, individualised needs 
assessment and intervention. Only one PROM designed specifically for use in MCI exists 
and this was developed in a mixed sample of PWCMI and AD, no equivalent measures exist 
for use in caregivers of PWMCI. 
In conclusion, the findings described here suggest that there is a need for a focused 
exploration of the experiences of people living with MCI and their carers, with particular 
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reference to healthcare, so that valid outcome measures can be developed to evaluate the 
health of these groups and appropriate improvements to services may be suggested. 
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Chapter 3: Interviews 
3.1 Introduction 
In the first part of the study in-depth, semi-structured interviews were carried out with people 
with mild cognitive impairment (PWMCI)  and their advocates in order to gather detailed 
information about the experiences of these groups. In the first part of this chapter the 
interview methodology is described – including details of the development of the interview 
topic guides, recruitment of study subjects, conduct of the interviews and analysis of the 
resulting data.  The advantages and limitations of the methods used are also discussed. In 
the second part of the chapter the results of qualitative analysis of the interview data for 
patients and advocates are described. In the final part of the chapter the results of the 
patient and advocate interviews are discussed and compared, both with each other and with 
the existing literature on the topic 
3.2 Interview Methodology  
3.2.1 Development of Interview Topic Guides 
Initial topic guides for the patient and advocate interviews were developed based on the 
themes which had been found to recur frequently in the literature review described in 
Chapter 2. The broad areas covered by the interview guides for both groups were: the 
impact of mild cognitive impairment (MCI) on subjects’ daily life, their experiences of 
healthcare services (both the general practitioner (GP) and Memory Services), suggested 
improvements to these services and their current sources of information and support. An 
iterative process was used to alter the topic guides to include novel subjects introduced by 
interviewees as the interviews progressed. The final topic lists for patient and advocate 
interviews are given in Appendix 1 
3.2.2 Recruitment 
A purposive sample of PWMCI was identified from memory clinics (and ‘analogous services’) 
in the UK in Oxfordshire, Buckinghamshire, Berkshire, Northamptonshire and Essex, from 
research databases in Oxfordshire and Essex and via advertisements (in the form of posters 
and patient leaflets) placed in clinical areas in these regions. ‘Analogous services’ were 
defined as ‘equivalent memory services being provided outside the ‘traditional’ setting of a 
hospital outpatient memory clinic’, for example services provided in the patient’s home by 
community mental health teams (CMHTs).   
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PWMCI included were aged 50 years or older and had all been diagnosed with MCI in a 
memory clinic (or analogous service), using the clinical criteria applied by the clinician 
making the diagnosis, within 6 months of recruitment. In addition, eligible subjects had an 
absence of: any significant barrier to communication, current ‘International Statistical 
Classification of Diseases and Related Health Problems’ (ICD-10) based major psychiatric 
disorder or clinically significant or unstable medical condition that could account for their 
cognitive deficits.  
Patients recruited from clinic were approached at their appointment with initial information 
about the study. If they expressed an interest in taking part in the study they were asked to 
complete a form giving their contact details and consent for their medical notes to be viewed 
for the purposes of research. The details were passed on to the author who screened each 
patient’s medical notes to ensure that they were eligible for inclusion in the study (as per the 
criteria above). Patients who were eligible were sent full information about the study by post 
and contacted by telephone two weeks later to arrange an appointment for interview. 
Patients who had been clinically assessed within 6 months and diagnosed with MCI were 
identified from the following research databases: 
• Derwent Memory Clinic Research database 
• The ‘Dementia and Neurodegenerative Diseases Research Network’ (DeNDRoN) 
research database for Oxfordshire Health Trust 
• The ‘Dementia Electronic Prescribing and Research Contact System’ (DEEPARC) 
database 
• The ‘Oxford Project to Investigate Memory and Aging’ (OPTIMA) database. 
All patients with details recorded on these databases had given prior written consent to 
being contacted for the purposes of research. Patients identified from the database were 
sent full information about the study by post, including a form to complete giving their contact 
details and consent for their medical notes to be viewed for the purposes of research which 
they were asked to return if they were interested in taking part in the study. When reply 
forms were received the author screened each patient’s medical notes to ensure that they 
were eligible for inclusion in the study (as per the criteria above). PWMCI who were eligible 
were then contacted by telephone to arrange an appointment for interview. PWMCI who did 
not return a reply form within two weeks of being sent full study information were sent a 
reminder letter; if no reply form was received subsequent to this they were not contacted 
about the study again. 
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PWMCI who contacted the researcher having seen an advertisement for the study were sent 
full study information by post and recruitment proceeded as for PWMCI identified from the 
research databases as described above. 
Advocates were recruited via PWMCI. An advocate was defined as ‘a relative or friend who 
the patient felt had been affected by their memory problems’ (often a spouse or other family 
member). When the PWMCI was sent full study information by post an ‘advocate recruitment 
pack’, comprising an information sheet, covering letter and reply form was included. When 
the patient was telephoned to arrange an interview they were asked whether they were in 
contact with anyone who might be a suitable advocate whom they would be happy for the 
researcher to interview. If the patient identified a suitable advocate they were asked to pass 
the ‘recruitment pack’ on to that person. Information included in the ‘recruitment pack’ 
instructed the advocate to complete the reply form with their details and return it to the 
researcher if they wished to take part in the study. When the reply form was received by the 
author the advocate was telephoned to arrange an interview. 
Examples of the relevant study literature – including information sheets and consent forms – 
are included in Appendix 2. 
Interviews were continued until data saturation was reached i.e. the point at which new 
interview data provided no new information in terms of codes identified by qualitative data 
analysis. It was hypothesised, based on the previous experience of one of the supervisors of 
this research (CJ), that this would occur after approximately 25 patient and 25 advocate 
interviews and this was therefore the recruitment target. 
3.2.3 Conduct of Interviews 
Approval for this study was obtained from the Southampton and South West Hampshire 
Research Ethics Committee (REC) (B) and the Research and Development (R&D) 
Departments of each hospital trust involved.  Written informed consent was obtained prior to 
each interview. 
Semi-structured interviews were conducted with PWMCI and advocates at a location of their 
choosing: either their home, the home of a friend or relative or a hospital outpatient 
department. Interviews were conducted in a private room and PWMCI and advocates were 
interviewed separately (unless both expressed a strong desire to be interviewed together) in 
order to maintain confidentiality and encourage freedom of expression. Respondent 
validation was carried out towards the end of each interview by summarising the key points 
of the discussion and confirming that the subject agreed with their accuracy. In addition to 
the semi-structured interview the ‘Hospital Anxiety and Depression Scale (Zigmond and 
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Snaith, 1983)’ (HADS) was administered to PWMCI and information was collected (either 
from patient notes at screening, or via the information gathered at interview) as to whether 
the Petersen criteria (Petersen et al., 2001b) for diagnosis of MCI were fulfilled. The Mini 
Mental State Examination (MMSE) score (Folstein et al., 1975) at the time of diagnosis was 
also noted if this was available in the subject’s clinical notes at screening. 
Interviews were recorded and analysed anonymously with only the author aware of the 
identity of each subject. The majority of interviews (19 of those with PWMCI and 17 those 
with advocates) were carried out by the author in order to maintain consistency in 
questioning style and topics. At one point during the recruitment process there was a high 
volume of simultaneous referrals and therefore another interviewer completed some 
interviews: four patient and two advocate interviews were carried out by Mrs Claire Merritt 
(CM) who had extensive experience both in community psychiatric nursing and research, 
including conducting semi-structured interviews. Most interviews lasted between 30 minutes 
and one hour. 
Where scores from the HADS suggested symptoms of anxiety or depression of moderate 
severity or greater the subject’s GP was informed in writing (if the subject consented to it). 
The subject’s GP was also informed (again, with the subject’s consent) if any issues were 
identified during the interview with which either the subject or interviewer felt the GP could 
be of assistance. 
3.2.4 Data Analysis  
The audio-recorded interviews were professionally transcribed and the transcripts checked 
for accuracy by the researcher who read each transcript whilst listening to the audio file. 
Transcripts were then coded by the researcher in a two stage process using an inductive 
approach: in an initial line-by-line reading, open coding was used i.e. the concepts identified 
were given labels (‘codes’) and categories were developed into which these concepts were 
grouped. Once this initial process was completed, an analytic framework was developed and 
focussed coding of the transcripts was carried out using this framework i.e. codes and 
categories were eliminated, combined or subdivided as recurring ideas and underlying 
themes connecting the codes were identified. NVivo software (version 9) was used to 
organise the data and assist with analysis. This thematic analysis was conducted in parallel 
with the interviews to allow monitoring for data saturation and addition of any new themes 
emerging from the data to the interview topic guide.  
56 
 
 
 
3.2.5 Discussion of Methodology 
3.2.5.1 Advantages of Method and Methodology 
The overall approach used in the study, (i.e. in-depth interviews and, later, subject 
questionnaires), was chosen so that a detailed picture of subjects’ own experiences might be 
built up. Grounded theory methods were chosen as the most appropriate approach for the 
first part of this study (to generate items for the outcome measures and healthcare 
experience survey) as there has been relatively little research in this area and hence existing 
information about the concerns of PWMCI and their advocates is limited i.e. it is an 
undocumented phenomenon. The use of semi-structured interviews allowed subjects to 
raise issues of importance to them whilst ensuring that information about matters of 
particular interest to the researcher, such as healthcare services, was also gained. 
The PWMCI in this study were recruited from a number of sources in various geographical 
areas with different healthcare arrangements. As a result the subjects recruited had had 
experience of a range of services and the study results are more broadly applicable than had 
recruitment been from a single clinic. Advocates were recruited via PWMCI to ensure that 
patient confidentiality was maintained. No advocate was interviewed without express verbal 
and written consent from the linked patient and no advocates were interviewed unless a 
linked patient was taking part in the study. 
The inclusion criterion that PWMCI should be 50 years of age or older was selected to 
maximise the likelihood that the diagnosis was accurate as it is known that the incidence of 
MCI increases with age (Ritchie, 2004, Luck et al., 2010b) hence the pre-test probability of 
MCI is greater in older patients. The criteria that subjects should not have significant medical 
or psychiatric comorbidities were also chosen to increase the probability that the MCI 
diagnosis was accurate. That subjects must have been diagnosed with MCI not more than 
six months before recruitment was stipulated in order to maximise recall of subjects’ 
concerns before and around the time of diagnosis and to minimise the risk that the subject 
might have developed dementia prior to interview. Evidence suggests that in MCI cognitive 
scores such as the mini-mental state examination (MMSE) tend to remain relatively stable 
over a 6 month period (Petersen et al., 2001b). It was important that subjects had no 
significant barrier to communication to allow a fluent interview process and accurate 
transcription and analysis. A diagnosis of MCI made using the criteria used in the clinic 
(rather than one based on research criteria) regardless of subtype was used for the inclusion 
criteria to ensure that the study results would be as widely applicable to actual clinical 
practice as possible. Due to the nature of recruitment and the referral process, explicit 
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details of the diagnostic criteria applied were not always available. However, in those cases 
where these details were obtained (e.g. where the clinical notes gave sufficient information) 
it appeared that most clinicians had applied criteria similar to the Petersen criteria i.e. 
subjective memory complaint, cognitive impairment on testing, largely intact activities of daily 
living and not meeting the criteria for dementia. Advocates were defined as any friend or 
relative the patient felt had been affected by their MCI so as to broaden this category as 
much as possible and not limit it to spouses who have been the main focus of research into 
‘caregiving’ in MCI thus far.  
Where possible, interviews with PWMCI and their linked advocates were carried out 
separately. This allowed preservation of confidentiality and encouraged subjects to speak 
freely, often broaching subjects they might not have done in presence of study partner. 
Indeed, it was noted that some subjects lowered their voices when discussing sensitive 
topics during interviews indicating that they did not wish to be overheard and suggesting that 
they would not have discussed that particular issue in the presence of the linked subject. 
Separate interviews allowed comparison of the attitudes and understanding within PWMCI-
advocate dyads. This approach also allowed discrepancies in the accounts of linked study 
partners to become apparent, unlike in joint interviews where each may have been 
influenced or prompted by the other’s responses. 
Although the inclusion criteria stipulated that diagnosis of MCI could be made by whichever 
criteria were used by the diagnosing clinician, information about whether each patient met 
the diagnostic criteria described by Petersen was collected in order to allow comparison of 
the results of this study to other work in the field (as Petersen’s criteria are the most 
commonly used in research). Information about symptoms of anxiety and depression was 
collected for each patient using the HADS. This allowed analysis of the incidence of these 
neuropsychiatric symptoms (NPS) in the MCI group. 
Respondent validation was carried out during the interviews i.e. the information that had 
been discussed was briefly summarised by the interviewer and repeated back to the 
interviewee in order to verify accuracy.  This process helped maximise the accuracy and 
internal and external validity of the findings. 
Interview data were analysed inductively (as per grounded theory); this allowed subjects’ 
opinions to determine the results of the first part of the study and hence dictate the content 
of the resulting questionnaires as far as possible. The overall approach used in this study, 
including inductive analysis, was chosen to allow the development of outcome measures 
that are patient (or advocate) response guided. Coding was primarily carried out by the 
author and she maintained overall responsibility for coding to ensure consistency was 
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maintained. The emerging coding scheme was reviewed and discussed with other 
researchers experienced in this field until 100% agreement was reached.  
3.2.5.2 Limitations of Method and Methodology  
ETHICAL APPROVAL AND RECRUITMENT  
The process of obtaining ethical and research approval from the REC and the R&D 
departments of the five different hospital trusts involved was time consuming and involved a 
heavy administrative burden. Some difficulties with recruitment occurred as a result of the 
burden of paperwork, mandated by REC guidance, which involvement with the study 
incurred for research staff and participating subjects. For example a ‘double-consent’ 
process was requested by the ethics committee, this involved all interested potential 
participants having to complete an ‘initial’ consent form to indicate that they consented to 
being contacted by the author. As a result, staff at some participating sites were reluctant to 
take part in recruitment because it involved seeking this ‘informed consent ’and there were 
some administrative challenges involved in ensuring that all sites had supplies of the 
appropriate paperwork. Participants recruited from research databases were sent a large 
volume of paperwork comprising a covering letter, information sheet, consent to contact form 
and information for their linked advocate which included the logos of both the local NHS trust 
and the study sponsor (the University of Oxford). For some potential participants this caused 
some confusion and reluctance to take part in the study. Some of the participants with MCI 
also found the process of having to complete the initial consent form and return it by post 
confusing and delegated this to their advocate. 
In some of the centres involved in recruitment to the study it was routine practice for the 
diagnosis to be made following a multidisciplinary team meeting after the patient’s initial 
clinic assessment but for the diagnosis not to be communicated to the patient until their 
follow up appointment which usually occurred six months after the initial appointment. This 
meant that by the time the patient was aware of their diagnosis they were no longer eligible 
for the study as the diagnosis had been made more than 6 months previously. 
Several methods were adopted to increase recruitment in the face of the challenges 
described above: Where clinic patients expressed an interest in taking part in research but 
recruitment paperwork was not available in clinic or there was insufficient time to complete it 
research staff and clinicians were encouraged to enter the patient’s details onto the local 
research database (with their permission) and inform the author that this had occurred. The 
author was then able to approach the patient via the research database. In some areas 
subjects listed on research databases were contacted by a local member of research staff by 
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telephone to give them some brief information about the study and find out whether they 
would be interested in receiving information about it. This helped to address the issue of 
subjects being unclear about why they had been contacted about the study, particularly for 
those not in the Oxford area. About half way through the recruitment process a 
teleconference was held with research staff from participating sites in order to remind them 
about the study and discuss approaches for increasing recruitment. 
INTERVIEW PROCESS 
A potential limitation of interviewing subjects some time after diagnosis is that the anxieties 
and uncertainties engendered by their memory problems may have been dispelled at the 
time of diagnosis and be difficult to recall several months later. However, existing evidence 
(Frank et al., 2006b, Lu et al., 2007a, Kuo and Shyu, 2010) suggests that one of the 
attributes particular to receiving a diagnosis of MCI is the uncertainty this causes and it 
therefore seems unlikely that subjects would have no further concerns after receiving this 
diagnosis. 
The recruitment procedure may have resulted in an element of selection bias in that those 
people who had experienced greater dissatisfaction with healthcare services may have been 
more likely to respond to the invitation to take part in the study so that they could have their 
complaints heard. However, the data from the interviews does not suggest that a large 
proportion of the PWMCI interviewed were particularly dissatisfied with the care they had 
received. 
On interviewing PWMCI, particularly when comparing their responses with those of linked 
advocates’, it became apparent that many had difficulty recalling the diagnostic process and 
some had limited insight into their difficulties. Although this limited the information about the 
exact process of assessment at memory clinic which could be obtained from the PWMCI, the 
fact that many had little recall of what was often a fairly lengthy diagnostic process was an 
interesting finding in itself. As most PWMCI had a linked advocate with good recall of the 
medical assessment process the advocates were usually able to supply at least some of the 
details which the PWMCI was unable to remember. It also became apparent during the 
interviews that not all subjects, in fact very few of them, were aware of the term ‘mild 
cognitive impairment’ as applied to the PWMCI’s memory problems.  Although this limited 
discussion of their understanding of the term this finding is a valid comment on the 
diagnostic disclosure process.  
It was noted, particularly in early interviews, that subjects had a tendency to continue talking 
about relevant topics after the interview had been officially concluded and the audio-
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recording stopped. In early interviews this was addressed by the use of additional field notes 
to capture these issues, the notes were subsequently transcribed and uploaded to NVivo for 
coding. In subsequent interviews efforts were made to make the audio-recording process as 
unobtrusive as possible to remove the distinction between the artificial setting of ‘the 
interview’ and more general conversation, in which the subject might be more relaxed and 
expansive. The interview procedure was also altered so that audio-recording was continued 
until the subject (or interviewer if the interview was has taken place at the subject’s home) 
was preparing to leave to ensure that all relevant comments were captured as far as 
possible. 
Another phenomenon noted in early interviews was that of the interviewer (the author) being 
perceived by subjects in a ‘doctor role’ which resulted in subjects asking her questions about 
medical issues. This had the effect of interrupting the subject’s narrative and introduced the 
risk that the interviewer’s answer would influence the subject’s subsequent responses. In 
order to address this difficulty, the interviewer’s introductory comments were modified to shift 
emphasis away from her being a ‘clinical doctor’ onto being a ‘researcher’. In addition 
subjects were asked to keep any clinical questions for the end of the interview at which point 
the researcher gave general information where appropriate or directed subjects to their own 
healthcare provider. Administration of the HADS questionnaire, which has a somewhat 
‘medical’ emphasis, was moved to end of interview in order to avoid introducing medical 
connotations at the beginning of the session. The additional researcher (CM) who carried out 
some interviews during a period where quite a number of simultaneous referrals were 
received at once was not a medical doctor. The themes apparent in the interviews 
conducted by CM were not substantially different to those in the interviews carried out by the 
author – this suggests that the adjustments described above did prevent subjects from being 
unduly influenced by the author’s medical background. 
Although the majority of subjects agreed to be interviewed separately some PWMCI-
advocate dyads wished to be interviewed together. Although these interviews remained 
revealing it was more difficult to get an accurate picture of each subject’s individual 
recollections and concerns, particularly as the PWMCI tended to defer to advocates in 
matters where recall of particular events was required e.g. the process of assessment at 
memory clinic. One positive aspect of interviewing PWMCI and advocates together was the 
enhanced opportunity it provided to detect discrepancies between recall of events on the 
part of the PWMCI and their linked advocate. 
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DATA ANALYSIS 
Although it is not possible to conduct this type of qualitative analysis without some degree of 
bias resulting from background reading and personal experiences the effect of this was 
minimised by remaining vigilant for undue prejudice whilst analysing the data. 
  
62 
 
 
 
3.3 Interview results 
 
3.3.1 Descriptive Results of Interviews of People with Mild 
Cognitive Impairment 
3.3.1.1 General Description of Interviews 
In total 23 semi-structured interviews were carried out with people with mild cognitive 
impairment (PWMCI), 19 of these were conducted by the author and 4 by another 
researcher (CM). 19 of the interviews were carried out with the subject alone and 4 in the 
presence of the advocate. Interview durations ranged from 15 – 52 minutes, with a mean of 
31 minutes. Participants were aged between 63 and 86 years old with a mean age of 77.8 
years. Thirteen interviewees were male and 10 were female, all were of White British origin. 
Mini-mental state examination (MMSE) (Folstein et al., 1975) scores were available for 14 of 
the subjects interviewed, the mean MMSE for these subjects was 26.9 (range 22 – 30). 
Sixteen of the subjects met the Petersen diagnostic criteria for mild cognitive impairment 
(MCI) (Petersen et al., 1999). Hospital Anxiety and Depression Scale Scores (Zigmond and 
Snaith, 1983) measured at the time of interview ranged between 1 and 20 with a mean of 
11.3.  
In the description of the interview results given below individual subjects are referred to by 
their unique identifier which has the format letter00number. 
All subjects interviewed were happy to discuss all topics on the interview guide – none 
declined to discuss a particular topic, although occasionally some were less expansive when 
discussing their memory problems than other, more general topics. Subjects commonly used 
humour and none displayed evidence of frank emotional distress during their interview. In 
many cases there was evidence that subjects had limited recall regarding their experiences 
and reduced insight into their limitations: In a number of interviews there were 
inconsistencies either within the patient’s own account or between their descriptions and 
those of the linked advocate. Subjects often freely admitted that they were unable to recall 
certain details, particularly those relating to the process of assessment at the memory clinic, 
for example: 
Interviewer: And how did you find going to the memory clinic? 
E001:  Dare I say I can't remember (laughs) 
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Some subjects appeared to attempt to minimize their problems – be it consciously or 
subconsciously - when their accounts were compared with those of their linked advocates. 
Others demonstrated awareness that their insight into their limitations might be limited, for 
example: 
U006: I feel that 90% of the time I’m as right as ninepence (laughs). That’s how I feel. But, of 
course, I don’t know how other pe’, what other people are having to put up with, do I? 
Several subjects appeared to attempt to ‘cover up’ their lack of recall by moving the 
discussion away from their own experiences onto a more general discussion, or by  
recounting anecdotes unrelated to the topic at hand.  
The themes emerging from the interviews carried out by the two researchers (the author and 
CM) were very similar. 
3.3.1.2 Challenges Presented by Mild Cognitive Impairment and 
Coping Strategies Developed 
The vast majority of problems noticed by subjects as a result of MCI were related to recall. 
Most commonly this manifested as difficulties remembering recent events or conversations, 
the names of friends, future plans such as appointments and the location of items around the 
house. Several reported that problems with naming extended to objects and that their verbal 
fluency was affected by word finding difficulties. A number of subjects said that they had also 
developed difficulty with writing and reading comprehension. Some subjects described 
increasing difficulty with general activities of daily living, particularly managing personal 
paperwork and finances and some reported episodes of spatial disorientation and impaired 
driving skills. As a result a small number reported that they had become increasingly reliant 
on their spouse. Many subjects described the detrimental effect that their cognitive problems 
had had on their social lives and ability to continue with hobbies that they had previously 
enjoyed. A perceived change in personality, sometimes associated with decreased self-
confidence, was reported by about half the subjects and a number reported feeling ‘generally 
slowed down’. 
A minority of subjects reported that, although they recognized that they had a memory 
problem, it had not had any significant impact on their daily life, for example:  
Interviewer: And the problems that you've had with remembering, does it have much impact 
on your day-to-day life? 
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D007: That's a good question, that. No, I don't think it does. Because I keep a diary, and I 
write down all the people I have to go and see, and also the engagements I've got. 
Given the age group of the subjects interviewed it is not surprising that a number reported 
having concurrent medical conditions, such as arthritis and cardiac failure, which adversely 
affected their quality of life. It was not uncommon for these subjects to report either being 
more concerned about, or more limited by, their physical health problems than the symptoms 
of their MCI, for example: 
D003: Two or three of the things that really irritate me: Not being able to write a decent 
(sentence)... That's really the, umm…result of the TIA, because my hand hasn't got much by 
the way of delicacy about it. 
A similar view was expressed by another subject who had physical limitations due to ill 
health: 
 
E005: Both my hands are useless basically. Small things cannot be held. I've had operations, 
but not successful….and this is the thing that depresses me (gesturing to hands), not that 
(referring to memory problems).  
Many subjects reported being aware that their memory problems had an impact on 
relationships with those around them – most commonly a negative impact on a relationship 
with a cohabiting spouse. The most frequently reported impact was frustration or irritation 
arising between the couple as a result of memory lapses, for example: 
D002: The only problem I have is my dear wife, she gets so upset. And when I ask her to tell 
me something, instead of saying “Darling, it’s so-and-so” she goes (in a loud voice) “It’s so-
and-so”. And I (say)“Oh, tell me off then, see if I care”. 
Another interviewee remarked: 
 
R001: I think sometimes it can be a bit exasperating for him, you know, if it's something like, 
some small arrangement we've made and, and you know, it's, I've forgotten it. 
Several subjects reported being concerned about the distress that their condition caused 
their spouse, for example: 
D003: And it's distressing to (my wife) when I can't remember when you're coming… or what 
plane our granddaughter's caught this morning and so on. It's everyday minutiae really, and 
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it, it does cause a certain amount of marital irritation. (whispers) (My wife’s) dad had 
dementia, so she's very sensitive about that. 
There was a roughly equal split between those subjects who reported openly discussing 
their memory problems with their spouses and those who said they did not. Subjects who did 
not discuss their difficulties with their spouse said that this was either because they felt there 
was no need to do so or because they found it difficult. A significant minority of subjects had 
not discussed the subject with other family members, such as their grown-up children, most 
often for fear of adding burden to what they perceived as their already very busy lives. 
Interestingly, in contrast to this, many subjects had discussed their memory problems with 
friends, saying either that they had no hesitation in doing so as they did not feel that their 
memory was much worse than their peers or that they valued the support that their friends 
were able to offer once they were made aware of their difficulties. For example: 
Interviewer: And do you mind people knowing particularly? 
D013: Not particularly. Because I think if they know and they see some of the loss I get into, 
if that's the best word, they don't bat an eyelid. Because they know that's what's happening, 
you know. 
Interviewer: So it's reassuring to know that they understand why... 
D013: They sometimes try to help me by telling me what we were talking about before. 
Where subjects described strategies they had developed to cope with the challenges 
presented by their symptoms of MCI these almost exclusively related to the use of written 
reminders – either produced themselves, for example personal diaries, or by family 
members, for example reminder notes left around the house. About a third of subjects 
admitted to attempting to cover up their difficulties for fear of causing embarrassment, for 
example:  
R002: Sometimes somebody comes up…and says “We haven't met for years have we? And 
how's (your wife)? How are things? Did you get on all right with that holiday?” I haven't the 
faintest idea who they are or what they're talking about. Of course, I have to pretend I do, 
don't I? (laughs) Otherwise she might think I was rude. 
Some reported attempting to overcome their difficulties by greater ‘mental effort’, for 
example trying to pay more attention in an effort to retain information. 
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3.3.1.3 Feelings About Mild Cognitive Impairment 
Perhaps unsurprisingly no subjects reported positive feeling about their memory problems. 
The commonest negative emotions described were irritation and frustration, related to the 
effects subjects’ symptoms had on the practicalities of daily life. For example: 
K006: The problem that I have is I start doing one job, and then I change to another one, and 
I try to…do it but it's sometimes  awful ‘cos I can't do it and I get frustrated…’cos I can't fix 
something or other. 
Many subjects also described experiencing anxiety about their symptoms. One subject 
described her concerns about her memory difficulties: 
R001: (There is a) certain amount of apprehension in case I've forgotten something really, 
really important, or maybe forgotten to meet a friend or something, but I haven't, I never 
have, but it's kind of at the back of my mind. 
Feelings of sadness related to symptoms were also commonly described. 
About half of those interviewed described feeling embarrassed by their difficulties or being 
concerned about the way other people would react to them. One subject said: 
 
R008: I do miss my friends. And I'm trying to make contact with them now a bit more, and... 
But, you know, then I worry they'll come and they'll say, 'she's gone off her rocker,' you know. 
Interestingly, many subjects used the negative labels they had expressed concerns about 
when referring to themselves in the course of the interviews, for example: 
E009: I did say to my, one of the GPs (general practitioners) I went to, “I really do think I’m 
going round the bend” 
Although negative emotions were common, a significant minority of subjects reported a 
neutral reaction to their symptoms. Where this was the case it was usually because either 
the subject felt that their memory changes were within normal limits for their age or that they 
had very little impact on their life, for example: 
U002: I accept that I have something, it's not unusual and it's nothing to be ashamed of. 
Again, emotions related to thoughts about the future were all either negative or neutral. The 
negative emotions reported were almost exclusively anxiety about the possibility that their 
memory might continue to deteriorate with time. About a quarter of the subjects interviewed 
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indicated (entirely unprompted) that they would consider euthanasia should they develop 
severe memory problems, for example: 
E009: I don’t want to be a nuisance, you know, anyone…..I’d rather, you know, just get out 
and I said to my GP, “I don’t want any heroics, I mean, if it keeps you in a state when you 
can go on and exist but I don’t want to be utterly miserable and depressed on someone else, 
you know and be a burden 
In contrast, many subjects reported that they were not particularly concerned about what the 
future might bring, for example: 
R002: I don't think too much on the future. I think my own view is that at my age it's best to 
live in the present. Because you can try and make provision for all the things that might 
happen, and you simply can't. There are so many contingencies that can possibly happen.  
Many subjects’ feelings about their symptoms seemed to be related to their experiences of 
others’ memory problems. Those who reported being aware of others with ‘mild’ difficulties 
often stated that their symptoms were on a par with others of their age and that they were 
therefore not particularly concerned about them. Those who reported having experience of 
others with dementia were particularly likely to report being concerned that their symptoms 
might represent a serious problem. For example, one subject whose cousin and aunt had 
both had severe dementia said: 
D013: Well the only shock was when my cousin, when I understood that he had Alzheimer's. 
And his mother…Just, it goes through the back of your mind is that is there any genes that 
are running around that would eventually end up...? I don't go around thinking about it all 
day long, but it goes through my mind at times. 
3.3.1.4 Attributions 
Subjects attributed their symptoms to quite a wide variety of causes. Most commonly they 
reported either being unsure about their origins or felt that they were part of the ‘normal’ 
ageing process. Some subjects held coexisting ‘external’ factors such as physical health 
problems, stress or fatigue responsible whilst others blamed ‘internal’ factors such as their 
personality or a lack of effort to maintain cognitive function.  
Only a minority of subjects were aware of the term ‘mild cognitive impairment’ pertaining to 
their memory problems and those who used the term often indicated that they had gleaned it 
from the study information pack (which they often had to hand during the interviews). This 
may well have reflected lack of recall of the information given at clinic as all of the clinic 
68 
 
 
 
letters reviewed during the screening process explicitly stated that the diagnosis of MCI had 
been given to the subject and in most cases a discussion regarding its nature and 
implications had occurred. However, none of the subjects who had apparently learned the 
name of their diagnosis from the study information pack appeared distressed by this, most 
appearing to accept it as part of the diagnostic process. Most subjects who were aware of 
the term ‘mild cognitive impairment’ were unable to elaborate significantly on its meaning, for 
example: 
Interviewer: So what's your understanding of that term, that mild cognitive impairment? 
D003: Well, that is it. I don't remember what I used to remember. I have certain difficulties 
that I've already explained to you… 
3.3.1.5 Current Sources of Information and Support 
The vast majority of subjects reported having received little or no information from health 
professionals about their diagnosis. However, aside from a small number of subjects who 
were angry at the perceived lack of information offered, most were ambivalent about it and 
few had made efforts to look elsewhere for relevant information. For example,  
Interviewer: When you went to clinic, and they said to you, 'well, there's nothing too bad,' 
was that enough information for you? Would you have wanted any more information about 
the results of the tests, or...? 
K002: No, I felt all right. I was quite pleased. 
Several subjects stated that they had not looked for information from other sources (such as 
the internet) as they did not wish to do so until they had received personal feedback about 
their diagnosis. These subjects reported that they wished to be certain that any information 
they accessed was relevant to their specific situation.  
D008: I don’t want to put myself into a, what ‘I think’, rather than what’ I know’ I’m told 
that I’ve got, because I don’t wanna type into the computer and it gives me out all these 
anxiety lists of things ‘Oh, you’ve got this, you look that way’. I don’t want any of that, you 
know. I just want, if you tell me that I’ve got X, Y, Z, then that’s what I’m gonna focus on, but 
I don’t have an open mind to what I haven’t got….To ‘think’ is one thing, but to ‘know’ is the 
best thing, and that’s what I want. 
Given the fact that many of the subjects interviewed had difficulty recalling the details of the 
assessment process it is difficult to know whether subjects were genuinely given little 
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information about their diagnosis or were simply unable to remember being given it. As 
noted above the clinic letters for these subjects recorded the fact that the diagnosis had 
been given in clinic and that, in many cases, a discussion about the diagnosis had occurred. 
However, many of the subject reports on this subject did correlate with those of their linked 
advocate suggesting that, in some cases at least, subject reports were probably accurate. 
An alternative explanation is that advocates also had poor recall of information given at the 
clinic appointment. For example, when asked about the information they were given at the 
clinic appointment these linked subjects and advocates, who were interviewed separately, 
stated: 
Interviewer: And what information did they give you at the end of that appointment?  
D003 (PWMCI): Nothing. 
And: 
Interviewer: aside from the information that I've sent out to you, what other feedback did you 
have after all these assessments? 
D006 (advocate of D003): Nothing, not a thing 
 
This experience was also reported by others: 
 
Interviewer: And what did they tell you at the end of that assessment process? 
U002 (PWMCI): (pause) I can't remember exactly. Um, I mean just say yes, you do have a 
memory problem but I can't say I was given any tips or information. 
And: 
Interviewer: So, what other information did they give you? 
U003 (advocate of U002): Not a lot really. 
Where subjects did report receiving information about MCI roughly equal numbers reported 
having obtained it from healthcare professionals and from the media. 
The most commonly reported sources of support were subjects’ spouses and friends. 
Subjects most often described their spouses acting as a ‘back-up’ to jog their memories 
when necessary. For example: 
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D007: If I want to ask a question about recent work, I ask my wife, and she'll tell me what I 
want to know. 
Where subjects described receiving support from friends within the community this was often 
a mixture of the practical and the emotional, for example: 
D012:  I've got nothing to hide from (my friend) no. She's been to the hospital with me when I 
used to go for different various things, yeah. 
Other relatively frequently reported sources of support were church groups, other family 
members (aside from spouses) and formal services provided by health and social care. 
3.3.1.6 Experiences of Health Services  
Most subjects reported either positive or neutral experiences of consulting their GP about 
their memory problems. Those who reported positive experiences generally reported a good 
relationship with their GP and being pleased that they had been referred promptly to 
secondary care. For the few subjects who reported negative experiences this was most 
commonly because they felt that their memory complaints had initially been dismissed as 
part of ‘normal ageing’ rather than properly investigated. Subjects described various reasons 
for their initial presentation to the GP, roughly equally divided between having instigated the 
consultation themselves, having been prompted to do so by others (usually a family 
member) or having reported a memory problem during a consultation about a coexisting 
physical health problem. For example, when discussing this topic a subject who had 
instigated the initial GP consultation himself said: 
E005: But I noticed that things weren't quite right. And in view of my experience with the 
medical profession with these (referring to neuropathy affecting hands), I immediately went 
to the doctor, who immediately got me to (the memory clinic at the hospital). 
When asked why she had consulted her GP, a subject who had been prompted to do so by 
her son and daughter-in-law, said:  
 
E001: I think it was because of the family. 
Interviewer: Okay. And what concerns did they have? 
 
E001: (short pause) Concerns that I was forgetting and perhaps not eating properly and, um, 
err forgetting appointments. 
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A subject who had reported their memory problems during a consultation about another 
health matter said: 
E007: I was seeing the GP anyway, and I said, 'another thing I wanted to ask you about is 
this memory situation, not remembering to do... Well, is there anything I can do about it?' 
The reports of experiences at memory clinics (and analogous services) were more varied. 
Some subjects had a generally positive opinion of the memory service, particularly of how 
well it was run and how pleasant the staff had been. Quite a number of subjects reported 
feeling relieved that the assessments hadn’t identified a more serious memory problem, for 
example: 
K002: I'm glad, I'm glad I went now, because I realize that I am like all... We're all the same, 
and it's not dramatic.  
Many subjects, however, were left with negative impressions of the memory service they had 
attended. The most common complaints were focused on the assessment process, 
particularly cognitive testing and neuroimaging. Many subjects reported finding this process 
unpleasant - either because it seemed too lengthy or difficult or because they felt it did not 
seem appropriate to their symptoms. For example, one subject said of his experience of 
cognitive testing: 
K002: I felt daft, yeah. It made me... Oh, I thought, don't want all this 
Another common cause for complaint was the perceived lack of feedback following the 
assessment: many subjects reported feeling they had not been given a diagnosis or had 
received insufficient information about their condition or potential treatment options: 
D008: I’m going through a sort of ping-pong, because I’ve been sent here, sent to (Hospital 
A) for MRI scans – never seen the results of those, over, over a month ago – and I’ve got this 
other appointment in a clinic in (Hospital B). So I, you know, in my head, no-one’s told me a 
single thing about this since I started, you know. And I go to the doctor, no idea. No idea 
where the results are going to. 
Negative impressions of memory services were also caused by practical issues such as 
lengthy waiting times for follow-up appointments and difficulty with hospital parking.  
While many subjects did have strong positive or negative feelings about their experiences 
within memory services roughly an equal number felt ambivalent about them. 
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3.3.1.7 Suggested Improvements to Services 
CHANGES TO SERVICES 
Many of the subjects, when questioned, could not think of any specific changes they would 
like to see made to memory services – which was in keeping with the ambivalence many 
displayed about their experiences. The vast majority who reported not wanting any particular 
changes to services stated that they felt they simply didn’t need any additional information or 
support at the current time, for example: 
Interviewer: And is there any other support that you think would have been useful for them to 
suggest to you from clinic, anything particularly around memory, or not really? 
E007: No, I don't think anything’s ever been suggested. Any help that might help in that 
direction at all. No. 
Interviewer: Okay. And there's nothing that you wish you could access? 
E007: I don't honestly think so.  
In accordance with this view very few subjects had searched for information on available 
support independently, for example at public libraries or on the internet. 
Some subjects reported that, although they felt that that their experiences within memory 
clinics were imperfect they were unable to suggest improvements as they felt that alternative 
assessment processes or the information or support they really wanted just didn’t exist at the 
current time, for example: 
E005: If there was any, any material that could have been given to me to improve the 
situation, then I would have liked to have heard about that. But I don't think there is. 
 
Where changes were suggested these fell into two main categories: those relating to the 
process of assessment and those relating to the interaction with memory service staff. 
Several subjects reported that they would have liked to have been assessed using tests 
which appeared more appropriate for their cognitive complaints, for example: 
Interviewer: Do you think if they'd used a different assessment, more difficult questions, that 
might have changed things? 
E007: Yeah, I think it might… But I mean the questions, as I explained to you, were so very 
simple that I didn't really think they were testing my memory at all. 
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Subjects who suggested possible improvements to interactions with staff reported varied 
concerns such as feeling they needed more time in clinic and wanting more reassurance and 
support. 
INFORMATION PROVISION 
Where subjects did make a suggestion about improving experiences of healthcare this was 
most commonly that more information should be provided. Subjects reported wanting 
information on a variety of topics, the most common of which were: 
Strategies to cope with existing symptoms  
Many respondents said that ‘hints’ and tips’ about how best to deal with their limitations 
would be helpful, for example: 
R001: Maybe there would be, could be hints of how to, get round it, you know. Yes, I would 
quite appreciate that. 
How to prevent further deterioration in memory  
Quite a number of subjects stated that they would be interested in information about what 
they could do to preserve their cognitive function, for example: 
D008: If that’s what I’ve got then what is the help or, you know, how can I help myself or 
what is the way, the way forward with it, you know? Does it, you know, if it means sort of a, a 
digestion of drugs? 
Feedback of the results of their assessment 
Some subjects were particularly interested in receiving details of the results of the tests 
which they had undergone at memory clinic, both cognitive tests and other investigations 
such as imaging. For example: 
D007: I suppose an assessment from the hospital would have, would have helped as well, 
from, the doctor there. But he didn't tell me a lot at the end. 
Treatment options 
Many interviewees expressed an interest in receiving information about potential therapeutic 
options (both pharmacological and non-pharmacological) for their cognitive problems, for 
example: 
R001: if there was a cure I'd love to know about it (short laugh) 
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Other topics that subjects reported wanting information about included their likely prognosis 
and common causes of cognitive impairment. 
Many subjects did not have particularly strong preferences about how information should be 
provided but there was a general consensus that face-to-face feedback of individual 
assessment results combined with provision of general written information would be the 
most helpful.  
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3.3.2 Descriptive Results of Advocate Interviews 
3.3.2.1 General Description of Interviews 
In total 20 semi-structured interviews were carried out with advocates, 17 of these were 
conducted by the author and 3 by another researcher (CM).  15 of the advocate interviews 
were carried out with the subject alone and 5 in the presence of the linked PWMCI. Interview 
durations ranged from 16 minutes to 1 hour and 8 minutes, with a mean of 31 minutes. The 
age of the subjects interviewed ranged from 42 to 84 years with a mean of 69 years. 
Eighteen of the interviewees were female and 2 were male, all were of White British Origin. 
Thirteen of the advocates were spouses of the PWMCI, 2 were offspring, 3 were other family 
members and 2 were friends.  
For the most part advocates were willing to discuss the subjects on the topic guide openly. In 
two cases advocates (both spouses of PWMCI) became distressed during the interview but, 
despite being offered the opportunity to terminate or pause the discussion both wished to 
continue. Indeed, one stated at the end of the interview how helpful it had been having 
someone to talk to about their experiences. Occasionally advocates appeared reticent to 
discuss a particular issue, for example their thoughts on the future; this manifested as either 
very brief answers on the topic or the advocate steering the conversation away from the 
original question. The majority of advocates were spouses of PWMCI and therefore had, for 
the most part, accompanied PWMCI during their contact with healthcare services and had a 
good insight into the day to day challenges posed by the PWMCI’s cognitive problems. 
Amongst non-spousal advocates the degree of contact with the PWMCI, and hence 
awareness of their difficulties and experiences of healthcare services, was more varied. 
The themes emerging from the interviews carried out by the two researchers (the author and 
CM) were very similar. 
3.3.2.2 Challenges Presented by Mild Cognitive Impairment and 
Coping Strategies Developed 
Advocates reported a very wide range of difficulties which they attributed to the PWMCI’s 
cognitive problems. Foremost amongst these were challenges caused by impairments of the 
PWMCI’s short to medium term memory for a variety of things including recent events and 
conversations, arrangements that had been made and the names of acquaintances. One 
advocate said of his wife: 
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R003: I mean, you know, (we) sort of discuss what we're going to buy in the shops, and then, 
you know, she'll get to the shops and she's totally forgotten... 
Another change very commonly reported by advocates was PWMCI having increasing 
difficulty managing paperwork and finances, for example an advocate, referring to her 
husband, said: 
D006: If he hasn't got anything to do, he will start going through the filing cabinet. Months 
ago he came out, he said “Look, we've got more in the bank than we thought.” And I looked 
at it, and I looked at the date of the statement. I said “This is at least two years old.” 
About half of those interviewed reported noticing a change in the PWMCI’s personality with a 
variety of manifestations including increased anxiety or irritability, low mood and decreased 
self-confidence. Speaking of her husband one advocate said: 
U007: He's always been one that's had a bit of a short fuse about things. But never with me. 
And since he's had this, he is sometimes quite nasty. 
Many advocates reported that the PWMCI’s social interactions and ability to continue with 
previous hobbies had been affected by their cognitive problems. Most commonly they 
described the PWMCI finding that their cognitive problems made it difficult for them to 
socialise, particularly in large groups and that they had consequently become more isolated. 
Describing her relative, one advocate said: 
K007: I’ve tried to encourage him to go to social occasions... but I've noticed that where he 
used to love coming to our house, and he would engage with us, if there's anyone else there, 
he'll actually remove himself, and he will go and sit in another room. 
Other, relatively frequently described, changes included episodes of spatial disorientation, 
interruptions to family plans such as holidays and verbal problems such as word finding 
difficulties. 
As in the interviewees with PWMCI, who frequently mentioned co-existing medical 
conditions, the advocates often referred to either their own health problems or those of the 
PWMCI. Several advocates described finding it difficult to be certain whether many of the 
problems they described were caused by the PWMCI’s physical or cognitive problems – or 
indeed whether the cognitive problems were caused by physical ill health in the first place. 
For example, describing the onset of his wife’s memory problems this advocate said: 
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R003: ..whether, whether the minor stroke actually caused it, or whether they just happened 
at the same sort of time, is, I mean….not at all clear 
In an interesting contrast to the subjects with MCI , where advocates referred to their own 
health it was most commonly their mental health that they talked about – either in terms of 
emotional burden or, more frequently, concerns about their own memory deteriorating. 
Unsurprisingly, given the myriad of problems advocates described many reported these 
problems had had an impact on their relationship with the PWMCI, particularly in causing 
increased arguments. This advocate said of her husband: 
U007: I mean, some days it is very difficult. I mean I have a... we've had sort of several 
little... we've never really argued much. In fact all the years we've been married. I think we've 
had more arguments this last year than we've ever had. 
There was a roughly equal split between those who felt able to discuss the PWMCI’s 
cognitive problems with them openly and those who did not. One advocate said of 
attempting to initiate a discussion with her relative about her memory problems: 
E002: I don't know if she'd like to talk. We've tried to give her the openings once or twice, but 
she hasn't taken them. Like: “It must be quite worrying to people” she's a bit sort of “Well it 
happens to old people doesn't it?” sort of... And you feel well if that's her choice, I don't feel 
able to push any harder. 
Whereas another, referring to her husband said: 
U003: (My husband) and I talked about it, very open about it, and we sort of said well, as we 
get older, something's going to go on in life, you know, we just said well it looks as if this 
might be your lot, you know, but we're all in it together, so we talked about it openly and 
realised, yes, there was a problem 
There was also an equal split between those who were able to discuss their situation with 
other family members and friends and those who did not. Advocates reported a variety of 
reasons for not being open with others including the subject never seeming to come up in 
conversation and a reluctance to burden others with their problems. This advocate said of 
discussing her husband’s memory problems with their grown up children: 
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R004: it seems hardly fair to ring them up at nine o'clock in the evening and say “By the way, 
about this memory problem...” And when we see them, it's not always possible to discuss 
private matters like this.  
Overall, many advocates described a feeling of watching the person they had known 
changing significantly in a number of ways, often associated with a degree of ‘loss’. A 
minority, however, said that they had not noticed that the PWMCI’s cognitive problems had 
had any impact on their life. 
Advocates also described a range of new responsibilities that they felt they had been obliged 
to take on as a result of the PWMCI’s cognitive problems. These responsibilities tended to 
reflect the practical areas where PWMCI had developed limitations and hence the most 
commonly mentioned were taking over the organisation of household administration and 
finances and providing a greater level of general supervision to PWMCI on a day to day 
basis. 
Some advocates described strategies which they had adopted to try to cope with the 
difficulties caused by the PWMCI’s condition. Most commonly these involved practical 
approaches such as the use of written reminders or physical adaptations to make things 
easier around the house. A few advocates talked about the importance of maintaining some 
time for themselves in order to have a short break. For example, this advocate had 
developed a routine which involved the PWMCI (her husband) having a short afternoon nap, 
she said: 
D006: It gives me a break. It sort of relieves the pressure. That sounds awful – we've been 
married fifty-seven years this year. But it is stressful. And I'm so thankful I instigated that, 
because I don't think I'd cope otherwise. 
Several described attempting to ‘prompt’ the PWMCI’s memory by trying to let them 
remember things by themselves, although those who used this approach were often unsure 
whether it was the right thing to do. One advocate described trying to prompt her husband’s 
memory thus: 
D005: Whether I should be telling him things or whether I should leave it and let him try and 
remember on his own? I mean, sometimes he says to me all of a sudden something, “I know 
what it is.” I said, “Well think about it, just think for a little while and then I’ll….” If I know 
what it is I’ll tell him a bit later on but even that doesn’t seem to work sometimes. 
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3.3.2.3 Feelings About Mild Cognitive Impairment 
Whilst a few advocates described neutral feelings about the PWMCI’s cognitive problems 
the overwhelming majority reported negative emotions. The most commonly reported 
reaction was sadness, for example this advocate said of her mother: 
R0011: .. in the last few months, I went through a period where I got quite upset about it. Not 
hugely, but you know, I did a bit of sort of mourning. Just sort of saying to my husband that 
“You know, you don't realise that she used to be like me. You never saw her like that, but she 
was.” 
Advocates also commonly reported feelings of anger and frustration, either related to 
changes they had observed in the advocate or due to difficulties in accessing services. 
Describing his reaction to his wife’s memory problems, this advocate said:  
R003: Well, I think she does realize how frustrating I find it sometimes… I mean it's, it is sort 
of, I have to sort of pull myself together and say, say to myself, you know, that it's not her 
fault. She's not just being awkward  
Anxiety and feelings of increased stress were also commonly reported, for example this 
advocate described her reaction when she first realised that her husband had a problem with 
his memory: 
E006: It was the fact that he, he had forgotten that his relative had died. And we’d been to 
the funeral. And my heart... I can remember my heart just going, dropping, you know. Oh my 
god. 
In several cases interviewees reported a discrepancy between the level of anxiety about the 
PWMCI’s problems displayed by the PWMCI and their linked advocate. Where 
discrepancies existed there was a roughly equal split between cases where the advocate 
was the more concerned about the PWMCI’s problems and vice versa. For example, this 
advocate said of her friend: 
R007: Well, more recently, I mean she's been complaining for some years that she was losing 
her marbles. And I thought. 'Well, (PWMCI’s name), you're so far up there I can't notice it 
yet. 
Advocates’ feelings about what the future might hold in light of the PWMCI’s cognitive 
problems were also mostly negative. Many advocates reported anxiety about the future – 
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particularly regarding the possibility that the PWMCI might develop dementia or about their 
ability to cope with any further deterioration. This advocate said of her husband: 
U007: But I do think, I think what might make it difficult that I can't cope with it, because 
sometimes when he gets like this, he does get very aggressive. And I think erm, if there's no 
aggression, I think I'd be able to cope with it. But I think if there was aggression, I would 
have trouble coping with it, you know. 
Others reported uncertainty about the future: this advocate, the wife of a PWMCI, said: 
U003: And I mean does the sort of memory loss that (my husband) has, does it necessarily 
lead on to all those terrible things, is, you know..?(You) cross each bridge, don't you, no 
point in preparing myself (short laugh) for something that might not come. 
Quite a number of advocates reported having had experiences of other friends or relatives 
with significant cognitive problems such as dementia. In many cases these experiences 
appeared to influence their reactions to the PWMCI’s difficulties – particularly in causing 
increased concern about the PWMCI developing more serious problems in the future. This 
advocate described her experiences of dementia in a family member and how it influenced 
her perceptions of her husband’s early memory problems as follows:  
D008 …. to put into context, his sister had I don’t know how many years ..of virtually very, 
very bad dementia. But there was a few triggers that happened many, many years prior to 
this that we didn’t pick up on at the time. And sadly my husband found that there was a 
couple of incidents where he did the same thing. 
In contrast, however, some advocates reported experiences of dementia in other friends and 
family but either did not equate them with the advocate’s problems at all or felt very certain 
that they were a completely different entity. This advocate, who had experience of several 
friends with dementia, said of her friend (the PWMCI’s) cognitive problems: 
R007: I have had quite a number of friends who have had Alzheimer's or cardiovascular 
dementia and so on. …. But it was, I could see that it was a very, totally, totally different 
thing... 
Although a few advocates mentioned noticing mild cognitive problems in their 
contemporaries none reported being aware of others with a specific diagnosis of MCI. 
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3.3.2.4 Attributions 
There were quite a variety of causes to which advocates attributed the problems they had 
noticed in the PWMCI. The commonest of these were changes which they perceived as 
‘normal’ for their age group. One advocate said of her husband: 
R004: He doesn't remember things that I would expect, events usually that I would expect him 
to remember. But then I don't sometimes either, so some of this must be ageing 
PWMCI’s physical health problems were also commonly blamed for contributing to their 
cognitive problems, at least in part. This advocate described her cousin’s physical and 
memory problems thus: 
K004: She's had other issues, which are gradually getting put right. And when I say from 
head to toe, that is literally from head to toe. 
Interviewer: So other physical health problems? 
K004: Yeah. Which we gradually getting sorted. You know, and did wonder whether some of 
those didn't help either. 
Quite a few advocates referred to MCI by name or described the PWMCI’s problems a 
something that was ‘not dementia’. This advocate described the information they were given 
following her husband’s appointment with a memory service: 
Interviewer: And did they give you any feedback at the end of the appointment? 
K005: Really just this mild cognitive thing. And they said it wasn't Alzheimer's, it wasn't 
dementia, which was phew, huge, huge... 
Some advocates attributed the changes they had noticed to aspects at least partially under 
the PWMCI’s control, such as their personality or the amount of effort they put into 
remembering things. For example, this advocate said of her husband: 
K005: It's... how much is memory, how much is concentration is very difficult to tell. Because 
it depends a lot on how interested he is in a subject or whatever 
3.3.2.5 Current Sources of Information and Support 
When asked about sources from which they had obtained information about MCI many 
advocates said they simply had not received any. In the words of this advocate: 
D006: Information – there's been a dearth of it, none 
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Where information had been obtained the commonest reported source was from written 
material and the internet; roughly equal numbers also reported receiving information directly 
from healthcare professionals (including what they had gleaned during the assessment 
process) and friends or family members. 
The most common sources of support reported by advocates were friends and social groups 
(e.g. local church communities) and family members, including, in some cases, the PWMCI. 
This advocate, whose husband had cognitive problems, said: 
U007: Yeah, I've got two good friends, that when I'm feeling really, wanting a good rant, I 
can go and have a good rant to them. And they listen very ni', you know. And that, it does 
make a great difference. ‘Cos sometimes you just got to let it out. And once I've let it out, then 
I can sort of calm back down and then I can carry on then.  
However quite a number of advocates (about the same number who reported receiving 
support from friends and family) said they did not receive any support 
3.3.2.6 Experiences of Health Services 
Many advocates had been involved to some degree in the PWMCI’s assessment by their GP 
and the majority of them reported that there were at least some negative aspects to the 
encounter. A common reason given for negative experiences was the GP not appearing to 
pay sufficient attention to the problems reported by the PWMCI or advocate. One advocate 
said of her and her husband’s experience of consulting his GP about his memory problems: 
K005: Well it was, he just sort of totally blanked me. And was talking to (my husband). And I 
sort of, although I don't like to, I interjected and say “Well I think you know, his specialist at 
the hospital said he should be checked.” “Well okay then, I'll get you an appointment.” It 
took that, which I'd rather, I think that with older people and the fact that they can do things 
now, that if somebody is going, the GP should be picking this up. 
Another common concern was a perceived lack of confidentiality: several advocates 
reported feeling uncomfortable ‘reporting’ on the PWMCI in their presence because they had 
been unable to discuss their concerns with the PWMCI’s GP in confidence. This advocate 
said: 
D006: As a result of my concern, we both went to see the doctor together. And it's very 
difficult to talk about your husband in front of him, very difficult. Because he said “I can only 
speak to you together.” So we went to see him together. 
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Where advocates reported positive experiences of the GP assessment this was usually due 
to feeling that the GP took their (or the PWMCI’s) concerns seriously or a perception that 
they acted quickly in making a referral to secondary care. 
Advocates most commonly reported that the PWMCI had consulted their GP about their 
cognitive problems after prompting by themselves or another family member and in quite a 
number of cases the PWMCI had visited the GP about another matter and mentioned their 
concerns at that appointment. It was rare for advocates to report that the PWMCI had sought 
help from the GP regarding their cognitive problems spontaneously. 
Most advocates had also been involved in the process of assessment at memory clinic and 
again negative experiences at memory clinics were common. The most frequent cause for 
complaint was related to the assessments used by the clinic; in many cases advocates 
reported that the process of assessment was unpleasant for them and / or the PWMCI. 
Many felt that the assessments used were not appropriate for the PWMCI’s mild degree of 
cognitive problems, for example this advocate described the assessments she took part in at 
the clinic as follows:  
D011: the questions I was being asked, you know “Did he get aggressive? Did he hit me? 
Did he do this, did he do that”. It was all proform’. Yes it might be applicable to some people 
but it was totally un-applicable (to me). 
Another common cause for complaint was a perceived lack of information about the 
diagnosis and treatment or support options – including, in some cases, feeling that the 
PWMCI had not actually received a diagnosis following the (often quite extensive) 
assessments. In a similar vein a number of advocates reported that they felt the 
communication from memory clinic had been poor. One advocate said of her experiences of 
the memory clinic which her husband attended: 
 
U007:  Yeah, the communication has been really poor, really. Which does make you feel, in 
my position, I don't know how he feels, but in my position, you feel a bit well they've told me 
that and they're just letting me get on with it, in a way. 
Advocates also commonly described dissatisfaction with the set-up of the memory service, 
for example feeling that the gap between appointments was too long or disappointment at 
the PWMCI not being offered a follow up appointment. This advocate said of her mother 
being discharged from the memory clinic: 
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R011: What is quite difficult to take was that it was like “Yeah, there's a problem, it's not that 
bad. Off you go.” 
Some advocates reported that they felt the service they were offered by the memory clinic 
was limited by financial constraints within the NHS. 
However, in addition to the reports of negative experiences at memory clinics many 
advocates reported not feeling particularly strongly one way or the other about the clinic 
assessment process, indicating that they found it straightforward and satisfactory.  A not 
insignificant minority also reported positive experiences – most commonly relating to the 
practical aspects of the memory service such as pleasant staff or an efficiently run clinic. 
This advocate said of the memory clinic her husband attended: 
R004: Well the whole establishment, you know, I mean it's so careful, it's like NHS used to 
be. And nothing is too much trouble and it's excellent. 
3.3.2.7 Suggested Improvements to Services 
The majority of advocates felt that services could be improved. The most frequent 
suggestion was the provision of more information, particularly regarding likely prognosis, 
treatment options and what they themselves could do for the PWMCI. When asked what 
additional information she would have liked to have received regarding her husband’s 
cognitive problems, this advocate said: 
D007: Well, what help can be given. And I mean, can I do more, can I sort of... somebody 
said (I) should make (him) tell me exactly what we did yesterday sort of thing. I mean, would 
that help? This is the sort of thing, if I know what I can do… 
About half of those who wanted extra information stated a preference for this being given 
face to face from a healthcare professional and half preferred a written format. 
Another common request was for the provision of more support for the PWMCI and / or 
themselves, or at least some information on the sources of such support. Areas that 
advocates mentioned being interested in were support groups for themselves or the PWMCI, 
psychological support and practical services such as ‘home help’. 
Several advocates suggested changes to the practical aspects of the assessment process 
including the type of assessments used and whether the advocate and PWMCI were 
interviewed together or separately. This advocate, who was asked to give collateral history 
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during her husband’s memory assessment in his presence, when asked by the interviewer 
whether she would have preferred to talk to the doctor in confidence, said: 
U007: I think actually it would have been quite helpful. Because I wouldn't, there were some 
things... I mean, I'm saying things to you that I wouldn't say if he was here. Because I think it 
would be quite sort of hurtful to say them. So I think it could have been. He did give me, I did 
go outside and have a sort of a questionnaire to fill in. But that wasn't all that big, and it was 
a very broad spectrum really. Not exactly what... no, it would have been easier I think if I 
could have put my four penn’orth in as it were, you know. 
On the other hand some of the advocates whose assessments took place separately from 
the PWMCI reported that they would have preferred to have remained with the PWMCI 
during the process, for example this advocate who saw the doctor separately from her 
husband said: 
E008: I realise that they wouldn't know whether he was giving the right answers, so if I could 
have been there to just indicate whether what he was saying was correct…. 
In keeping with the reports of poor communication from the memory clinic several advocates 
suggested that their experiences could have been greatly improved by better communication 
from the clinic – both in terms of sensitive discussions about diagnosis and regarding 
practical matters such as the timing of follow up appointments. 
Some advocates felt that there wasn’t much scope to improve services. This group generally 
fell into two categories: those who felt that they didn’t need any extra information or support 
at the current time and those who, despite reporting unsatisfactory experiences, couldn’t see 
how changes to services would improve matters. In the latter group many advocates 
reported feeling that the information they really wanted, such as how the PWMCI’s cognition 
would change over time, just wasn’t possible to provide. 
When asked about whether she would wish to attend a support group one advocate said:  
D016: No, not really my cup of tea, no. Not at the moment. I mean, I think if he was... please 
God not, but if he did get worse.. maybe I would then.  
This advocate, who reported that her relative had become quite distressed by the 
assessment process, said: 
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K007: But the doctor was very good. I mean he said “Now, come on, take your time.” It 
wasn't that he was aggressive. And I don't really know how else you would do the 
questioning. 
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3.4 Discussion of Interview Results 
3.4.1 General Comments 
Interviews with people with mild cognitive impairment (PWMCI) and advocates were 
undertaken in order to document the experience of living with mild cognitive impairment 
(MCI) from the perspectives of those living with the effects of the condition. Interviewing 
continued until data saturation was reached i.e. no new substantive themes were revealed 
by further interviews. This occurred after 23 interviews with PWMCI and 20 advocate 
interviews – approximately the number that it was hypothesised would be required.  
There were no significant difficulties with the conduct of the interviews. Although it was 
planned that, ideally, PWMCI and advocates should be interviewed separately, there were 
several cases where subjects expressed a wish to be interviewed together, usually stating 
that they wished to make sure that all information was discussed with both parties. There is 
a possibility that this influenced the content of these interviews, particularly in the topic areas 
that may have been difficult to discuss in the presence of the study partner, such as 
relationship difficulties. However, the themes apparent in these interviews were not 
substantially different from those in interviews where the subjects were interviewed 
separately.  
The mean duration of interviews with both PWMCI and advocates was just over half an hour. 
There were a few very short interviews; interviews with PWMCI were often short where they 
had particularly poor recall regarding their experiences and advocate interviews tended to be 
short if they were a friend of the PWMCI (rather than a family member) or had minimal 
concerns regarding the PWMCI’s cognition. Despite recruiting for the study in a wide variety 
of both urban and rural areas in the south of England, the subjects were all of white British 
origin which meant that no information regarding issues which might be of particular concern 
to ethnic minorities was obtained. At 78 years the mean age of PWMCI in the study reflected 
the older age of most PWMCI in the community. The lower mean age of advocates (69 
years) reflected the fact that, while over half were spouses of PWMCI, a significant minority 
were offspring or other younger relatives. Interestingly all but two of the advocates 
interviewed were female despite the fact that there was a roughly equal split between male 
and female PWMCI. This was mostly due to the fact that, where the advocate was non-
spousal (i.e. another type of relative or friend) they were usually female – in keeping with the 
fact that informal carers in the general population are more commonly female (The NHS 
Information Centre, 2010). 
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Recruitment to the study was designed in such a way that it should reflect the diversity of 
patients seen in memory clinics. Consequently, it was not mandatory for participants to fulfil 
the Petersen diagnostic criteria for MCI. However, it was encouraging to note that the 
majority of the PWMCI interviewed (N = 16) did, in fact, meet the criteria meaning that the 
study population, as well as reflecting the diversity of memory clinic patients, was 
comparable to many of the populations studied in previous research in this area. The mean 
Mini-Mental State Examination score (MMSE) (Folstein et al., 1975) (for those PWMCI for 
whom it was available) was 26.9.The MMSE score has poor sensitivity for identifying MCI 
and is therefore not an ideal screening tool; however it was used as an approximate marker 
of general cognition in this study as it was the cognitive test which was most commonly 
performed across all study sites and therefore the greatest number of subjects had scores 
available for this test. The MMSE has been shown to have a fairly good sensitivity (86%) for 
identifying dementia  when used as a screening tool with a cut-off of 25 (McDowell et al., 
1997) or 26 (Kuslansky et al., 2004). The fact that the mean MMSE score for our subjects 
was above these values provides some reassurance that these subjects were unlikely to 
have a diagnosis of dementia. The mean Hospital Anxiety and Depression Scale (HADS) 
score (Zigmond and Snaith, 1983) for the MCI group was 11.3 which corresponds to 
‘moderate symptoms of anxiety / depression’. This is in keeping with the known association 
between MCI and neuropsychiatric symptoms (NPS) (Lyketsos et al., 2002, Feldman et al., 
2004). 
Although the themes identified in the interviews with the PWMCI and their advocates were 
broadly similar there were several areas where disparity was evident – both between the 
accounts of individual linked PWMCI/advocate dyads and in the overall analysis of 
responses from the MCI and advocate groups. One reason for this, as noted in the 
‘Descriptive Results of Interviews with People with Mild Cognitive Impairment’ section, 
appears to be the fact that many of the subjects clearly had limited recall of their experiences 
and insight into the challenges resulting from their cognitive problems, a phenomenon which 
has been reported in other studies (Vogel et al., 2004, Frank et al., 2006a). Another likely 
reason is that many of the advocates interviewed were beginning to take on caring roles and 
experiencing the psychological and practical burdens associated with this, further widening 
the gap between themselves and the PWMCI – especially where the PWMCI’s impaired 
insight resulted in minimal concern about their own condition. Several advocates described 
being in a situation where they were ‘falling between two stools’: neither being in the 
situation of caring for someone with dementia who lacks decision making capacity and 
therefore feeling ‘entitled’ to take on that role, nor being a carer for someone with a physical 
disability who retains full cognitive capabilities and therefore does not require advocacy in 
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decision making. Rather, many advocates described feeling that they had a key role to play 
as an ‘intermediary’ in the PWMCI’s care without necessarily having any official recognition 
of this. This reflects the rather unique role of the advocate in MCI and is in keeping with the 
difficulty we had in finding a suitable term to describe this group – who would be labeled as 
‘caregivers’ if the person were to have dementia – but for whom a suitable term does not 
seem to exist at present. 
3.4.2 Challenges Presented by Mild Cognitive Impairment  and 
Coping Strategies 
The challenges described by PWMCI were similar to those that have previously been 
reported in comparable studies and were in keeping with the cognitive deficits known to 
occur in  MCI (Albert et al., 2011, Joosten-Weyn Banningh et al., 2008, Frank et al., 2006b, 
Lu et al., 2007a): e.g. problems with recall of recent events relate to deficits of episodic 
memory, problems with naming, verbal fluency and comprehension relate to language 
deficits, difficulties managing paperwork and finances relate to executive dysfunction or 
attention deficits and spatial disorientation relates to visuospatial deficits. Advocates’ 
descriptions of the challenges faced by PWMCI were broadly similar to the PWMCI’s 
descriptions and both groups reported consequent effects on the PWMCI’s day to day lives, 
for example limitations in completing instrumental activities of daily living (IADLs), socializing 
with their peers and negative effects on family relationships. These findings were once again 
in keeping with those of other similar studies (Adams, 2006, Frank et al., 2006b, Lu and 
Haase, 2009, Blieszner and Roberto, 2010, Blieszner et al., 2007, Kuo and Shyu, 2010, 
Garand et al., 2007, McIlvane et al., 2008) 
New responsibilities reported by advocates reflected the deficits PWMCI had developed (as 
described above) and were similar to the ‘carer burdens’ described in previous studies of this 
topic (Joosten-Weyn Banningh et al., 2008, Beard and Neary, 2012, Adams, 2006, Frank et 
al., 2006b, Lu and Haase, 2009). Coping strategies described by both PWMCI and 
advocates were overwhelmingly practical (or ‘problem focused’) in nature, for example the 
use of written reminders. One significant exception to this was the advocates who had 
developed a policy of maintaining some free time for themselves to allow a rest from their 
‘caring’ responsibilities reflecting a combination of problem and emotion focused approaches 
to coping. Many previous studies have found that roughly equal proportions of carers of 
PWMCI use problem-focused and emotion-focused coping strategies (Lu et al., 2007a, 
McIlvane et al., 2008, Beard and Neary, 2012, Roberto et al., 2011, Lu and Haase, 2009, 
Blieszner et al., 2007), hence the emphasis on problem-focused coping identified in this 
study was in contrast to previous findings. 
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3.4.3 Emotional Consequences of Mild Cognitive Impairment 
PWMCI and advocates described a range of negative emotional responses to the PWMCI’s’ 
cognitive problems and regarding the future, again in keeping with previous work in this area 
(Joosten-Weyn Banningh et al., 2008, Lu et al., 2007a, De Vriendt et al., 2012, Adams, 
2006, Frank et al., 2006b, Lu and Haase, 2009, Blieszner et al., 2007, Kuo and Shyu, 2010, 
Roberts and Clare, 2012). In a number of cases there was a discrepancy between the 
emotions expressed by PWMCI about their condition and those expressed by their linked 
advocate: Whilst advocates described almost exclusively negative emotions quite a number 
of the PWMCI reported neutral feelings about their difficulties, often stating that they felt that 
they were within normal limits for someone of their age. This discrepancy was commented 
on by a few subjects who stated that the advocate was much more concerned about the 
PWMCI’s problems than they themselves seemed to be – but it was also apparent in quite a 
number of the PWMCI-advocate dyads, even when not explicitly mentioned. Explanations for 
this inconsistency include the limited insight and / or recall exhibited by some PWMCI and 
the emotional and practical burdens described by some advocates which affected them but 
not the linked PWMCI. Previous studies have confirmed that, in people with cognitive 
impairment (including MCI) who have reduced insight, measures of self-rated quality of life 
are less reliable than in those in whom insight is preserved (Berwig et al., 2009, Ready et al., 
2006).The challenges of measuring insight and the potential effect that decreased insight 
might have on patient reported outcome measures (PROMs) in MCI were also discussed in 
a recent review by Frank et al. (Frank et al., 2011). They commented on the fact that most 
measures of insight in MCI rely on informant reports as a ‘gold standard’ – with discrepancy 
between reports from the PWMCI and the informant indicating decreased insight on the part 
of the PWMCI. However they argue that, where the informant is a caregiver (as in this study) 
the accuracy of their report may be affected by factors such as their own health, level of 
burden and presence of NPS and therefore discrepancies in reporting may not always be 
attributable to decreased insight on the part of the PWMCI. Many advocates in our study did 
indeed express concern about their own mental health – sometimes creating an interesting 
contrast to a linked PWMCI who had expressed minimal concern about their diagnosis.  A 
further possible explanation for the discrepancy in the emotional reactions of PWMCI and 
advocates is the phenomenon described by Roberts and Clare whereby, despite high level 
‘meta-representational’ awareness of cognitive difficulties being intact in the PWMCI they 
studied, the expression of this awareness was influenced (and reduced) by various 
psychological and social factors (Roberts and Clare, 2012).  
In a small number of cases the PWMCI in our study reported greater concern about their 
condition than their linked advocates. Frank et al. also commented on this phenomenon -  
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pointing out that PWMCI may become aware of deficits before they are detectable by others 
resulting in an apparent ‘overestimation’ of deficits as rated by subject reports compared to 
those of informants (Frank et al., 2011) – and it has also been noted in some other studies 
and a review of insight in PWMCI (Farias et al., 2005, Tabert et al., 2002, Roberts et al., 
2009).  
Many subjects reported having had experiences of others with memory problems and these 
often appeared to influence their feelings about the PWMCI’s current difficulties. This was 
particularly the case for those who had ‘first-hand’ experience of family members or close 
friends with dementia: this group was more likely to express anxiety about their symptoms 
potentially representing a serious condition, an association also identified in Lingler et al’s 
and Robert and Clare’s studies (Roberts and Clare, 2012, Lingler et al., 2006). However, this 
is in contrast to Beard and Neary’s findings that participants in their study of experiences of 
MCI vehemently denied any association between their experiences and Alzheimer’s disease 
(AD) (Beard and Neary, 2012). The participants in that study reported that they felt their 
awareness of their deficits was what distinguished their condition from AD. It is also in 
contrast to Roberto et al.’s finding that, in family triads where a member had prior personal 
experience of dementia acknowledgement of the PWMCI’s problems was less likely than in 
triads where a member had previous professional experience of dementia (e.g. as a 
healthcare worker) (Roberto et al., 2011). 
3.4.4 Attributions 
Both PWMCI and advocates attributed the cognitive changes they noticed to a wide variety 
of causes. Subjects in both groups commonly reported that they felt the changes were no 
more than they would expect in their age group i.e. part of ‘normal’ ageing. Both the MCI and 
advocate groups frequently mentioned the PWMCI’s’ physical health problems but often 
from different viewpoints: The MCI group tended to be more concerned about their physical 
than their mental health and tended to view them as separate entities whereas the 
advocates who talked of the linked PWMCI’s physical health problems often did so in the 
context of attributing at least some of their cognitive symptoms to them. This is in keeping 
with the finding of previous studies, in which PWMCI most commonly attributed their 
cognitive changes to ‘normal ageing’ (McIlvane et al., 2008, Lingler et al., 2006, Beard and 
Neary, 2012, Roberts and Clare, 2012) whereas advocates expressed more uncertainty 
about their cause and often attributed them to physical health problems (Frank et al., 2006a, 
Blieszner et al., 2007) 
Some PWMCI, however, did report uncertainty about the cause of their symptoms and very 
few were aware of the term ‘mild cognitive impairment’. Uncertainty amongst PWMCI 
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regarding the cause of their symptoms has been identified in several other studies: Beard 
and Neary found that the participants in their qualitative study of experiences of MCI 
generally did not know how to describe MCI and were not sure that their doctor had ever 
defined it for them (Beard and Neary, 2012) and Frank et al. commented that most of the 
PWMCI they had interviewed ‘were not given a specific name for their disorder’ (Frank et al., 
2006b). Similar to the subjects in this study, none of the 25 PWMCI interviewed in Roberts 
and Clare’s study used the term MCI for their memory problems, despite having been given 
this diagnosis at their memory clinic appointment (Roberts and Clare, 2012). 
In contrast to the MCI group, quite a few advocates were aware of the term MCI in relation to 
the PWMCI’s cognitive problems. In Roberto et al.’s study of family triads about one third of 
the triads were categorized as displaying ‘complete acknowledgement’ which was described 
as ‘all members indicating they fully acknowledged the diagnosis of MCI’ (Roberto et al., 
2011). However, even in this study it is not clear whether the care partners were aware of 
the specific term ‘mild cognitive impairment’ pertaining to the PWMCI’s diagnosis. No studies 
have specifically focused on the awareness of MCI as a diagnostic term among caregivers of 
PWMCI; it is therefore unclear whether the knowledge of the term displayed by the 
advocates in this study was unusual, although the diagnostic uncertainty on the part of 
advocates described in many of the studies cited above suggests that it may be.  
Attributions for cognitive symptoms are important as they can influence coping and important 
decisions (such as whether to seek medical assessment) in both PWMCI and advocates. 
Hurt et al.’s paper on help-seeking in adults with subjective memory complaint (SMC) 
provided some evidence for this (Hurt et al., 2012). The authors also discussed the fact that 
attribution of cognitive changes to normal ageing or physical health problems appeared to be 
associated with a decreased likelihood of help-seeking whereas perceptions of serious 
consequences, a greater knowledge of AD and negative emotions were associated with a 
greater likelihood of help seeking. 
3.4.5 Current Sources of Information and Support 
The majority of PWMCI and advocates reported having received little or no information about 
MCI, although it is difficult to know how accurate these reports were as, at least in some 
cases, clinic letters were available for the PWMCI which specifically stated that such 
information had been provided. Regardless, even if verbal information had been provided it 
was clear that, in many cases, it had not been retained which suggests that provision of 
written information might have been more helpful. This apparent lack of provision of written 
information is in keeping with the findings of the survey of members of the American 
Academy of Neurology, only 27% of whom reported providing information in a written format 
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to people newly diagnosed with MCI (Roberts et al., 2010). Unfortunately no equivalent 
survey of practice in the UK has been carried out for comparison.  
The sources of support described by both the MCI group and advocates were almost 
exclusively informal (i.e. family members and friends) – very few had received support from 
formal health or social care services. A lack of satisfactory provision of formal support for this 
group has been identified in other studies, for example a survey of memory clinic users in 
Holland which found that only 20% advocates were happy with the advice and support they 
received at the clinic (van Hout et al., 2001). Some caregivers in this study described feeling 
that they did not require any additional support at the current time (although they felt that 
they might do in the future) – a similar finding to Adams’ study of caregivers of PWMCI 
(Adams, 2006). 
Interestingly, although advocates were often angry or distressed by the perceived lack of 
information or support they had received, the PWMCI tended to be ambivalent about it. 
Previous studies have found that many carers of PWMCI do report increased support needs 
(Ryan et al., 2010, Blieszner and Roberto, 2010). No studies have specifically examined the 
PWMCI’s perceptions of their support needs but in light of the decreased insight into their 
condition displayed by many it seems likely that this group may also underestimate their 
need for support. This may explain the discrepancy between PWMCI and advocate 
responses to the perceived lack of information and support described in this study. 
3.4.6 Experiences of Health Services and Suggested Improvements 
The MCI group tended to report that the experience of consulting the general practitioner 
(GP) about their cognitive problems was either positive or neutral, whereas advocates 
tended to have more negative impressions of the consultation – citing as issues of particular 
concern a dismissive attitude on the part of the GP or disappointment at not being able to 
discuss the PWMCI with the GP in confidence. In a meta-analysis of studies of GPs’ ability 
to diagnose MCI only about 45% of cases were recognized (Mitchell et al., 2011) – this 
problem with recognition of MCI in primary care may explain the dismissive attitude 
encountered by some advocates. The discrepancy between PWMCI and advocate 
experiences within primary care has not been formally described in previous studies. 
Reports from the PWMCI and their linked advocate of the mechanism by which the PWMCI 
presented to the GP were not always consistent – quite a number of the PWMCI reported 
that they consulted their GP about their memory spontaneously whereas most advocates 
reported that the consultation was either prompted by them (or another relative) or occurred 
when the PWMCI was consulting the GP about another health matter (‘unintentional help-
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seeking’ a phenomenon noted in a previous study (Kuo and Shyu, 2010)). Again, this may 
reflect a lack of recall on the part of the PWMCI.  
Both the PWMCI and advocates reported varying opinions of their experiences at memory 
clinic. Overall, more PWMCI than advocates reported positive experiences – often related to 
practical aspects of the memory clinic or to feeling relived that they had not received a 
diagnosis of dementia. However, a significant proportion of both groups reported negative 
experiences, most commonly related to aspects of the assessment process or memory 
service or a perceived lack of information provision. These mixed reports are in keeping with 
the findings of the Dutch study of patients and carers attending memory clinics (van Hout et 
al., 2001) but no previous studies have specifically focused on the discrepancy between 
patient and caregiver experiences at memory clinics. 
It may be that differing expectations on the part of patients and caregivers attending memory 
clinics go some way to explaining the discrepancies in the degree of satisfaction they 
describe. Indeed, a study of memory clinic users in Ireland found that, while patients 
described general expectations of being provided with ‘help’, carers had more specific 
expectations, such as identification of the cause of the patient’s memory problems and 
provision of treatment (Cahill et al., 2008). In a similar vein, a German study of participation 
preferences of people with amnestic MCI found significant discrepancies between the 
degree of involvement in decision making that patients stated they would like compared to 
the degree of involvement that caregivers wanted them to have (Hamann et al., 2011). This 
finding may reflect different expectations on the part of patients and caregivers regarding the 
process of assessment at memory clinic.  
The most common suggestion for improving services, from both the PWMCI and advocates, 
was the provision of more information. Both groups described a variety of similar topics on 
which they would like further information including coping strategies, treatment options, 
feedback of test results and what they could do to prevent further deterioration. Some 
advocates also mentioned that they would like information on sources of available support – 
a topic not brought up by the PWMCI. Information provision has been mentioned by several 
authors of observational studies in this area when making suggestions for improvements to 
services for PWMCI and their carers (Adams, 2006, Joosten-Weyn Banningh et al., 2008, 
Blieszner et al., 2007, Kuo and Shyu, 2010, Austrom and Lu, 2009, Lu and Haase, 2011). A 
number of advocates were interested in the possibility of psychological support, either for 
themselves and / or the PWMCI. Where advocates mentioned this topic it was either in the 
context of ‘support groups’ involving other PWMCI or advocates or individual sessions with a 
healthcare professional to discuss the difficulties they had encountered. Few of the other 
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suggestions made in the literature, such as cognitive rehabilitation and physical training, 
were spontaneously mentioned by the PWMCI or advocates in this study. 
Many in the MCI group did not have any suggestions for improving services – often stating 
that they didn’t feel improvements were required. Again, this attitude may be, at least in part, 
related to decreased insight in the PWMCI interviewed. In contrast, whereas some 
advocates did not feel that changes to services were needed (or, in some cases, possible), 
most did have suggestions for improvements: These generally related either to provision of 
information (as described above), changes in the assessment process or interaction with the 
memory services, for example improvements in communication. 
3.5 Summary 
The PWMCI and advocates in this study described noticing a range of cognitive changes 
and resulting functional limitations in keeping with the common symptoms of MCI. Many also 
described negative emotional consequences, although it was not uncommon for there to be 
a discrepancy between the PWMCI and the linked advocate in this area – with the advocate 
often describing a greater degree of distress than the PWMCI. Subjects who had had 
previous experience of dementia in a family member or close friend were particularly likely to 
express anxiety about the PWMCI’s cognitive problems. 
Attributions for symptoms varied in both the MCI and advocate group and differences 
between the two groups were also evident here: PWMCI most commonly ascribed their 
symptoms to ‘normal ageing’ whereas advocates were more uncertain as to the cause, often 
blaming physical health problems. Some advocates were aware of the term ‘mild cognitive 
impairment’ pertaining to the PWMCI’s condition but few of the interviewees with MCI were. 
Both groups described a perceived lack of provision of information and formal support by 
healthcare services, although advocates were much more likely to report that this had been 
a source of distress for them than PWMCI were. Overall, PWMCI were more likely to report 
neutral or positive experiences of health care services than advocates, whose reports were 
frequently negative. Most advocates had suggestions for improvements to services, whereas 
many of the PWMCI stated that they didn’t think any improvements were necessary. The fact 
that PWMCI reported less dissatisfaction with their experiences of healthcare and less desire 
for changes to be made should be interpreted in light of the possible reduced recall and / or 
insight in this group. The commonest suggestion from both groups was that more 
information about topics related to MCI should be provided. 
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Overall, the results of the interviews suggest that the experiences of advocates differ 
markedly from the experiences of the PWMCI themselves in many areas. This should be 
taken into account designing assessment tools and support measures for these groups. 
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Chapter 4: Questionnaires 
4.1 Introduction 
The aims of this part of the study were twofold: Firstly, to produce draft versions of the 
outcome measures for people with mild cognitive impairment (PWMCI) and advocates, to 
refine the number of items in these measures thus producing the final versions of the 
outcome measures (the MCQ and MCQ-Carer) and to assess the domains being measured 
by the MCQ and MCQ-Carer items. The second aim was to establish which of the issues 
relating to healthcare identified by analysis of the interview data were deemed to be 
particularly important by a larger group of subjects. In order to achieve these aims, 
questionnaires incorporating the draft versions of the MCQ (or MCQ-Carer for advocates) 
and a survey about experiences of healthcare were administered to patients and advocates 
by post. In the first part of this chapter the methods by which the questionnaires were 
developed, administered and analysed are described. The advantages and limitations of the 
methods used are also discussed. In the second part of the chapter the results of factor 
analysis of the datasets obtained from administration of the draft versions of the outcome 
measures and the results of the descriptive analysis of the healthcare experiences survey 
data are given. In the final part of the chapter the final versions of the MCQ and MCQ-Carer 
are presented and the results of the descriptive analyses are discussed and summarised. 
4.2 Questionnaire methodology 
4.2.1 Initial Questionnaire Development 
The analytical framework presented in Chapter 3 was used to guide analysis of the interview 
data (using NVivo software (version 9)) as described. NVivo is a qualitative data analysis 
software package which facilitates the organisation and structuring of text based data. The 
results of the coding process were used to identify the themes which recurred most 
frequently across the PWMCI and advocate interviews. Using these themes as a basis two 
questionnaires were developed – one for PWMCI and one for advocates. Themes were 
included in the draft versions of the questionnaires where they either recurred frequently or 
appeared particularly salient. Each questionnaire comprised two sections: The first section, 
which contained items relating to subject quality of life (QoL), was the draft version of the 
Mild Cognitive Impairment Questionnaire (MCQ) or, in the case of advocates, the Mild 
Cognitive Impairment Questionnaire for Carers (MCQ-Carer). The second section, the 
‘healthcare experiences survey’, contained items relating to the subject’s experience of 
healthcare services and opinions about how these might be improved. A section on ‘subject 
background’ was included to provide information on basic participant demographics and a 
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previously validated generic measure of health status (the Medical Outcomes Study short 
form health survey, 12 item version, version 2 (SF-12v2)) (Ware et al., 1996) was included at 
the end of the questionnaire. 
The initial drafts of the questionnaires were reviewed by an expert panel consisting of: a 
Professor of Geriatric Medicine with a specialist interest in memory disorders, a consultant 
old age psychiatrist and a professor of Health Services Research with a specialist interest in 
the measurement of health related quality of life (HRQL) and the evaluation of patient 
experiences of medical care. As a result of this process the drafts were refined: items which 
were deemed to duplicate concepts were combined and those seeming to incorporate more 
than one concept were split. The QoL items included in the instrument were written, as far as 
possible, using language that reflected that used by the interview subjects. 
A similar process was used to develop the ‘healthcare experiences survey’ part of the 
questionnaires. The initial drafts of the questionnaire were reviewed and refined by the group 
of individuals with a specialist interest in this field as described above. Some additional 
items, based on those used in the 15 item Picker Patient Experiences Questionnaire (PPE-
15) (Jenkinson et al., 2002) were included on the basis of the professional judgement of the 
group. The PPE-15 is a validated, reliable measure of patient experience of healthcare 
which is used to measure the quality of care in several countries including the UK. 
The QoL section was laid out as a set of 17 statements describing phenomena that the 
respondent might have experienced with a Likert type rating scale for the subject to 
complete (Likert, 1932). The response options given were: ‘never / rarely / sometimes / often 
/ always’.  
The ‘healthcare experiences survey’ section was divided into sections entitled ‘Your 
Experiences at the GP and Memory Clinic’, ‘Your Support and Sources of Information’ and 
‘Improvements to Services and Information’ each of which included several questions 
relating to these topics. The response options were a mixture of ‘yes/no’, Likert scales (with 
response options ‘yes / to some extent / no’) or ‘tick all that apply’. 
4.2.2 Focus Group Consultation 
A draft of each of the questionnaires was produced as described above; these were shown 
to a focus group comprised of PWMCI and their advocates. The PWMCI were identified from 
a local research database; they were each sent an invitation to attend a two hour session, 
with a suitable advocate if possible, during which they would take part in an informal 
discussion about the questionnaire. Eleven PWMCI attended the focus group, each with an 
advocate. Focus group participant demographics are summarized in Table 1: 
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Group Demographic Value 
PWMCI Age (years) – range, mean 63-86, 75.9 
(N = 11) Gender (N male) 7 
Advocates Age (years) – range, mean 42-84, 71.0 
(N = 11) Gender (N male) 3 
 Relationship to patient (%) Spouse: 8 
  Other relative 1 
  Friend 2 
Table 1. Questionnaire focus group participant demographics 
At the beginning of the focus group session a brief introduction was given in which the 
nature of the study and the development of the questionnaires was outlined. It was 
emphasized that the main purpose of the session was for participants to comment on the 
contents, layout and ease of completion of the questionnaires and it was explained that it 
was not necessary to complete the questionnaires in their entirety (unless they wished to do 
so). 
As mentioned above, participants were recruited from a local research database. 
Consequently many of the PWMCI had received their diagnosis during participation in 
research rather than via a clinical memory service. It was therefore mentioned during the 
introduction that those parts of the questionnaire relating to ‘experiences of memory 
services’ may not have been directly applicable to all members of the focus group. Those 
who had not had contact with memory services were asked to respond to the questions 
relating to that topic by simply commenting on their wording and layout rather than whether 
they seemed relevant to their experiences.  
Participants were divided into a mild cognitive impairment (MCI) group and an advocate 
group and each participant was given the appropriate questionnaire and a sample version of 
the letter and information sheet which would accompany it when being used in the study. 
They were given approximately 30 minutes to read through the information and 
questionnaire and told that, at the end of that time, they would be asked for their feedback. 
They were given the option of either writing comments on the questionnaire or providing 
feedback verbally, whichever was their preference. 
At the end of the 30 minute review period participants were asked individually for their 
feedback regarding questionnaire content, layout and ease of completion. Verbal responses 
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were audio-recorded and written responses collected. The responses were reviewed and 
summarized. Those points deemed to be particularly relevant and those raised by two or 
more participants, were taken into account in revising the draft questionnaires. 
4.2.2.1 Focus Group Feedback Summary – Mild Cognitive 
Impairment Group 
The PWMCI in the focus group gave feedback about most aspects of the questionnaires; 
this feedback is summarized below: 
Overall, the feedback regarding the contents, layout and wording of the questionnaire was 
positive. Several minor formatting improvements were suggested. It was suggested that an 
option for ‘not sure’ or ‘can’t remember’ be added for several questions where distant recall 
was required (specifically the timing of the last memory clinic appointment and questions 
pertaining to patient experiences during their appointments with the general practitioner (GP) 
and memory clinic). It was also suggested that not all PWMCI would necessarily have seen 
their GP about their memory prior to being referred to memory clinic and that there should be 
an option to state this in the relevant section. 
Three questions appeared to require changes to their wording: The meaning of the question 
‘Would you have liked to have been assessed using tests that seemed more appropriate for 
mild memory problems?’ was queried by two subjects who asked for further clarification. 
Some subjects gave information in the ‘other comments’ section about the fact that, despite 
their best efforts and for various reasons, they did not feel it was possible for the health 
service to address all their needs. The question ‘Do you feel that there’s not much anyone 
can do for you at present?’ had been designed to describe this concept, but the fact that 
PWMCI included these comments elsewhere suggested that the wording of this question 
may not have adequately conveyed its meaning. The meaning of the QoL item ‘Worry about 
feeling ‘slowed down’ in both mind and body’ was queried as appearing to refer to two 
separate concepts. 
 
Few subjects suggested the inclusion of additional questions. However, several did mention 
in the ‘other comments’ section that a significant problem with their care had been a lack of 
coordination between services. This is something which reflected observations made by a 
number of the interviewees in the semi-structured interviews and which had not been 
included in the questionnaire at this point. 
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There were two areas where a clearer explanation about the rationale for collecting 
particular information appeared to be required: Several subjects queried the need to collect 
demographic information, particularly about ethnicity, and a number commented that the SF-
12v2 questions appeared incongruous with the main part of the questionnaire to the extent 
that they were unsure about the need to complete them. 
There were some minor difficulties in obtaining full feedback from all subjects attending the 
focus group: Despite the fact that the invitation to the feedback session was carefully worded 
to explain the nature of the questionnaire and the rationale for inviting each participant, two 
subjects felt that the questionnaire was not applicable to them as they did not agree that they 
had any memory problems. The fact that some of the subjects had not had any contact with 
memory clinics (having received their diagnosis via the local research group) also caused 
some difficulties: Despite the explanation at the beginning of the session that it was 
understood that not all subjects had been in contact with memory clinics and the directions 
simply to give general feedback about the sections pertaining to their experiences at clinic if 
this was the case, several subjects felt unable to comment on these sections at all if they 
had not attended a clinic. 
4.2.2.2 Focus Group Feedback Summary - Advocates 
Advocates in the focus group also provided feedback about most areas of the questionnaire 
designed for their use; this is summarized below: 
Again, the overall feedback regarding the contents, layout and wording of the questionnaire 
was positive. Several advocates commented on how pleased they were to be asked about 
their experiences and health concerns as they felt that these issues had been neglected in 
their contact with healthcare services thus far.  
It was pointed out by one participant that a more specific description of who the 
questionnaire was intended for would be helpful. Despite classifying herself as a ‘relative 
who might have been affected by the PWMCI’s memory problems’ (the definition of advocate 
given in the participant literature) she had contact with the PWMCI less than once a week on 
average and, consequently, felt she would be unable to answer many of the questions in the 
questionnaire. 
Topics for some additional questions were suggested for inclusion and several of these 
reflected subjects which had been raised by advocates in the semi-structured interviews but 
not included in the questionnaire at this point: One participant suggested including an item 
about the ‘loss of partnership’ she had experienced, for example in social situations or for 
holidays. As in the MCI group, the lack of coordination of services was mentioned several 
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times and one participant commented that she was concerned about the practice of 
providing feedback about test results at a follow-up appointment and the delays involved in 
this. 
Like the MCI group, some advocates queried the need to collect demographic information, 
particularly about ethnicity. Several also commented that the SF-12v2 questions not only 
appeared incongruous with the main part of the questionnaire but that, because the focus 
had shifted abruptly from the PWMCI to them, they were not clear who the SF-12v2 
questions referred to. 
As for the PWMCI who had not attended a memory clinic, several of their linked advocates 
also felt unable to comment on the sections of the questionnaire which asked about their 
experiences at clinic. 
4.2.3 Final Revisions to Questionnaires 
The feedback from the focus group described above was discussed by the expert panel 
involved in the initial questionnaire development. Following this process a number of 
changes were made to the draft questionnaires, the most important of which were as follows: 
In the PWMCI questionnaires a number of minor changes to the wording of questions were 
made to ensure clarity of meaning, the option to answer ‘not sure’ was added to several 
questions (particularly those where an element of recall was required), an item about 
‘coordination of healthcare services was added and a short explanatory paragraph was 
included before the SF-12v2 in order to emphasise and clarify the need for subjects to 
complete it. The same changes were made to the advocate questionnaires; in addition a 
guide as to who should complete the questionnaire was added (incorporating the suggestion 
that they should have contact with the PWMCI at least twice per week), as was a new item in 
the QoL section regarding ‘loss’ of the person with MCI and an emphasis on the fact that it 
was the advocate’s views (rather than the PWMCI’s) that were being sought. Full details of 
the changes made are given in Appendix 3. The final versions of the questionnaires are 
included in Appendix 4. 
4.2.4 Questionnaire Administration 
The questionnaires developed in the process described above were administered to a group 
of PWMCI and a group of advocates. Subjects with MCI included in this ‘questionnaire stage’ 
of the study were identified from memory clinics (and ‘analogous services’) and research 
databases. ‘Analogous services’ were defined as ‘equivalent memory services being 
provided outside the ‘traditional’ setting of a hospital outpatient memory clinic’, for example 
services provided in the patient’s home by community mental health teams (CMHTs).   
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Inclusion criteria for PWMCI for this part of the study were: being 50 years of age or older, 
having had a diagnosis of MCI confirmed (using whichever criteria the diagnosing clinician 
applied) at a memory service within the past 12 months and being able to read and write in 
English. 
‘Recruitment packs’ were given out at memory clinics (and ‘analogous services’) in 
Oxfordshire, Buckinghamshire, Northamptonshire, Leicestershire and North London to 
eligible patients who had been given brief verbal information about the study and had 
indicated that they were interested in taking part. The recruitment packs included a patient 
information sheet, the patient questionnaire, a pre-paid envelope in which to return the 
questionnaire and an advocate ‘recruitment pack’, in a separate, labeled envelope. The 
patient was asked to complete the questionnaire (either in clinic or at home) and to return it 
in the pre-paid envelope; they were also asked to pass the advocate ‘recruitment pack’ on to 
a suitable advocate if available. 
‘Recruitment packs’ were also sent out to eligible subjects on the following research 
databases: 
• Oxford Project to Investigate Memory and Aging (OPTIMA) research database 
• Thames Valley Dementia and Neurological Diseases Research Network (DeNDRoN) 
Network research database 
• Dementia Electronic Prescribing and Research Contact System’ (DEEPARC) 
database (Oxfordshire and Buckinghamshire) 
• Derwent Memory Clinic research database (Essex) 
• Berkshire Healthcare NHS Foundation Trust Memory Clinic research database 
• Northamptonshire Healthcare NHS Foundation Trust Memory Clinic research 
database 
• Avon and Wiltshire Mental Health partnership NHS Foundation Trust Memory Clinic 
research database 
• Imperial College Healthcare NHS Foundation Trust Memory Clinic research database 
• The West London Dementia Registry (DemReg) 
• The North Thames Dementia Registry (DemReg) 
The recruitment packs included the same material as those used in clinic together with a 
covering letter explaining why the pack had been sent. Those subjects with MCI who had not 
replied within two weeks were sent a reminder letter about the study. 
Advocates were recruited via PWMCI. Inclusion criteria for advocates were: being aged 18 
or over, being a relative or friend of the PWMCI (and preferably in contact with them at least 
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twice per week) and being able to read and write English. As mentioned above, the patient 
’recruitment pack’ included a separate envelope containing the advocate ‘recruitment pack’. 
The information given to the patient included a request for them to pass this pack on to ‘a 
friend or relative who you feel may have been affected by your memory problems, and who 
you are in contact with at least twice a week’. The advocate recruitment pack included a 
covering letter, an information sheet, the advocate questionnaire and a pre-paid envelope in 
which to return the questionnaire. The advocate was asked to complete the questionnaire 
and return it in the pre-paid envelope. The questionnaires for the PWMCI and the advocate 
supplied in each pack were given linked identifier codes, this was the only identifying 
information included on the returned questionnaires.  
All subjects on the research databases used for recruitment had given prior consent to being 
contacted for the purposes of research. Consent to involvement in this study was implied by 
completion and return of the questionnaires (this was explained in the information supplied 
to subjects). Ethical approval for this part of study was obtained from the Southampton and 
South West Hampshire Research Ethics Committee (REC) (B) and the Research and 
Development (R&D) departments of each hospital trust involved.   
The aim was to obtain at least 100 completed questionnaires from each group to ensure a 
sufficient sample size to allow evaluation of the psychometric properties of the outcome 
measures under development. 
4.2.5 Analysis of Questionnaire Data 
4.2.5.1 Data entry  
The completed questionnaires returned by study subjects were collated and logged and the 
data was entered into an Excel (2010) spread sheet. Difficulties with data entry were 
addressed as follows: Where contradictory information was given (e.g. the age of an 
advocate and their specified relationship to the patient being incompatible) – the information 
was corrected if there was sufficient information in other sections of the questionnaire to do 
so, otherwise it was entered as it was given in the questionnaire. Those subjects stating that 
their last clinic appointment was more than 12 months ago were not excluded from data 
analysis. Where a ‘multiple entry’ was given (i.e. two or more boxes were ticked) for items 
where the instruction had specified ‘tick one box only’ the data was coded as missing. Where 
no box was ticked for items where the instruction had specified that an option be chosen 
(e.g. those with Likert scales or ‘yes’/’no’ options) the data was also coded as missing. 
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All data analysis was performed using the SPSS 18.0 computer programme. Analysis of the 
data from the demographic section, the healthcare experiences survey and the QoL 
questionnaire was carried out separately for the PWMCI group and the advocate group. 
4.2.5.2 Statistical Analysis of Quality of Life Data 
QoL items with high floor or ceiling effects were removed as were those with greater than 
10% missing data. A figure of 40% or more of respondents answering ‘never’ or ‘always’ was 
used as a guide to identify items with high floor or ceiling effects respectively. Correlations 
were calculated between items to ensure none were very highly correlated (i.e. greater than 
0.8) and therefore tapping the same issue. The data was then analysed using exploratory 
factor analysis in which items most strongly interrelated tend to gain high loadings on a 
single factor suggesting they are assessing the same underlying concepts. Varimax rotation 
was used to produce an orthogonal solution. Factors with an eigenvalue of greater than 1 
were retained in the analysis. Where item loading was less than 0.4 on a factor the item was 
removed and where items loaded onto more than one factor they were included in the scale 
which seemed more theoretically meaningful. 
Cronbach’s alpha statistic (Cronbach, 1951) was used to assess the internal consistency of 
each domain identified by the factor analysis. 
The total item scores for each domain identified by the factor analysis were transformed to 
create a scale score as follows: scale score = ((total of the raw scores of each item in the 
scale minus the number of items in the scale) divided by (the maximum possible raw score 
of all the items in the scale minus the number of items in the scale)) multiplied by 100. Scale 
scores ranged from 0 (best i.e. no problem at all) to 100 (worst i.e. maximum level of 
problem) 
Construct validity was examined by correlation of the scale scores with scores from  the SF-
12v2 mental health component score (MCS). It was hypothesised that those scales relating 
to the emotional aspects of living with MCI would correlate most highly with the MCS i.e. the 
‘emotional effects’ scale in the MCQ and the ‘anxiety’ and ‘relationship effects’ scales in the 
MCQ-Carer. 
4.2.5.3 Statistical Analysis of the Healthcare Experiences Survey 
Data 
Prior to analysing the ‘healthcare experiences survey’ data, responses for some questions 
were converted to problem scores:  In several sections of the survey subjects were asked 
about aspects of the care they had received from healthcare services; the reply options 
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given for these questions were:  ‘yes’, ‘to some extent’, ‘no’ or ‘not sure’. For the purposes of 
analysis, the responses ‘no’ and ‘not sure’ were combined to give a ‘problem score’ and ‘yes’ 
was taken to indicate a ‘no problem score’. In a small number of cases the item was coded 
in the opposite direction – in these cases the responses ‘yes’ and ‘to some extent’ were 
combined to give a ‘problem score’ and ‘no’ taken to indicate a ‘no problem score’. In all 
cases a response of ‘not sure’ was coded as missing data.  
The proportion of subjects falling into each response category for the healthcare experiences 
survey questions was calculated, using problem scores where these had been generated. 
For most questions the percentage of subjects falling into each response category was 
calculated as a proportion of the overall number of questionnaire respondents (i.e. including 
those who had not answered that particular question and were therefore counted as 
‘missing’).  An exception to this was the question about whether the subject had been 
present when the linked PWMCI / advocate underwent their assessment at memory clinic – 
in this case the percentages were calculated as a proportion of those who had answered the 
question. 
Multivariate regression analysis was used to explore the data from the PWMCI surveys 
further:  
In order to establish whether PWMCI’s opinions about improvements to various aspects of 
the memory clinic were related to their mental health (as measured by the SF-12v2 MCS) 
regression analysis was performed using subjects’ problem scores for the ‘possible 
improvements to memory clinic’ items from the ‘healthcare experiences survey’ (together 
with age and sex) as independent variables and the SF-12v2 MCS as the dependent 
variable. To establish whether to subjects’ QoL, as measured by the MCQ, was related to 
their opinions about improvements to the memory clinic this regression analysis was 
repeated using the scale scores from the MCQ as the dependent variable. 
Cronbach’s alpha statistic (Cronbach, 1951) was calculated to establish whether the problem 
scores from the ‘possible improvements to memory clinic’ items could be summed to 
produce a valid summary score reflecting overall subject experience of healthcare services 
i.e. a ‘healthcare experience summary score’.  
In order to establish whether PWMCI’s experiences of individual aspects of their care at 
memory clinic were related to the overall ‘healthcare experience summary score’ described 
above, regression analysis was performed using subjects’ problem scores for ‘going to the 
memory clinic’ items (together with age and sex) as independent variables and their 
‘healthcare experience summary score’ as the dependent variable.  
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4.2.6 Discussion of Methods Used 
4.2.6.1 Questionnaire Development 
The overall methods used to develop the questionnaire in this study were chosen as they 
have been shown to be effective in the development of similar questionnaires in the past 
and, in many areas, were compliant with the United States Food and Drug Agency’s (FDA) 
guidance on the development of patient reported outcome measures (RPOMs) (US 
Department of Health and Human Services et al., 2009): For example, the FDA guidance 
suggests that, in the early phase of development, the domains intended be measured by the 
PROM should be guided by review of the relevant literature and expert opinion and that, in 
the subsequent phases of development, patient interviews, focus groups and qualitative 
cognitive interviewing should be used to refine these initial domains and generate the final 
items to be included in the instrument. Wackerbarth et al. used a similar method to that 
described here (semi-structured interviews followed by focus group discussion) to generate 
items for a survey of carers’ reasons for seeking memory assessment for linked patients 
(Wackerbarth et al., 2002). They compared the items they generated by this method to two 
previous studies exploring the same topic which had used only literature reviews and focus 
groups to generate items. They found that their method generated 34 unique items not 
generated by the two previous studies and missed only 6 identified by those studies. They 
concluded that researchers should consider generating survey items for undocumented 
phenomena using ‘informant interviews followed by focus groups to confirm themes because 
of the comprehensiveness of items generated’. 
To ensure content validity, the content and wording of the items in the questionnaire were 
based on the concepts raised, and language used, by the interview subjects in the first stage 
of the study. This is in accordance with the FDA guidance, which states: ‘The exact words 
used to represent the concepts measured by domain or total scores should be derived using 
patient input to ensure the conclusions drawn using instrument scores are valid’. Revision of 
the draft questionnaires with input from the focus group is also in line with the guidance, 
which states that the target population ‘should be involved in evaluating the completeness of 
item coverage and performing initial an assessment of.. clarity and readability’. 
Where interview subjects had displayed poor recall about a particular topic area, for example 
PWMCI’s’ experiences of consultation with their GP, the number of frequently recurring 
items relating to that topic tended to be low. Therefore, for these topics, professional 
judgement was used to include additional items in the questionnaires which seemed likely to 
be relevant to the target study population. These items were selected from those included in 
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the short form version of the PPE-15 questionnaire, as described above (Jenkinson et al., 
2002).  
It was decided that questions about potential improvements to services should relate to 
memory services only as it was intended that these should be the main focus of any draft 
guidance produced as a result of the study. It was not intended that guidance for GPs was 
should be produced for two reasons: firstly, the topic of patient satisfaction with GP 
consultations is a large one and outside the scope of this research project. Secondly, as the 
subjects interviewed in the first part of this study were recruited following memory service 
consultations (rather than following consultations with GPs specifically about memory) it was 
difficult to be certain what the agenda of initial consultation with the GP actually was. 
Therefore subjects’ comments about their GP’s management of their memory problems may 
not have reflected the GP’s usual practice in a consultation about memory. 
Careful consideration was given to the response options provided in the questionnaire. A 
Likert scale was chosen for the MCQ and MCQ-Carer because it has been successfully 
used in other well validated, widely used questionnaires e.g. The 40 item ALS assessment 
questionnaire (ALSAQ-40) (Jenkinson et al., 1999),  the Endometriosis Health Profile-30 
(EHP-30) (Jones et al., 2001) and the Medical Outcomes Study 36-Item Short-Form Health 
Survey (SF-36) (Ware and Sherbourne, 1992). For the ‘healthcare experiences survey’ 
section, an option to answer ‘not sure’ was included for questions which required the 
respondent to remember specific details (e.g. those relating to experiences at the GP 
appointment). This was done to give respondents who were unable to recall their 
experiences the option of not answering the question (as suggested by the focus group). 
This had two advantages: it reduced the likelihood that respondents might attempt to guess 
at answers if they had poor recall and avoided any distress which might be caused by the 
subject having to state ‘I can’t remember’. 
Construct validity of the MCQ and MCQ-Carer was assessed by comparing results from 
these measures with similar dimensions of the SF-12v2. The SF-12v2 is a generic, multi-
purpose health survey which provides measures of functional health and well-being as well 
as psychometrically based summary measures of physical and mental health. It was 
included in the survey pack so that the results from the QoL section could be compared with 
the SF-12v2 mental health summary measure to allow an estimation of construct validity. 
This instrument was chosen because it has been well validated, including for postal use (Lee 
et al., 2008a, Chen et al., 2009, Martinez et al., 2008) and extensively used. Although there 
are no published studies in which it has been validated for use specifically in people with 
cognitive impairment the SF-12v2 has been shown to be psychometrically sound for 
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assessing QoL in people with severe mental illness such as psychosis and major mood 
disorders (Salyers et al., 2000). In addition, it has been shown that there is a high degree of 
correspondence between summary physical and mental health measures estimated using 
the SF-12v2 and SF-36 (Gandek et al., 1998) and that the SF-36 has reasonable 
psychometric properties for assessing QoL in people with mild to moderate dementia 
(specifically those with a Mini-Mental State Examination score of 15 or greater) (Novella et 
al., 2001).  
4.2.6.2 Questionnaire Administration 
The methods by which the questionnaires were administered were chosen to allow the 
largest sample to be obtained whilst maximizing the likelihood that the study sample 
remained representative of the target population and that ethical research principles were 
adhered to. 
The inclusion criteria for PWMCI for this stage of the study were similar to the first (interview) 
stage and chosen for similar reasons i.e. to maximize the likelihood that subjects’ diagnoses 
were both accurate and reflected those made in clinical practice. The main difference was 
that the inclusion criteria for the questionnaire stage allowed recruitment of people who had 
had their diagnosis of MCI confirmed (i.e. not necessarily newly made) within the preceding 
12 months (rather than 6 months). These criteria were chosen so that the study sample 
would include people who had been living with MCI for some time as it is likely that people 
with a relatively long history of MCI will form part of the clinical population to whom the 
results of the study are intended to apply. The inclusion criteria for advocates for this stage 
of the study included the stipulation that the advocate should be someone with whom the 
PWMCI had contact ‘at least twice per week’. This suggestion was included (following 
feedback from the focus group) to ensure that advocates being given questionnaires had 
had sufficiently frequent contact with the PWMCI to complete the questionnaire in an 
accurate and meaningful way. 
PWMCI were recruited from memory clinics (and analogous services) and research 
databases in various regions. Whilst this increased the burden of administrative work (e.g. 
obtaining REC and R&D approval for multiple sites) it had the advantage of providing a 
geographically diverse study population who had had contact with a range of different 
healthcare services. The inclusion of subjects listed on research databases allowed 
recruitment of a sufficiently large sample for the purposes of the study which would 
otherwise not have been possible in the time available. It may, however, have introduced a 
degree of selection bias, as some of these subjects had taken part in other research projects 
(e.g. the Oxford Project to Investigate Memory and Aging and the ‘Thinking Fit’ project in 
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Essex) which, whilst not part of their standard clinical care, may have influenced their 
experiences of living with MCI and hence their questionnaire answers. All advocates were 
recruited via PWMCI to ensure that the linked PWMCI was aware of, and in agreement with, 
the advocate’s involvement in the study. 
Consent for involvement in this part of the study was implied by completion and return of the 
questionnaire in order to reduce the administrative burden for the study subjects. The 
implied consent process was clearly explained in the information supplied with the 
questionnaires. Questionnaires were marked with an identifying code, the subject details for 
PWMCI corresponding to each code were known only to the author. This allowed a record to 
be kept of the return rate from the various recruitment sources and meant that reminder 
letters, where necessary, could be sent out at the appropriate time to PWMCI recruited from 
research databases. It also provided reassurance for participants that their answers would 
be confidential between them and the researcher - something which is particularly important 
for those commenting on clinical services who might otherwise feel unable to be honest 
about their experiences.  
The estimated number of completed questionnaires required was calculated based on the 
number of items in the QoL section. It is known that, in order to produce reliable results, 
such questionnaires should be administered to approximately 3 subjects per item with a 
minimum sample size of 100, preferably 120 for a conservative (i.e. large) sample size 
(Barrett and Kline, 1981, Costello and Osborne, 2005) . As there were 17 and 18 items in the 
QoL sections of the PWMCI and advocate questionnaires respectively a minimum sample 
size of 100 was set. 
4.2.6.3 Questionnaire Analysis 
The conventions used for data entry described in Section 4.2.5.1 were set for the following 
reasons: Despite the inclusion criteria stipulating that PWMCI should have been seen in a 
memory clinic (or analogous service) within the preceding 12 months, respondents who 
stated that their most recent clinic appointment was more than 12 months ago were not 
excluded from the analysis. This group was included because the recruitment mechanisms 
used strongly suggest that patients recruited for the study were seen within 12 months – 
therefore it is likely that those stating that their appointment was greater than 12 months 
previously did so due to poor recall rather than the appointment genuinely being outside that 
timeframe. As this group may represent a cohort with particularly pronounced memory 
impairment, and therefore possibly a particular set of support needs, it was decided that they 
should not be excluded from the analysis. Furthermore this group was small in number, 
including only 6 subjects 
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There are various options for dealing with ‘multiple entry’ data; the option to code it as 
‘missing’ was chosen as this allows easy identification, via the high proportion of missing 
data, of items which are ambiguous and therefore result in a high rate of ‘multiple entry’ data 
and which should therefore be considered for removal from the final version of the measure. 
This approach to dealing with ‘multiple entry’ data is in line with that suggested in the SF-12 
User’s Manual (Ware et al., 2010) 
QUALITY OF LIFE DATA 
The QoL data from the questionnaires was analysed to produce the final versions of the 
MCQ and MCQ-Carer. Data analysis was conducted using SPSS version 18.0, in 
accordance with accepted methods for this type of data analysis (Streiner and Norman, 
2003, Kline, 1999) including the FDA guidance on the development of PROMs (US 
Department of Health and Human Services et al., 2009) e.g. removal of items with a high 
proportion of missing data, those which had high floor or ceiling effects (with 40% subjects 
giving a ‘never’ or ‘always’ response used as a guide for the latter) and those which were 
redundant. As there was no pre-existing hypothesis about the structure of the underlying 
variables, principle components analysis was used to explore the dimensions underlying the 
questionnaire. As per convention, factors with eigenvalues greater than 1 were retained 
(Fayers and Machin, 2000). Orthogonal varimax rotation was used to provide a simple 
structure where each factor included the smallest number of items. As per generally 
accepted criteria, items were included in a factor where they had loadings of 0.4 or greater 
and if items loaded on more than one factor they were included in the scale which seemed 
more theoretically meaningful (Fayers and Machin, 2000). The Cronbach’s alpha coefficients 
were high for all dimensions the MCQ and MCQ-Carer (Sections 4.3.1.1 and 4.3.1.2 for 
details) which suggests that the measures are reliable. 
 
Scores for each domain were transformed into scale scores with a minimum possible score 
of 0 and maximum possible of 100 to facilitate interpretation of scores and comparison 
between scales and groups. 
The construct validity of the MCQ and MCQ-Carer was examined by correlation of their 
scale scores with the SF-12v2 MCS – again in keeping with accepted practice (Streiner and 
Norman, 2003) and  FDA guidance (US Department of Health and Human Services et al., 
2009). It was hypothesised that the scores for the MCQ and MCQ-Carer scales relating to 
underlying ‘emotional’ constructs would be most highly correlated to the SF-12v2 MCS score 
i.e. both scale scores for the MCQ and the ‘anxiety’ and ‘relationship effects’ scores for the 
MCQ-Carer. 
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HEALTHCARE EXPERIENCES SURVEY DATA 
For questions regarding respondents’ experiences of healthcare and desired improvements 
to services the data was converted to dichotomous ‘problem scores’ to facilitate statistical 
analysis. This approach also has the advantage of ensuring that sample sizes in the 
‘problem’ and ‘no problem’ groups do not become too small – a risk when the population is 
divided between the original 4 response categories of ‘yes’, ‘to some extent’, ‘no’ and ‘not 
sure’. This method has been used successfully in other patient experience questionnaires 
such as the PPE-15 (Jenkinson et al., 2002). It is particularly useful in this context as the 
combination of two response categories (i.e. that indicating the problem is present and that 
indicating it is present ‘to some extent’) to form a ‘problem’ score (as opposed to the single 
response, indicating that the problem is not present which generates a ‘no problem’ score) 
‘weights’ the questionnaire towards detecting problems. 
 
The questionnaire items relating to ‘possible improvements to memory clinic services’ were 
chosen as a potential marker of subjects’ overall experiences of healthcare because many of 
these items reflect respondents’ general opinions about their experiences rather than 
relating to one specific time point or detail of their contact with healthcare services (cf. the 
items about subjects’ experiences at the GP and memory clinic). Multiple regression 
analyses were performed to establish whether these items were related to respondents’ 
mental health (as measured using the SF-12v2 MCS) with the intention that, if the analysis 
did show a significant relationship, the scores for the ‘desired improvements to memory clinic 
services’ could be used as a measure of overall subject experience of healthcare. 
Regression analyses were also performed to establish whether the items relating to ‘possible 
improvements to memory services’ were related to QoL as measured by the scale scores 
from the MCQ so that comment could be made about the effect of subjects’ experiences of 
healthcare on the various aspects of QoL measured by these scales and not just mental 
health (as measured by the SF-12v2 MCS). 
The validity of summing the individual items relating to ‘desired improvements to memory 
clinic services’ to produce a summary score was also tested (by calculating the Cronbach’s 
alpha) to establish whether this could be used as a potential single ‘summary’ score of 
subjects’ experiences. Correlations between this summary score and individual aspects of 
respondents’ experiences at the memory clinic were then sought to establish whether 
experience in any of the individual elements could ‘predict’ overall experience.   
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4.3 Questionnaire Results 
4.3.1 Outcome Measure Results 
4.3.1.1 People With Mild Cognitive Impairment: The Mild Cognitive 
Impairment Questionnaire (MCQ) 
The final versions of the draft questionnaires, developed as described in the first part of this 
chapter, were administered to people with mild cognitive impairment (PWMCI). 
Approximately 280 questionnaires were distributed to patients in clinics (and at analogous 
services) and posted to PWMCI listed on research databases. Two hundred and twenty five 
questionnaires were sent to subjects on research databases, 132 (59%) of which were 
returned. One hundred and seventy recruitment packs were distributed to memory services 
55 of which were given to patients, 18 of these (33%) were returned. Therefore in total 150 
completed questionnaires (54%) were returned, 88% of them by subjects recruited from 
research databases. 4 subjects were excluded as their age was below the minimum age cut-
off and therefore 146 eligible subjects were included in the analysis. The subjects ranged in 
age from 52 to 91 years with a mean of 75.4 and a standard deviation (SD) of 7.6. The 
remainder of the demographic details of the subjects are given in Table 2 
Characteristic  Number % 
Gender Male 82 56.2 
 Female 61 41.8 
Ethnicity White 135 92.5 
 Asian 7 4.8 
 Mixed 1 0.7 
Table 2. Demographic details of questionnaire subjects with mild cognitive impairment 
The Medical Outcomes Study short form health survey, version 2 (SF-12v2) Physical Health 
Component Scores (PCS) for PWMCI ranged between 18.5 and 66.4 with a mean of 46.1 
and a standard deviation (SD) of 11.5. Comparing these results to published population 
norms (which are given in Appendix 5) revealed that 66.1% of subjects had PCS at or below 
the 50th centile for the general population. However, when compared to norms for an age 
group more representative of the PWMCI in the study (who had a median age of 76.5, 
therefore a comparison to over 75 year olds in the general population was made) (Ware et 
al., 2007) only 27.4% had a PCS at or below the 50th centile for this age group. SF-12v2 
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Mental Health Component Scores (MCS) ranged between 22.0 and 63.4 with a mean of 46.8 
and a standard deviation (SD) of 9.0; 70.4% of subjects had MCS at or below the 50th centile 
for the general population and 64.5% were below the 50th centile when compared with norms 
for the over 75 age group. 
ITEM REDUCTION AND SCALE GENERATION 
The 17 item QoL questionnaire, developed as described in the first part of this chapter, was 
completed by 146 eligible subjects.  
No items had >10% missing data and none were very highly correlated with other items. 
Four items were removed because of floor effects, these were (% respondents selecting 
‘never’ given in brackets): not being able to take part in hobbies or social events’ (42.8%), 
‘feeling that you have had to cover your memory problems up to avoid upsetting someone 
(51.1%), ‘worry about a change in your personality’ (39.3%), ‘feeling unable to talk to friends 
or relatives about your memory problems because it is upsetting or embarrassing’ (38.6%). 
A factor analysis was performed on the remaining 13 items; two domains were identified 
accounting for 61.8% of the total variance: 
Emotional effects (6 items): This domain addresses the emotional effects of living with MCI 
including irritation/frustration, anxiety, low mood, concern about the future, worry about the 
reactions of others and worry that their memory problems are more severe than those of 
their peers. The Cronbach’s alpha for this domain is of 0.91 which indicates high internal 
consistency reliability by the accepted standard (Streiner and Norman, 2003, Cronbach, 
1951, Nunnally and Bernstein, 1994). 
Practical concerns (7 items): This domain covers the practical effects of living with MCI 
including worry about: having forgotten things (e.g. names), plans or appointments, 
problems with conversation due to memory difficulties, feeling generally ‘slowed down’ or 
less independent and concern about upsetting others. The Cronbach’s alpha for this domain 
is 0.85 which indicates good internal consistency reliability. 
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The rotated component matrix resulting from the factor analysis is given in Table 3. 
 
 
Component 
1 2 
Worry that you have forgotten things such as recent conversations 
or the names of things or people 
.382 .661 
Worry that you have had problems constructing a sentence when 
talking 
.261 .577 
Worry that you have forgotten what you had planned to do .335 .714 
Worry that you have had problems remembering appointments or 
important dates, such as birthdays 
.174 .794 
Worry about feeling generally ‘slowed down’ .308 .632 
Worry that you have upset other people because of your memory 
problems 
.362 .623 
Feeling that you have become less independent because you have 
had to rely on your partner or other people to help you remember 
things 
.407 .650 
Irritation or frustration about your memory problems .723 .356 
Feeling worried about your memory problems .823 .351 
Feeling downhearted or depressed about your memory problems .826 .336 
Worry about other people’s reactions to your memory problems .606 .403 
Worry that your memory problems are more severe than those of 
other people of your age 
.716 .367 
Worry about your memory problems getting worse in the future .825 .250 
Extraction Method: Principal Component Analysis. Rotation Method: Varimax with Kaiser 
Normalization. Rotation converged in 3 iterations. 
 
Table 3. Rotated component matrix resulting from factor analysis of questionnaire quality of life data for 
subjects with mild cognitive impairment  
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The correlations of items to their domain totals and the internal consistency reliability of the 
domains are shown in Table 4. 
Domain Items Corrected 
item to total 
correlation 
Cronbach’s 
alpha 
Emotional effects Irritation or frustration about 
memory 
0.71 0.91 
 Worry about memory 0.82  
 Feeling downhearted about 
memory 
0.82  
 Worry about others’ reactions to 
memory problems 
0.64  
 Worry that memory is worse than 
peers’ 
0.73  
 Worry about memory worsening in 
the future 
0.77  
Practical concerns Worry about forgetting things e.g. 
names 
0.64 0.85 
 Worry about sentence construction 0.51  
 Worry about forgetting plans 0.67  
 Worry about forgetting 
appointments 
0.65  
 Worry about feeling slowed down 0.59  
 Worry about upsetting others 
because of memory problems 
0.61  
 Feeling less independent 0.66  
Table 4. Correlation of MCQ items to total correlations and internal reliability of domains  
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EVALUATING CONSTRUCT VALIDITY 
The ‘emotional effects’ scale was adequately correlated with the SF-12v2 MCS (rho = -.43, 
p<0.001, N = 111) as was the ‘practical concerns’ scale (rho = -.56, p<0.001, N=113). The 
negative correlations reflect the fact that the MCS and the MCQ scale scores operate in 
different directions:  a higher MCS indicates ‘better’ mental health whereas higher MCQ 
scale scores indicate ‘worse’ outcomes. 
FINAL OUTCOME MEASURE 
The final version of the MCQ, developed as described above, is shown in Appendix 6. 
RESULTS OF QUALITY OF LIFE DATA FOR PEOPLE WITH MILD COGNITIVE 
IMPAIRMENT 
The scale scores for PWMCI in the study are shown in Table 5. 
 
Scale Mean 
(SD) 
N Range of 
Scores 
N (%) 
minimum 
score 
N (%) 
maximum 
score 
Emotional 
effects 
46.60 
(24.19) 
137 0 - 100 2 (1.5) 1 (0.7) 
Practical 
concerns 
45.43 
(19.90) 
139 0 - 96 1 (0.7) 0 (0.0) 
Table 5. Descriptive statistics for the dimensions of the MCQ from results of the survey.  
SD = standard deviation, N = number 
4.3.1.2 Advocates: The Mild Cognitive Impairment Questionnaire for 
Carers (MCQ-Carer) 
Of the approximately 280 questionnaires given out via patients in clinics (and analogous 
services) and posted to PWMCI listed on research databases 101 completed questionnaires 
(36%) were returned by advocates. 3 subjects were excluded as the linked PWMCI was 
ineligible for the study therefore 98 advocates were included in the analysis. Respondents 
were aged between 21 and 84 years with a mean age of 66.3 and a SD of 12.8. The 
remaining demographic details of the advocates are summarised in Table 6. 
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Characteristic  Number % 
Gender Male 26 26.5 
 Female 72 73.5 
Ethnicity White 91 92.9 
 Asian 3 3.1 
 Black 3 3.1 
Relationship to 
PWMCI 
Spouse 67 68.4 
 Offspring 17 17.3 
 Other relative 5 5.1 
 Friend 6 6.1 
 Other 3 3.1 
Table 6. Demographic details of the advocate questionnaire subjects 
SF-12v2 PCS for advocates ranged between 19.1 and 65.5 with a mean of 49.6 and a 
standard deviation (SD) of 10.8. Comparing these results to published population norms 
revealed that 54.6% of subjects had PCS at or below the 50th centile for the general 
population. However, when compared to norms for an age group more representative of the 
advocates in the study (who had a median age of 69.5 years, therefore a comparison to 65 – 
74 year olds in the general population was made) only 26.5% subjects had a PCS at or 
below the 50th centile for this age group (Ware et al., 2007). Population norms for the SF-
12v2 are given in Appendix 5. SF-12v2 MCS ranged between 20.7 and 68.7 with a mean of 
48.8 and a standard deviation (SD) of 10.0; 51.6 % of subjects had MCS at or below the 50th 
centile for the general population and 57.0% below the 50th centile for the 65-74 age group. 
ITEM REDUCTION AND SCALE GENERATION 
The 18 item QoL questionnaire, whose development was described in the first part of this 
chapter, was completed by 98 eligible subjects. 
No items had >10% missing data and none were very highly correlated with other items. 
Three items were removed because of floor effects, these were (% respondents selecting 
‘never’ given in brackets): feeling worried about leaving the PWMCI by themselves’ (42.9%), 
‘feeling unable to talk to the PWMCI about their memory problems (42.9%), ‘feeling unable 
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to talk to others about the PWMCI’s memory problems’ (38.5%). A further item ‘feeling less 
worried about the PWMCI’s memory problems than they seem to be’ was removed as it 
appeared to duplicate the concept captured by the item ‘feeling more worried about the 
PWMCI’s problems than they seem to be’. To ensure that the removal of this item did not 
compromise the internal consistency reliability of the domain in which it had been included 
(the ‘anxiety’ domain described below) Cronbach’s alpha was calculated for the domain with 
the item included and with it removed. The alpha value when the item was removed (0.86) 
was greater than when it was included (0.76) suggesting that internal consistency reliability 
was not reduced by the removal of the item ‘feeling less worried about the PWMCI’s memory 
problems than they seem to be’. 
A factor analysis was performed on the remaining 14 items; three domains were identified 
accounting for 65.7% of the total variance. The rotated component matrix resulting from the 
factor analysis is shown in Table 7. 
Anxiety (6 items): This domain addresses the emotional effects of being an advocate of a 
PWMCI, most of which incorporate an element of anxiety: feeling worried or depressed 
about the memory problems, feeling more worried about the memory problems than the 
PWMCI,  feeling uncertain about whether ‘prompt’ the PWMCI and feeling worried or 
uncertain about the future. The Cronbach’s alpha for this domain is 0.87 which indicates 
good internal consistency reliability by the accepted standard. 
Burden (5 items): This domain covers the practical effects of being an advocate of someone 
with MCI including worry about: the PWMCI having forgotten things such as appointments, 
that they are having more difficulty with finances and paperwork, that their personality has 
changed and that they are less independent and feeling increasingly burdened by having to 
help out with financial and administrative matters. The Cronbach’s alpha for this domain is 
0.85 which indicates good internal consistency reliability by the accepted standard. 
Relationship (3 items): This domain covers the effects that MCI had had on the relationship 
between the advocate and the PWMCI including: frustration, relationship difficulties and a 
feeling of ‘losing the person they used to know’. The Cronbach’s alpha for this domain is 
0.67 which indicates acceptable internal consistency reliability by the accepted standard.  
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Component 
1 2 3 
Worry that they have forgotten things such as appointments, 
names or recent events 
.445 .631 -.077 
Worry that they have had problems dealing with bills, finances or 
paperwork 
.041 .900 .072 
Worry about a change in their personality e.g. they seem more 
anxious or irritable 
.357 .589 .312 
Feeling that you are increasingly burdened by having to help out 
with dealing with bills, finances or paperwork 
.369 .632 .388 
Feeling that they are less independent .442 .585 .273 
Feeling unsure about whether to try strategies to ‘prompt’ your 
relative / friend’s memory such as trying to let them remember 
something by themselves 
.534 .339 .167 
Feeling downhearted or depressed about their memory problems .583 .284 .500 
Feeling frustrated or angry about their memory problems .005 .089 .849 
Feeling worried, anxious or stressed about their memory 
problems 
.680 .216 .433 
Feeling more worried about their memory problems than they 
seem to be 
.673 .130 .346 
Worry about memory problems getting worse in the future .846 .244 -.041 
Uncertainty about the future .849 .240 -.045 
Difficulties in your relationship e.g. increased arguments .292 .487 .455 
Feeling you are losing the person you used to know .645 .373 .391 
Extraction Method: Principal Component Analysis. Rotation Method: Varimax with Kaiser Normalization.  
Rotation converged in 5 iterations. 
Table 7. Rotated component matrix resulting from factor analysis of questionnaire quality of life data for 
advocates 
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The correlations of items to their domain totals and the internal consistency reliability of the 
domains are shown in Table 8. 
Domain Items Corrected 
item to total 
correlation 
Cronbach’s 
alpha 
Anxiety Feeling unsure whether to try 
strategies to prompt the PWMCI’s 
memory 
0.51 0.87 
 Feeling downhearted about the 
memory problems 
0.68  
 Feeling worried about the memory 
problems 
0.73  
 Feeling more worried about the 
memory problems than the PWMCI 
0.64  
 Worry about the memory problems 
getting worse in the future 
0.74  
 Uncertainty about the future 0.71  
Burden Worry that the PWMCI has 
forgotten things e.g. appointments 
0.59 0.85 
 Worry that the PWMCI has 
problems dealing with bills or 
paperwork 
0.67  
 Worry about a change in the 
PWMCI’s personality 
0.62  
 Feeling increasingly burdened by 
having to help out with bills etc. 
0.74  
 Feeling that the PWMCI is less 
independent 
0.69  
Relationship Feeling frustrated or angry about 
the memory problems 
0.36 0.67 
Relationship Difficulties in the relationship 0.53  
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Domain Items Corrected 
item to total 
correlation 
Cronbach’s 
alpha 
(continued) 
 Feeling of losing the person they 
used to know 
0.58  
Table 8.  Correlation of MCQ-Carer items to total correlations and internal reliability of domains  
EVALUATING CONSTRUCT VALIDITY 
The ‘anxiety scale was correlated with the SF-12v2 MCS (rho = -.60, p<0.001, N = 80) as 
were the ‘burden’ scale (rho = -.40, p<0.001, N=81) and the ‘relationship’ scale (rho -0.47, 
p<0.001, N = 83). Again, the negative correlations reflect the fact that the MCS and the 
MCQ-Carer scale scores operate in different directions:  a higher MCS indicates ‘better’ 
mental health whereas higher MCQ-Carer scale scores indicate ‘worse’ outcomes.  
FINAL OUTCOME MEASURE 
The final version of the MCQ-Carer, developed as described above, is shown in Appendix 7. 
RESULTS OF ADVOCATE QUALITY OF LIFE DATA 
The scale scores for advocates in the study are given in Table 9. 
Scale Mean 
(SD) 
N Range of 
Scores 
N(%) 
minimum 
score 
N(%) 
maximum 
score 
Anxiety 52.06 
(20.86) 
95 0 - 100 1 (1.1) 1 (1.1) 
Burden 48.26 
(24.05) 
95 0 - 100 2 (2.1) 1 (1.1) 
Relationship 38.18 
(24.26) 
98 0 - 100 10 (10.2) 1 (1.0) 
Table 9. Descriptive statistics for the dimensions of the MCQ-Carer. 
SD = standard deviation, N = number 
4.3.2 Experiences of Healthcare Survey Results 
The  draft QoL measure and the ‘healthcare experience survey were distributed together in 
the form of one single questionnaire, therefore the number of surveys distributed and 
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returned, and the demographic details of the respondents are identical for the QoL measure 
and the healthcare experiences survey  
4.3.2.1 Patient Survey 
EXPERIENCES OF CARE AT THE GENERAL PRACTITIONER 
Most (87.0%) of the respondents had consulted a GP about their memory problems with the 
majority of those who had (61.4%) stating that ‘they had decided to talk to their GP about 
their memory because they were worried’. 
As described in the ‘Methods’ section of this chapter, the responses to the questions about 
PWMCIs’ experiences when they consulted the GP about their memory problem were 
converted to a ‘problem score’ for each item. The percentages of PWMCI reporting a 
problem with the various aspects of GP care are given in Table 10. PWMCI most commonly 
reported problems with aspects of their involvement in the care given by the GP: either 
wanting to be more involved in their care (40.4%), not being given enough information about 
what was happening (39.1%) or not having all their questions answered (23.2%). 
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Aspect of Care % Indicating a 
Problem 
GP acted quickly to get things done 19.2 
Confident in the GP’s ability 15.2 
GP took problems seriously 17.9 
Given enough information about what was happening 39.1 
Given right amount of time with the GP 17.9 
GP answered all questions  23.2 
GP talked as if patient wasn’t there 6.0 
Given enough privacy 1.3 
Would like to have been more involved in decisions  40.4 
Table 10. Percentage of people with mild cognitive impairment reporting a problem with aspects of 
general practitioner care in the ‘healthcare experiences survey’ 
19 subjects, who indicated that they had not consulted a GP about their memory problems, 
were excluded from this part of the data analysis. 
EXPERIENCES OF MEMORY CLINICS 
All respondents had attended a memory clinic; of those who specified when they had 
attended the clinic the majority (76.9%) had done so within the preceding 6 months and 
almost all (95.5%) within the preceding 12 months. 
Subjects were asked about their experiences at memory clinic; problem scores for the 
responses are summarised in Table 11. The most commonly reported problem was concern, 
prior to the clinic appointment, that their memory problems might have been due to a more 
serious diagnosis than MCI (64.2%). Other commonly reported problems related to the 
PWMCI’s involvement in their care: not being given all the information that they wanted 
(31.1%), the results of tests not being explained in a way that the PWMCI could understand 
(29.1%) and not feeling sufficiently involved with decisions about their care (21.9%). Finding 
the tests performed in the memory clinic stressful or upsetting was also a commonly 
reported problem (26.5%). 
Aspect of Care % Indicating a 
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Problem 
Found tests stressful / upsetting 26.5 
Wait for first appointment too long 23.2 
Gap between appointments too long 19.9 
Given all the information wanted 31.1 
Treated with dignity and respect 5.3 
Prior to appointment, worried that problem was serious 64.2 
Clinic well organised 8.6 
Felt sufficiently involved with decisions 21.2 
Results of tests explained in a comprehensible way 29.1 
Table 11.  Percentage of people with mild cognitive impairment reporting a problem with aspects of 
memory clinic care in the healthcare experiences survey 
72.2% of respondents indicated that they had had their assessments at memory clinic in the 
presence of a friend or relative and the majority of these patients (97.8%) were satisfied with 
this arrangement. 23.0% patients indicated that they had been assessed without their 
relative or friend present, 89.7% were satisfied with this arrangement. 20 subjects answered 
this question in a ‘contradictory’ fashion, indicating that an advocate both had and had not 
been present during their assessment, and were therefore excluded from this part of the 
data analysis. 
CURRENT SOURCES OF INFORMATION AND SUPPORT 
The most common sources of practical and / or emotional support reported by PWMCI were 
spouses (62.5%) and other family members (43.8%); notably only 6.3% reported receiving 
‘formal’ support from health or social care services. Some respondents (9.4%) reported that 
they had not received any help or support at all and a sizeable minority (23.4%) reported that 
they didn’t feel they needed any support at the current time. Of the 12 PWMCI reporting that 
they did not receive any help or support, just over half (N = 7) also indicated that they did not 
feel that they needed any help or support at the current time. 
18 respondents reported that they did not receive any support but simultaneously indicated 
sources from which they had received it – these subjects have been excluded from this part 
of the data analysis (the data was treated as missing). 
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By far the most commonly reported source of information about memory problems was the 
‘memory specialist seen by the patient’ with 72.7% patients indicating that they had found 
them a helpful source of information. Interestingly ‘friends and family’ were the second most 
commonly reported source of information (35.2%) – outranking ‘written material such as 
leaflets’ (28.9 %) and ‘other healthcare professionals’ (28.9%). Only 7.8% had obtained 
information from the internet. 
18 respondents reported that had not received any information but simultaneously indicated 
sources from which they had received it – these subjects have been excluded from this part 
of the data analysis (the data was treated as missing). 
POTENTIAL IMPROVEMENTS TO SERVICES 
The proportions of PWMCI endorsing each of the suggested improvements to services are 
summarised in Table 12.  The most popular suggestions were: the provision of more 
information at the clinic appointment (39.7%), assessment with tests that seem ‘more 
appropriate’ for the nature of their problem (39.0%) and being given more warning of what 
was going to happen at the assessment (32.2%). The concept of ‘being assessed using 
tests that seemed more appropriate for the problem’ was one which was frequently raised by 
interview subjects in the first stage of the study – many of whom felt that the tests they had 
undergone seemed more appropriate for people with more severe memory problems such 
as dementia and that, consequently, they may not have detected the less pronounced 
deficits caused by their mild cognitive problems.  
Only 21.2% respondents felt that they needed any extra support from the clinic at the current 
time and only 24.7% felt that it was possible for the clinic to provide such support. 
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Suggested improvement to service % Endorsing  
Provision of more information at the appointment 39.7 
More time at the assessment 18.5 
More warning of what was going to happen at assessment 32.2 
Shorter assessment 10.3 
More appropriate tests 39.0 
More reassurance from staff 18.5 
Better coordination of healthcare 18.5 
Feels needs extra help / support from memory clinic 21.2 
Feels possible for memory clinic to provide extra help / 
support 
24.7 
Table 12. Percentage of people with mild cognitive impairment endorsing suggested improvements to 
services in the healthcare experiences survey 
Aside from the question about potential improvements to services, subjects were also asked 
which topics they would like further information about and what format they would like to 
receive such information in. In response to the question regarding ‘topics on which they 
would like further information’ a majority of respondents indicated that they would like more 
information in all of the suggested topic areas with the most commonly requested being: 
what the PWMCI can do to prevent their memory getting any worse (93.8%), tips on how to 
get round memory problems (86.5%) and prognosis (82.9%). The least popular answer to 
this question was ‘provision of test results’ – only 58.2% of respondents indicated that they 
would like further information on this topic.  In response to the question about how subjects 
would like information to be provided the most popular choices were: ‘provision of 
information in a ‘face-to-face’ setting by a healthcare professional’ and ‘in writing’ (with 
69.2% and 45.2% requesting these formats respectively). Only 12.3% indicated that they 
would be happy to access information via the internet and 24.0% indicated that they actively 
disliked this option. 
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MULTIVARIATE ANALYSIS OF SURVEY DATA 
Relationship Between Opinions About Improvements to Services and Mental Health 
Multiple regression analyses were conducted to examine the relationship between PWMCI’s’ 
mental health (as measured by the SF-12v2 mental composite score (MCS)) and ‘predictors’ 
including: problem scores for desired improvements to memory clinic services items, age 
and sex. The multiple regression model with all predictors included produced: adjusted R² = 
0.14, F(11, 77) = 2.26, p <0.02 which suggests that, while the linear relationship between the 
variables is statistically significant, the scores for desired improvements to memory clinic 
services are a poor predictor of mental health as measured by MCS.  
Relationship Between Opinions About Improvements to Services and Quality of Life 
Multiple regression analyses were also conducted to examine the relationship between 
PWMCI’s scores for the two scales in the MCQ and the ‘predictors’ mentioned above (i.e. 
problem scores for desired improvements to memory clinic services items, age and sex):  
The multiple regression model for the ‘emotional effects’ scale, with all predictors included 
produced: adjusted R² = 0.16, F(11, 82) = 2.63, p <0.01 which suggests that, while the linear 
relationship between the variables is statistically significant, the scores for desired 
improvements to memory clinic services are a poor ‘predictor’ of the emotional effects of 
living with MCI.  
The multiple regression model for the ‘practical concerns’ scale, with all predictors included 
produced: adjusted R² = 0.12, F(11, 83) = 2.21, p <0.05 which suggests that, while the linear 
relationship between the variables is statistically significant, the problem scores for desired 
improvements to memory clinic services are a poor ‘predictor’ of the impact of the practical 
effects of living with MCI.  
The coefficients generated by the regression analyses described above are given in 
Appendix 8. 
Generation of the Healthcare Experiences Summary Score  
The Cronbach’s alpha for using the sum of the problem scores for the items relating to 
‘possible improvements to memory clinic services’ to produce a single ‘summary’ score was 
0.82. This suggests that items tap an underlying or ‘latent’ trait. 
Relationship Between Healthcare Experiences Summary Score and Experiences of 
Individual Aspects of Memory Clinic 
Multiple regression analyses were conducted to examine the relationship between PWMCIs’ 
overall experiences of healthcare (as measured by the ‘experiences of healthcare summary 
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score’ described above) and their experiences of individual aspects of the memory clinic 
(using the problem scores for these items) when corrected for age and sex. The multiple 
regression model with all items relating to experiences of individual aspects of the memory 
clinic included as predictors produced: adjusted R² = 0.54, F(11,47) = 7.21, p < 0.001 which 
suggests that there is a statistically significant relationship between the variables and that 
the scores for PWMCI’s experiences of individual aspects of the memory clinic are a 
reasonable predictor of their overall experiences of healthcare. The ‘predictors’ with 
significant regression weights were: ‘feeling sufficiently involved with decisions about care’ 
(b=0.28, p<0.02) and ‘test results explained in a way you could understand’ (b = 0.29, p < 
0.02) which suggests that these two items contribute the most to subjects’ overall 
experiences of healthcare. The coefficients generated by the regression analyses are given 
in Appendix 8. 
4.3.2.2 Advocate Survey 
EXPERIENCE OF CARE AT THE GENERAL PRACTITIONER 
Advocates were asked why they thought the PWMCI had consulted the GP about their 
memory problems. The commonest reasons given were: being prompted by friends or family 
to do so (55.1%) or ‘they went of their own accord’ (37.8%).  
About half the advocates surveyed (48.4%) indicated that they had been present when the 
linked PWMCI consulted the GP about their memory problem. The proportion of advocates 
reporting a problem with various aspects care when the PWMCI consulted the GP about 
their memory problems was calculated, these results are summarised in Table 13. The most 
commonly reported problems related to the issue of having to talk about the PWMCI in front 
of them at the GP appointment: 51.0% of advocates reported that they were not able to talk 
to the GP about the PWMCI in private and 22.4% reported that they found it difficult to talk 
about the PWMCI in front of them. Another commonly reported problem was not feeling that 
they had been given sufficient information by the GP (reported by 20.4% advocates). 
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Aspect of Care % Indicating a 
Problem 
GP acted quickly to get things done 6.1 
Able to talk to GP about PWMCI in private 51.0 
GP took PWMCI’s problems seriously 2.0 
Difficult to talk about PWMCI in front of them 22.4 
PWMCI given right amount of time with the GP 4.1 
Advocate given sufficient information  20.4 
GP talked as if advocate wasn’t there 4.1 
Table 13. Percentage of advocates reporting a problem with aspects of care at the general practitioner in 
the healthcare experience survey 
Subjects who indicated that they had not been present when the patient consulted the GP 
about their memory problems were excluded from this part of the data analysis. 
EXPERIENCES OF MEMORY CLINICS 
87.8% of advocates had attended memory clinic with the linked PWMCI. 
The proportions of advocates reporting a problem with various aspects of care at the 
memory clinic are given summarised in Table 14. Some of the most commonly reported 
problems related to waiting times – feeling that the wait for the first clinic appointment or to 
receive feedback at a second appointment was too long (31.4% and 33.7% respectively). 
Other commonly reported problems related to the assessments used at the memory clinic: 
either that advocates found their part of the assessment upsetting (32.6%) or that they did 
not feel the tests used were appropriate for the PWMCI’s memory problems (26.7%). It was 
also not uncommon for advocates to report having unanswered questions remaining at the 
end of the clinic appointment (20.9%). 
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Aspect of Care % Indicating a 
Problem 
Felt tests were appropriate for mild memory problems 26.7 
Long wait for first appointment 31.4 
Would have liked more than one appointment 7.0 
Unanswered questions remaining 20.9 
Found their part of assessment upsetting 32.6 
Clinic well organised 9.3 
Advocated treated with dignity and respect 2.3 
PWMCI treated with dignity and respect 2.3 
Results of tests explained to advocate in a 
comprehensible way 
14.0 
Wait for feedback too long 33.7 
Table 14. Percentage of advocates reporting a problem with aspects of memory clinic care in the 
healthcare experiences survey 
Subjects who indicated that they had not been present at the patient’s memory clinic 
appointment were excluded from this part of the data analysis. 
52.3% of advocates indicated that they had completed their part of the memory clinic 
assessments in the presence of the linked PWMCI, 97.8% of these advocates were satisfied 
with this arrangement. 19.8% of advocates indicated that the PWMCI had been absent 
during their part of the assessment, 82.4% of these advocates were satisfied with the 
arrangement. Again, some subjects (18.6%) answered this question in a contradictory 
fashion and these respondents have been excluded from this part of the data analysis (the 
data was treated as missing). 
CURRENT SOURCES OF INFORMATION AND SUPPORT 
Most advocates reported receiving practical help and emotional support either from their 
spouse (26.5%), other family members (44.9%) or friends (21.4%). Again, the percentage 
reporting that they received support from health or social care services was low (6.1%). 
18.4% respondents indicated that they did not receive any help or support. A significant 
minority (27.6%) indicated that they did not feel they required any help or support at the 
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current time. However, of the advocates reporting that they did not receive any help or 
support only 22.2% reported that they did not feel they needed it. 9 advocates reported that 
they did not receive any support but simultaneously indicated sources from which they had 
received it – these subjects have been excluded from this part of the data analysis (the data 
was treated as missing). 
The most commonly reported sources of information about memory problems were: the 
memory specialist seen by the PWMCI (59.2%), written material such as leaflets (27.6%) 
and the internet (21.4%). 15.3% of advocates reported that they had not received any 
information about MCI.  14 advocates reported that they had not received any information 
but simultaneously indicated sources from which they had received it – these subjects have 
been excluded from this part of the data analysis (the data was treated as missing). 
POTENTIAL IMPROVEMENTS TO SERVICES 
The proportions of advocates endorsing each of the suggested improvements to services 
are summarised in Table 15.  The most popular suggestions for improvements to services 
were: provision of more information (51.2%), a shorter gap between clinic appointments 
(34.9%) and improved communication from the clinic (30.2%). 22.1% of respondents 
reported that they felt they did need extra help or support from the memory clinic. 
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Suggested improvement to service % Endorsing  
Offer of practical support 26.7 
Different type of assessment 18.6 
Improved communication from the clinic 30.2 
Provision of more information 51.2 
Help to talk more openly with PWMCI 25.6 
Shorter gap between appointments 34.9 
Better coordination of healthcare 18.6 
Feels needs extra help / support from memory clinic 22.1 
Feels possible for memory clinic to provide extra help / 
support 
24.4 
Table 15. Percentage of advocates endorsing suggested improvements to services in the healthcare 
experiences survey 
Again, subjects who indicated that they had not been present at the PWMCI’s memory clinic 
appointment were excluded from this part of the data analysis. 
Aside from the question about potential improvements to services, advocates were also 
asked which topics they would like further information about and what format they would like 
to receive such information in. In response to the question about what ‘further information 
they would like’ the majority of advocates indicated that they would like more information on 
all the topics suggested, the most popular being: ‘what they should be doing to help the 
PWMCI with their memory problems’ (87.8%), possible treatments (86.7%) and prognosis 
(83.7%). Although the majority of respondents (66.3%) indicated that they would like more 
information about the PWMCI’s test results this was the least popular suggestion and a 
significant minority (22.4%) reported that they actively did not want to be given more 
information on this topic. In response to the question about how they would like information 
to be provided ‘provision of information by healthcare professionals in a ‘face-to-face’ 
setting’ (60.2%) or ‘in writing’ (43.9%) were the most popular options, only 12.2% indicated 
that they would be happy to access information via the internet. 
MULTIVARIATE ANALYSIS OF SURVEY DATA 
Multivariate analysis was not conducted for the advocate survey data as there were a large 
number of respondents who were missing small amounts of data meaning that the sample 
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size for which complete data was available was too small for meaningful multivariate 
analysis to be carried out. 
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4.4 Discussion of Questionnaire Results 
.  
4.4.1 General 
Recruitment to the ‘questionnaire stage’ of the study was fairly labour intensive, involving 
identification of potential subjects from ten research databases and memory services within 
seven hospital trusts. There was a relatively good response rate (54%) from people with mild 
cognitive impairment (PWMCI) which resulted in the recruitment target (minimum of 100 
completed questionnaires) being exceeded (146 eligible subjects were recruited). Response 
rates were higher from potential subjects approached via research databases (59%) than 
memory services (33%). The fact that 88% of subjects were recruited from research 
databases may have introduced an element of selection bias. 
The response rate from advocates was less good (advocate questionnaires were returned 
for 36% of the 280 advocate recruitment packs supplied to PWMCI to be passed on to 
advocates). Despite this, sufficient numbers of questionnaires were returned to allow the 
data to be analysed. The lower response rate from advocates was probably due to the fact 
that they were recruited via PWMCI included in the study rather than being approached 
directly – it is likely that quite a number of the PWMCI included either did not have a suitable 
advocate, did not wish to invite them to take part in the study or did not remember to do so.  
That the mean age of the PWMCI in the study was 75.4 years and that there was a roughly 
equal split between male and female participants is reflective of the fact that the incidence 
and prevalence of MCI are known to increase with age but that gender is not known to be a 
risk factor (Luck et al., 2010a, Luck et al., 2010b, Ritchie, 2004, Feldman and Jacova, 2005). 
The greater age range (21 – 84 years) and lower mean age (66.3 years) of the advocates in 
the study reflects the fact that approximately one third were non-spousal advocates and 
many of these were offspring of the PWMCI. Approximately three quarters of the advocates 
were female and two-thirds were spouses of the PWMCI, this is in keeping with the fact that 
informal carers in the general population are more commonly female and that, in 60 % of 
carers over the age of 65, the caring responsibility is towards a spouse or partner (The NHS 
Information Centre, 2010).  Approximately 90% of the PWMCI and advocates included in this 
part of the study classified themselves as ‘White British’ with the remainder describing 
themselves as ‘Asian’ (~5%), ‘Mixed’ (~1%)  or ‘Black’ (~2%). These proportions are in 
keeping with the ethnic mix of the general UK population (Office of National Statistics, 2002). 
Both the PWMCI and advocates included in the study appeared to have better levels of 
physical health (as measured by the Medical Outcomes Study Short Form health survey 
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(SF-12v2) Physical Health Component Score (PCS) (Ware et al., 2010)) than those of a 
similar age within the general population. As would be expected, SF-12v2 Mental Health 
Component Scores (MCS) were lower than those in the general population for both PWMCI 
and advocates. Although the population norms used for this comparison are based on SF-12 
data from the United States of America (USA) there is evidence that, for the SF-36 at least, 
algorithms used in the USA and UK give very similar results (Jenkinson, 1999). 
4.4.2 Patient Reported Outcome Measures 
4.4.2.1 Discussion of Statistical and Technical Aspects 
MILD COGNITIVE IMAPIREMENT QUESTIONNAIRE (MCQ) 
Certain items were removed from the MCQ due to a high proportion of respondents 
answering ‘never’. Factor analysis of the remaining items produced two domains (‘emotional 
effects’ and ‘practical concerns’) each of which had high a Cronbach’s alpha statistic 
indicating good internal consistency reliability. Indeed, the Cronbach’s alpha for the 
emotional effects scale was 0.91 and, as this is slightly above the suggested upper cut-off of 
0.9 (Cronbach, 1951, Streiner and Norman, 2003), it may suggest redundancy of items 
within this scale. However, as the statistic was only marginally above the upper cut-off and 
the domain already includes relatively few items it was decided not to attempt to further 
reduce the number of items in this domain.  
Scores for both scales correlated well with the MCS scores for PWMCI which indicated good 
construct validity. This was in keeping with the hypothesis that these scales, both of which 
incorporate significant ‘emotional’ components (as items in the ‘practical concerns’ scale 
mainly relate to worry about the practical challenges of living with mild cognitive impairment 
(MCI) rather than the challenges per se) would correlate with mental health as measured by 
the MCS. 
Finally, the high standard deviations and low percentage of respondents scoring minimum 
and maximum scores for each of the scales indicates that there was a good spread of data 
within both. 
MILD COGNITIVE IMPAIRMENT QUESTIONNAIRE FOR CARERS (MCQ-CARER) 
Certain items were also removed from the MCQ-Carer due to a high proportion of 
respondents answering ‘never’. Factor analysis produced three domains (‘anxiety’, ‘burden’ 
and ‘relationship’), the first two of which had had high Cronbach’s alpha statistics indicating 
good internal consistency reliability. The third domain (‘relationship’) had a lower Cronbach’s 
alpha of 0.67 which indicates adequate internal consistency reliability. These results are 
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promising in terms of the reliability of the measure, further testing on a larger sample would 
be helpful to confirm the reliability of all domains. 
MCS scores for advocates were significantly correlated with scores on the ‘anxiety’ and 
‘relationship’ scales. This was in keeping with the hypothesis that there would be the 
strongest relationship between advocate mental health and scores on scales with a high 
‘emotional’ component and indicates good construct validity. 
The high standard deviations and the low percentage of respondents scoring minimum and 
maximum scores for each of the scales indicate that there was a good spread of data within 
them. 
4.4.2.2 Discussion of Final Versions of the MCQ and MCQ-Carer  
The results discussed above indicate that the MCQ and MCQ-Carer have good 
psychometric properties: Internal consistency reliability is good for all but one domain (in 
which it is adequate) as demonstrated by the Cronbach’s alpha statistics, construct validity is 
confirmed by the fact that there is good correlation between SF-12v2 MCS and scale scores 
for those scales measuring constructs related to emotion and content validity is 
demonstrated by the fact that the measures were developed based on the results of 
interviews with PWMCI and advocates. 
The content of the measures reflects the varied issues which are relevant to PWMCI and 
their advocates: in the case of PWMCI most of these incorporate an emotional element, 
often pertaining to anxiety about the changes they have noticed. In the case of advocates, 
as well as anxiety, the scales also measure constructs relating to burden and the effect on 
the advocate’s relationship with the PWMCI. These elements are all consistent with the 
‘experiences of living with / caregiving in MCI’ described in the literature review in Chapter 2, 
although the process of factor analysis and item reduction involved in development of these 
measures has distilled the varied experiences described in the literature (and in the subject 
interviews in this study) to those which impact most on health related quality of life (HRQL) 
for these groups. 
The MCQ and MCQ-Carer are the first outcome measures designed specifically to assess 
HRQL in PWMCI and their advocates.  One other patient reported outcome measure 
(PROM), the Patient Reported Outcomes in Cognitive Impairment (PROCOG) tool (Frank et 
al., 2006a) has been developed for use in people with cognitive impairment but this includes 
both PWMCI and with mild Alzheimer’s Disease (AD):  the subjects interviewed in the focus 
groups during the initial development of the measure and those surveyed during validation of 
the PROCOG were comprised of roughly equal numbers of subjects with MCI and mild AD. 
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As discussed in the literature review in Chapter 2 it seems likely that the experiences of 
PWMCI and their advocates differ significantly from those in early dementia, therefore the 
fact that the MCQ was developed using only study subjects with a diagnosis of MCI means it 
is likely to be a more valid tool for assessing outcomes in this group than the PROCOG. In 
addition, the PROCOG has only been validated for use in the USA therefore it is unclear 
whether the results would be valid in a UK population. The scope of the PROCOG is much 
wider than the MCQ with a stated aim of ‘assessing symptoms and patient rating of their 
impact on function, behaviour and HRQL’, as a result the tool is lengthy with 55 questions 
which take up to 12 minutes to complete. The purpose of the MCQ and MCQ-Carer is more 
focussed: to assess HRQL in PWMCI / advocates – as a result the MCQ and MCQ-Carer 
are much shorter (with 13 and 14 questions respectively) and less burdensome to complete 
(with an estimated completion time of approximately 2 minutes). Finally, although advocates 
were involved in the development of the PROCOG the tool is designed to measure 
outcomes for PWMCI only, there is no equivalent measure for advocates. 
The MCQ and MCQ-Carer are short, simple assessment tools which could be used easily in 
variety of settings to assess the effect of interventions for these groups. At present the 
assessment of interventions in MCI is hampered by the lack of consensus regarding which 
outcome measures to use in interventional trials making the results difficult to interpret and 
compare (Frank et al., 2011). The MCQ and MCQ-Carer are a potential solution to this: for 
example, the MCQ could have a role in elucidating the effectiveness of single and multi-
component support programmes, trials of which, up to now, have produced conflicting and 
difficult to interpret results (Joosten-Weyn Banningh et al., 2011, Lautenschlager et al., 
2010), due in part to the variation in outcome measures used. In light of the United States 
Food and Drug Administration (FDA)  (US Department of Health and Human Services et al., 
2009)and European Medicines Agency (European Medicines Agency, 2005) guidance on 
the use of PROMs in drug trials it is also possible that the MCQ and MCQ-Carer, after 
appropriate further work, could play a role in the assessment of any pharmacological 
interventions developed for use in MCI in the future.  
4.4.2.3 Interpreting the Scores of the MCQ and MCQ-Carer 
Establishing the magnitude of change in scale scores which would be deemed ‘clinically 
important’ is outside the scope of this thesis. However, the following guide to the 
interpretation of scale scores, which is based on the Likert scale underlying each of the 
domains, could be used: a scale score of 0 – 20 indicates ‘never’ experiencing the 
phenomena represented by the domain, 21- 40 ‘rarely’ experiencing them, 41 – 60 
‘sometimes’ experiencing them, 61 – 80 ’often’ experiencing them and ’81 – 100 ‘always’ 
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experiencing them. This guide might be useful when using the MCQ or MCQ-Carer to 
assess outcome following an intervention, especially if the intervention resulted in a 
‘boundary line’ between categories being crossed. The calculation of a ‘standardised effect 
size’ for each measure could also be used to guide the assessment of the effect of an 
intervention, this is discussed further in Chapter 5 – ‘Potential Avenues for Further Work’. 
4.4.3 Healthcare Experiences Survey 
4.4.3.1 Discussion of Statistical and Technical Aspects 
Rates of missing data were generally relatively low for most questions in the two surveys. 
However, some questions in the PWMCI and advocate surveys resulted in high rates of 
missing or contradictory data which indicates that, in any future versions of the survey, these 
items should be re-worded to improve readability and clarity. The questions to which this 
applied were: those pertaining to whether the linked patient or advocate was present during 
the subject’s assessment at the memory clinic and the questions regarding sources of 
information and sources of support. In the latter two cases it was not uncommon for the 
respondent to select the option ‘I have not received any information / support’ as well as 
indicating sources from which they had received information / support. It may be that, rather 
than instructing respondents to ‘tick all that apply’ for these questions providing ‘yes’/’no’ 
options may have produced less contradictory results. 
4.4.3.2 Discussion of Results of Healthcare Experiences Survey 
PEOPLE WITH MILD COGNITIVE IMPAIRMENT 
Experiences of Care at the General Practitioner 
The problems with care reported by PWMCI who had consulted the general practitioner (GP) 
about their memory problems mainly related to their lack of involvement in their care, for 
example reporting that they did not feel that they had been given enough information about 
what was happening or that they would have liked to have been more involved in decisions 
about their care. As mentioned previously, any guidance produced as a result of this 
research would be for use in memory services rather than in primary care. This is, 
nonetheless, useful information in that it emphasises the fact that PWMCI, despite their 
cognitive complaints, maintain a wish to be fully involved in their care rather than 
relinquishing responsibility to an advocate or ‘carer’ as often happens in dementia. 
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Experiences of Memory Clinic Services 
Respondents very commonly reported that they had been concerned, prior to their memory 
clinic appointment, that their memory problem was of a serious nature. This is in keeping 
with previous studies which have shown that patients often find the time between referral to 
the memory clinic and the appointment a distressing time (Cahill et al., 2008). Although this 
is a natural concern and not one that can be eliminated, it emphasises the importance of 
openly acknowledging and addressing these concerns at the memory clinic. Like 
respondents’ complaints about the care they received from their GP, additional reported 
problems with the memory service related to feeling insufficiently involved with their care, for 
example not feeling that they were given all the information they wanted and not having the 
results of tests explained in a way which was comprehensible to them. This is in keeping 
with the results of the German study of memory clinic patients which confirmed that people 
with mild AD and MCI do wish to be routinely involved in decisions about their care (Hamann 
et al., 2011). These factors should be taken into account when communicating with PWMCI 
in clinic. Respondents did not appear to be particularly concerned about whether their 
assessment took place in the presence of the advocate or separately. 
Current Sources of Support 
Most respondents reported receiving support from family members, very few had received 
support from ‘formal’ health or social care services. About a quarter reported that they felt 
that they didn’t need extra support which implies that the remaining three quarters felt that 
they did need it. 10% of respondents indicated that they did not receive any support at all 
and only 50% of this group reported that they didn’t feel they needed any support – implying 
that the other 50% felt that they needed support but weren’t receiving it. Overall, these 
results indicate that most PWMCI report a need for help and support, that it is mostly 
provided by ‘informal’ sources and that, in a small minority, no support at all is provided 
despite a perceived need for it. 
Current Sources of Information 
The majority of subjects reported receiving information form the memory specialist they had 
seen; the fact that the memory service is the main source of information for PWMCI 
highlights the importance of providing the right information at the memory clinic appointment. 
One third of subjects reported receiving information about their condition from friends and 
family, this emphasises the importance of ensuring that advocates are provided with high 
quality information about MCI as it seems that many PWMCI turn to them for information 
they may not have requested at the clinic or been able to recall subsequently. Only slightly 
more than a quarter of the respondents reported receiving information via written material 
such as leaflets, something which may reflect the relative shortage of information leaflets on 
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this topic, as discussed in the literature review in Chapter 2. Less than 10% of respondents 
had obtained information about MCI from the internet. A recent study of internet usage in 
older people attending a urology outpatient clinic showed relatively low rates of internet 
usage in older patients: 59% of the patients in the 70 -79 year age group had access to the 
internet at home (compared to 100% in the 30-39 year age group) but 42% reported they 
had never used the internet (Macfarlane et al., 2012). The very low rates of internet usage 
reported by the PWMCI in the study are likely to be a reflection of their age, their cognitive 
difficulties (which may interfere with the skills required to use the internet) and possibly 
uncertainty about where to look on the internet for reliable information about health.  
Suggested Improvements to Memory Services 
INFORMATION PROVISION 
About 40% of respondents reported that they would have liked to have been given more 
information at the memory clinic appointment, while this is a significant minority it is worth 
noting that less than half of respondents responded in the affirmative to this general question 
about information provision. However, when asked whether they would like more information 
on specific topics the majority of subjects indicated that they did want more information on 
almost all topics listed (with between 76% and 93% endorsing the various subjects 
suggested) i.e. ‘possible treatments for your memory problems’, ‘tips on how to get around 
memory problems’, ‘what you can do to prevent your memory problems getting any worse’, 
‘the causes of your memory problems’ and ‘whether your memory problems are likely to get 
worse over time’. This is likely explained by the fact that patients may not be aware of areas 
of potential information until they are presented with them. Dissatisfaction with information 
provision at memory clinic appointments has been identified in other studies, such as the 
Dutch survey of memory clinic patients in which only ~40% were satisfied with the clarity of 
the information which they had been given (van Hout et al., 2001).  
 
A notable exception to the positive responses regarding information provision was the 
response to the question ’would you like more information on…the results of tests you have 
had?’, with only 58.2% of respondents answering ‘yes’ to this question (and 24.7% actively 
indicating that they did not want to be given this information). This suggests that PWMCI 
may fall into two groups: those who wish to be given detailed information about their test 
results (as was the case for several of the interview subjects in the first part of the study) and 
those who do not. It is recognised that there are two distinct coping styles in terms of 
information-seeking in response to a ‘health threat’: ‘monitoring’ (i.e. seeking and paying 
close attention to information about the threat) and ‘blunting’ (i.e. avoiding information about 
the threat’) (Case et al., 2005). It seems likely that the degree of information a patient seeks 
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about their test results, which have a particularly high potential to represent a threat to 
health, would be heavily influenced by their coping style. Therefore, a sensible approach in 
clinical practice would be to ask PWMCI how much detail regarding their test results they 
would like to be given so that information on this topic may be tailored accordingly.  
The majority of respondents indicated that they wanted information to be provided ‘face-to 
face’, by a healthcare professional’ and just under half endorsed information being given ‘in 
a written format e.g. letter or leaflet’. It seems likely that a combination of these two 
methods of information provision would be the most effective, especially as it is known that 
patients do not retain all of the information given to them by healthcare professionals, with 
studies suggesting that between 40 and 80% of the information given is forgotten 
immediately and that almost 50% of the information which is remembered is incorrect 
(Kessels, 2003). It has been shown that written information is remembered better by patients 
(Blinder et al., 2001) and of course it can be referred to again at a later date. For this reason 
the provision of written information to PWMCI, who are likely to have even greater difficulty 
with recalling information given during a consultation than the general population, is 
particularly important. Many of the subjects in Cahill’s study of memory clinic users 
expressed a preference for a combination of verbal and written information (Cahill et al., 
2008). Provision of information via the internet was not a popular option, probably due to the 
reasons discussed earlier. However, this finding should not necessarily completely preclude 
the use of the internet for this purpose as it may be that future generations of PWMCI, who 
are more familiar with the use of the internet to access information, would be more amenable 
to obtaining information in this way. 
TESTS USED IN CLINIC 
Respondents commonly reported that they ‘would like to have been assessed using tests that 
seemed more appropriate to the nature of their memory problems’. This is a concept which 
was mentioned by several of the interview subjects in the first part of the study, who felt that 
many of the tests used in the memory clinic appeared to be geared towards people with 
more severe cognitive problems such as dementia and did not take prior educational level or 
intellect into account. In the questionnaire stage of the study, information about which 
assessments the study subjects had undergone in clinic was not available. However, this 
information was available for many of the participants in the interview stage of the study 
(whose clinical notes were reviewed as part of the screening process); the majority had been 
assessed using commonly employed cognitive tests such as the Mini-Mental State 
Examination (MMSE) (Folstein et al., 1975), the Montreal Cognitive Assessment (MoCA) 
(Nasreddine et al., 2005) and the CLOX test (Royall et al., 1998). The MoCA was developed 
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as a screening tool for MCI as to this end does have a high sensitivity (90%) and specificity 
(87%) for this purpose (Nasreddine et al., 2005). Despite the fact that the MMSE is probably 
the most widely used cognitive screening tool in primary and secondary care in the UK its 
value in the detection of MCI remains uncertain; a pooled meta-analysis conducted in 2009 
estimated that it had a sensitivity of just 63% and specificity of 65% for distinguishing MCI 
from normal cognition (Mitchell, 2009). Evidence for the use of the CLOX test in screening 
for MCI is mixed but most studies suggest that it too has poor sensitivity and specificity for 
the detection of MCI (Forti et al., 2010, Ehreke et al., 2010, Lee et al., 2008b). In light of this, 
those PWMCI assessed using the MMSE and CLOX test were technically correct in their 
impression that tests they completed were more appropriate for people with dementia, but it 
should not be forgotten that clinicians in memory clinics are looking to diagnose or exclude a 
range of conditions, including dementia, and therefore the application of these tests at a first 
clinic appointment will very often be appropriate. Therefore it may be that, rather than 
changing the tests that are used in clinic, a clear explanation of the purpose of the tests 
should be given, including reassurance that performance on the CLOX test appears to be 
independent of educational level (Royall et al., 1998) and that scores on the MMSE (Crum et 
al., 1993) and MoCA (Johns, 2008) can be corrected to take education into account.   
 
OTHER SUGGESTED CHANGES 
About one third of respondents stated that they ‘would have liked more warning of what was 
going to happen at the assessment’, this is something which could be addressed fairly easily 
by provision of information in the letter which is sent to patients informing them of the date 
and location of their appointment. 
 
While about a quarter of respondents indicated that they didn’t feel they needed any help or 
support in response to the question about sources of support (implying that the remaining 
three quarters felt that they did need help or support) only one fifth of respondents reported 
that they felt that did need ‘extra help or support from the memory clinic at the moment’. This 
discrepancy is most likely due to patients feeling that they do need extra help and support 
but not that is should necessarily be provided by the memory clinic. In light of this it may be 
helpful to use ‘signposting’ to direct PWMCI to alternative sources of information and support 
e.g. ‘dementia advisor’ equivalents and voluntary organisations. Recommendations about 
the types of additional support which would be helpful for PWMCI are beyond the scope of 
this study, whose focus is issues directly relevant to PWMCI’s contact with healthcare 
services, but these are briefly discussed in the literature review in Chapter 2. 
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Summary Measures of Experience 
Multivariate analysis of the survey data revealed no significant relationship between 
respondents’ opinions about possible improvements to healthcare services and scores on 
the MCS or MCQ scales. This suggests that opinions about improvements to healthcare 
cannot be used as a reliable surrogate marker of the PWMCI’s overall experience of living 
with MCI, possibly due to the effect of difficulties with recall of the details of the clinic 
appointment. However, it was shown that individual aspects of respondents’ experiences at 
memory clinic did correlate well with their overall experience of healthcare (as measured by 
the ‘healthcare experience summary score’, calculated from the sum of the problem scores 
for ‘possible improvements to services’). The items contributing the most to overall 
experience were ‘feeling sufficiently involved with decisions about care’ and ‘test results 
explained in a way you could understand’, this is in keeping with the finding from the initial 
analysis of the survey data. 
ADVOCATES 
Experiences of Care at the General Practitioner 
The problems reported most commonly by advocates who had been present when the 
PWMCI consulted the GP related to having to discuss their concerns in front of the PWMCI, 
with half reporting that they were not able to talk to the GP in private and one fifth that they 
found it difficult to talk about the PWMCI in front of them. Advocates also commonly reported 
not feeling that they themselves had been given sufficient information by the GP. Again, 
guidance for GPs coming into contact with the advocates of PWMCI is outside the scope of 
this thesis, but this remains important information that should be borne in mind when 
providing support to advocates. 
Experiences of Memory Clinic Services 
The problems with memory clinic most commonly reported by advocates related to waiting 
times for either a first or second appointment, which they generally felt were too long. 
Information about the time from referral to first clinic appointment / time between 
appointments was not collected, therefore unfortunately it is not possible to comment on how 
long the actual waiting times were and hence what period of time the respondents deemed 
‘too long’ to wait.  
Problems regarding the assessments used in clinic were also commonly reported: About a 
quarter of advocates reported ‘not feeling that tests were appropriate for the PWMCI’s mild 
memory problems’. This is a similar concept to that expressed by the subjects with MCI who 
indicated that they ‘would like to have been assessed using tests that seemed more 
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appropriate to the nature of their memory problems’. Another common problem was 
advocates ‘finding their part of the assessment, such as having to ‘report on’ (the PWMCI), 
upsetting’. Although it might be hypothesised that part of the reason for advocates finding 
their part of the tests upsetting could relate to having to ‘report on’ the PWMCI in front of 
them it does not appear that the majority of advocates objected to completing their part of 
the assessment in the PWMCI’s presence: Advocates were asked about whether they had 
completed their part of the assessments at the memory clinic in the presence of the PWMCI 
or separately and how satisfied they were with this arrangement. Advocates more commonly 
reported completing their part of the assessments in the presence of the PWMCI than 
separately but the vast majority in both groups were satisfied with the ‘set-up’ for the 
assessment, therefore there does not seem to be a compelling reason to recommend a 
change in clinical practice either towards or away from joint assessments. It seems likely that 
the best solution to dissatisfaction with the tests used in clinic lies in a very clear explanation 
of their purpose, which is given to the advocate as well as the PWMCI, bearing in mind that 
this may need to be repeated if the PWMCI is not present during the initial explanation. 
Information about which tests the advocates taking part in the survey had felt were 
particularly inappropriate was not available. However, from the descriptions given by some 
of the advocates in the interview stage of the study it seems that, as well as feeling that the 
cognitive tests used to assess the PWMCI were too simple, many advocates had been 
asked to complete a Bristol Activities of Daily Living Scale (BADLS) (Bucks et al., 1996) for 
the PWMCI which they felt was inappropriate for their current level of functioning. The 
BADLS was developed as a tool to assess function at baseline, and its change over time, in 
people with dementia and it is well validated for this purpose. Although it is commonly used 
for the assessment of function in PWMCI it has not been validated for use in this group and 
therefore the advocates reporting that they did not feel that the tests used were appropriate 
were technically correct in cases where the BADLS had been used.  
Finally, in keeping with the theme of insufficient information provision which has emerged 
thus far, about a fifth of advocates stated that they had unanswered questions remaining 
following their clinic appointment. 
Current Sources of Support 
The majority of advocates reported receiving help and support from friends and family 
members, with very few (only just over 5%) reporting the use of formal services. About one 
quarter of respondents indicated that they felt they didn’t need any help or support – implying 
that the remaining three quarters felt that they did need it. Approximately a fifth of advocates 
reported not receiving any help and again, about three quarters of this group indicated that 
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they felt they did need it. The fact that a significant minority of advocates reported not 
wanting any support is in keeping with the findings of Adams’ study of caregivers in MCI 
which identified ambivalence about seeking formal and informal support in some carers, 
often due to feeling that it was ‘too early’ to do so or that it would place undue burden on 
family members (Adams, 2006). Overall, our findings indicate that the vast majority of 
advocates feel that they need help and support and that, worryingly, there is a significant 
minority who, despite feeling that they need this assistance, do not receive it. 
Current Sources of Information 
Like the PWMCI surveyed, the advocates most commonly obtained information from the 
memory specialist seen by the PWMCI. Although this group had obtained information about 
MCI from the internet more commonly than the respondents with MCI this remained a 
relatively unpopular source of information, used by only one fifth of advocates. As discussed 
for the PWMCI, this is likely to be a reflection of the older age group into which the majority 
of advocates fell. A significant minority reported receiving no information about MCI. 
Suggested Improvements to Memory Services 
INFORMATION PROVISION 
The most popular suggested improvement to the memory service was the provision of more 
information – with just over half of all advocates endorsing this option. An even greater 
proportion of respondents (between 68% and 88%) indicated that they would like more 
information on the individual topics suggested i.e.’whether the PWMCI’s problems are likely 
to get worse over time’, possible treatments for the PWMCI’s memory problems’, ‘what I 
should be doing to help the PWMCI with their memory problems’ and ‘other health problems 
that the PWMCI has that might affect their memory’. The fact that the majority of advocates 
wanted to be provided with more information about MCI is in keeping with the findings and 
recommendations of other studies in the area (Lu and Haase, 2009, Joosten-Weyn 
Banningh et al., 2008, Adams, 2006, Kuo and Shyu, 2010). The desire for information 
specifically about what the advocate ‘should be doing to help the PWMCI with their memory 
problems’ expressed by advocates in this study tallies with the recommendations form 
several other studies that advocates should be provided with strategies to assist the PWMCI 
in everyday life (Blieszner and Roberto, 2010, Austrom and Lu, 2009, Lu et al., 2007a, 
Roberto et al., 2011). 
 
Also reflecting the findings from the PWMCI healthcare experiences survey was the fact that 
the least popular suggested information topic for advocates was ‘the results of tests taken by 
your relative/ friend’, with only 66% endorsing this option. Again, this may be due to 
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differences in coping strategies used by different advocates and therefore a tailored 
approach to information provision on this topic would be sensible. Advocates reported that 
they would like information to be provided ‘face-to-face by a healthcare professional’ or ‘in 
written form e.g. a letter or a leaflet’ and, despite the fact that more advocates than PWMCI 
had already used the internet to search for information on MCI, it was an unpopular choice 
for the provision of further information with only just over 10% advocates indicating that they 
would choose this medium. Again, this is something that may change as future generations 
move into caring roles and become advocates. 
COMMUNICATION 
Another commonly endorsed suggestion was that ‘communication from the clinic could have 
been improved’ which reflects the views expressed by many of the advocates interviewed in 
the first stage of the study who felt that, following the clinic appointment, they had been ‘left 
in the dark’ about the outcome of the assessments and plans for follow up. Improvements in 
information provision at the clinic appointment, as described above and the inclusion of 
details of any plans for follow up, should go some way to addressing this issue. Provision of 
a written summary of the outcome of the appointment and follow-up plans would also be 
useful, particularly in light of advocates’ expressed preference for written information; it might 
also address some advocates’ concerns about the length of wait for feedback during a 
follow-up appointment.  It may be that ensuring that the advocate (with the consent of the 
PWMCI) receives a copy of the clinic letter which is sent to the GP would be a convenient 
way of improving communication without creating excessive additional paperwork. This is in 
keeping with Department of Health Guidance on the topic which recommends that, where 
possible and appropriate, clinic letters should be copied to patients and, if the patient gives 
consent, to carers (Department of Health, 2003). Studies have suggested that patients, 
including those attending psychiatry clinics, generally have positive attitudes about receiving 
a copy of the clinic letter (Imtiaz et al., 2012, Tahir et al., 2005) and that the practice may 
result in patients feeling more involved in their care (Williams and Kelsey, 2009). 
Unfortunately no studies have examined the effect of sending copies of clinic letters to 
carers of people with cognitive problems.  
 
INTERVAL BETWEEN APPOINTMENTS 
About a third of advocates stated that they would have liked a shorter gap between the 
PWMCI’s clinic appointments. Information on the interval between appointments for the 
PWMCI included in the study was not available but follow up for this group is usually 
provided at intervals of between 6 months and 1 year. More frequent follow up than this may 
not be feasible within the confines of the National Health Service (NHS) nor is it likely to be 
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particularly clinically useful as it unlikely that significant cognitive changes would be 
detectable in a PWMCI after an interval of less than 6 months, even when MCI is due to the 
pre-dementia phase of Alzheimer’s disease. 
Therefore, rather than altering the follow-up interval, a more helpful strategy may be to 
include in the information provided to the advocate a careful explanation of when the next 
appointment is likely to be, the reason for the time period between appointments and the 
details of who they can contact (e.g. the GP or a member of the memory clinic staff) should 
they have significant concerns about changes in the PWMCI’s cognition before the next 
scheduled appointment. Brief telephone contact with advocates between clinic appointments 
might also be helpful to address some of the concerns which cause advocates to seek more 
frequent follow up. 
OTHER SUGGESTED CHANGES 
The other commonly endorsed suggested improvements were ‘help for the advocate to talk 
more openly to the PWMCI about their memory problems’ and ‘being offered practical 
support e.g. home help or a support group’. The first of these could be addressed briefly in 
the clinic and information on sources of practical and emotional support (including, where 
required, counselling to facilitate communication within PWMCI-advocate dyads) could also 
be offered. Again, it is beyond the scope of this study to recommend which forms of 
additional support are most appropriate but those commonly suggested by other authors 
(such as psychosocial training and support groups) are discussed in the literature review in 
Chapter 2. 
 
Similar to the PWMCI surveyed there was a discrepancy between the proportion of 
advocates who reported that they felt they needed help (~75%, as discussed above) and the 
proportion who reported feeling that they needed extra help or support from the memory 
clinic (only about 20%). The reasons for this difference are likely to be similar to those 
discussed for PWMCI. The hypothesis that advocates do not feel that the memory clinic is 
the source from which they should be receiving help or support is supported by the fact that 
only a quarter of advocates indicated that they felt it was possible for the memory clinic to 
provide them with help or support at the current time. Again, ‘signposting’ alternative sources 
of support and information may be helpful for advocates. 
4.5 Summary 
The two outcome measures developed – the MCQ and the MCQ-Carer – have good 
psychometric properties and are potentially useful tools for measuring HRQL in PWMCI and 
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their advocates. The ‘experiences of healthcare surveys’ identified several areas in which 
the experiences of these groups might be improved: provision of information about various 
aspects of MCI, ‘signposting’ regarding appropriate sources of help and support, careful 
explanation of the tests used during clinical assessment and, for advocates, ensuring that 
communication from the clinic is effective. 
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Chapter 5 – Conclusion 
 
5.1 Summary of Findings 
The interview stage of the study provided in-depth information about the experiences of 
people with mild cognitive impairment (PWMCI) and their advocates, both about daily life 
with mild cognitive impairment (MCI) and about their experiences of healthcare services. 
Both groups described a range of cognitive changes and resulting functional limitations in 
the PWMCI. Negative emotional consequences were also commonly reported – but not 
infrequently there was a discrepancy between the degree of distress reported by the PWMCI 
and the advocate (in whom it was usually greater).  Attributions were varied in both groups 
but PWMCI most commonly ascribed their symptoms to ‘normal ageing’ whereas, in general, 
advocates were more uncertain as to the cause, often blaming physical health problems. In 
describing their experiences of healthcare services the advocates interviewed more 
commonly reported negative impressions than the PWMCI who more frequently described 
the encounters in a neutral or even positive way. Both groups reported receiving little 
information or formal support from health or social care services, although advocates 
reported being more distressed by this than the PWMCI interviewed. In keeping with these 
findings many PWMCI reported that they did not think any changes to healthcare services 
were necessary whereas most advocates had suggestions for improvements to services. 
Where changes were suggested these most commonly (for both groups) related to 
increasing the amount of information provided about MCI and related topics. These findings 
indicate that MCI represents a disease state which is often already having a clinical impact 
and are in also keeping with the concept of MCI as part of ‘pre-dementia Alzheimer’s 
disease’, as per the new diagnostic criteria (Albert et al., 2011).  
The questionnaire stage of the study provided data for two purposes: The first was the 
development of a patient reported outcome measure (PROM) for PWMCI and an equivalent 
measure for advocates. The data from the ‘quality of life’ section of the questionnaire was 
analysed using factor analysis and the two measures – the Mild Cognitive Impairment 
Questionnaire (MCQ) and the Mild Cognitive Impairment Questionnaire for Carers (MCQ-
Carer) - were produced (see Appendices 6 and 7). Both were found to have good 
psychometric properties. The second purpose of the questionnaire was to allow exploration 
of the issues relating to experiences of healthcare services, as identified in the interview 
stage of the study, in a larger sample. Analysis of the data from the ‘healthcare experiences’ 
sections of the questionnaires revealed that both PWMCI and advocates reported unmet 
needs for support and information: The PWCMI surveyed reported that their main concern 
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relating to the memory clinic appointment was worry, before the appointment, that their 
memory problems were due to a serious condition. Other complaints related to feeling 
insufficiently involved with their care at the clinic e.g. not being given all the information they 
wanted or their test results not being explained in a way they could understand. PWMCI 
most commonly reported receiving information about their condition from the memory 
specialist they had seen or from friends and family. Most reported wanting more information 
on a variety of topics (with the exception of additional information about their test results, 
about which opinion was divided) provided either ‘face-to-face’ by a health care professional 
and / or in writing. The majority of the PWMCI surveyed felt they needed help and support 
because of their MCI; very few reported receiving formal support from health or social care 
services, most received it from friends or family (and 10% reported not receiving any help or 
support at all). However, despite reporting this need for help and support most respondents 
indicated that they did not necessarily expect this to be provided by the memory clinic. Other 
improvements to services endorsed by PWMCI included the use of tests that seemed ‘more 
appropriate’ for their mild memory problems and being given more warning of what to expect 
at the clinic appointment. 
The concerns about memory clinic most commonly reported by the advocates surveyed 
related to the length of time the PWMCI had waited either for their first clinic appointment or 
for a follow-up appointment. Other common concerns related to the assessments used in 
clinic: either that they did not seem appropriate for the PWMCI’s mild memory problems or 
that they found the part of the assessment they took part in upsetting. A significant minority 
of advocates reported that they had unanswered questions remaining following the memory 
clinic appointment. Suggested improvements to the memory service that advocates 
frequently endorsed were: improved communication from the memory clinic, a shorter 
interval before or between clinic appointments and being offered practical support or help to 
talk more openly with the PWMCI about their memory problems. Like the PWMCI surveyed, 
the majority of advocates reported feeling that they needed help and support because of the 
PWMCI’s memory problems, although not that it should necessarily be provided by the 
memory clinic. Most advocates reported receiving support from friends or family, very few 
had accessed ‘formal’ health or social care support and 20% reported receiving no help or 
support at all. Also reflecting the findings from the PWMCI survey, the majority of advocates 
reported receiving information about MCI from the memory specialist seen in clinic and most 
wanted more information on all topics suggested, once again with the exception of the 
PWMCI’s test results, about which opinion was divided. Advocates also wanted information 
to be provided either face-to-face or in writing. 
152 
 
 
 
5.2 Potential Avenues for Future Work 
5.2.1 Further Development of the MCQ and MCQ-Carer 
There are several potential avenues for further work involving the MCQ and MCQ-Carer: As 
mentioned in the section on ‘Discussion of Questionnaire Results’ in Chapter 4, further 
testing of both measures in a larger sample would be helpful to confirm the internal 
consistency reliability of all their domains. Given the fact that cognitive problems affect 
people in all countries the translation of the measures into languages other than English and 
validation for use in these languages would increase the scope for their use. Indeed, it would 
be helpful to explore many of the issues discussed in this thesis both in other countries and 
within ethnic minority groups in the UK. As healthcare services are moving progressively 
towards the use of electronic patient records, adaptation of the measures for use in an 
electronic format, together with validation for use in this modality, would be useful.  
As discussed in the section ‘Interpreting the Scores of the MCQ and MCQ-Carer’ in Chapter 
4, the calculation of standardised effect sizes for the measures would be helpful if they are to 
be used for assessing outcomes following an intervention. However, this approach does not 
necessarily reflect the operating characteristics of an individual measure and therefore, in 
line with the US Food and Drug Agency (FDA) guidance on the topic, further work to 
establish the responsiveness of the MCQ and MCQ-Carer (via a sensitivity to change 
analysis) would be preferable to facilitate the use of the measures in assessing 
interventions. 
5.2.2 Guidance for Memory Services 
The findings regarding PWMCI and advocates’ experiences of healthcare services, as 
described in this thesis and summarised above, could potentially be used to develop 
guidelines for use by memory services when managing PWMCI and their advocates. The 
only published ‘support programme’ designed specifically for PWMCI is Lu and Haase’s 
‘Daily Enhancement of Meaningful Activity’ (DEMA) programme (Lu and Haase, 2011) which 
is described in the literature review in Chapter 2. Although this programme does include 
elements which reflect the findings of this study, for example an emphasis on information 
provision to the PWMCI and their advocate, its focus is on the provision of support after the 
diagnosis of MCI is made rather than during the process of assessment and diagnosis within 
healthcare services. Aside from those relating to purely clinical aspects, such as appropriate 
investigations and pharmacological therapies, no published guidelines regarding other 
aspects of the management of PWMCI and their advocates within healthcare services were 
identified by the literature review described in Chapter 2.  
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The data in this study was collected in such a way that it is valid for use at an aggregate, 
rather than individual level. Therefore any guideline developed based on this data would 
require further evaluation before it could be used within clinical practice. Nonetheless, the 
following suggestions represent a potential starting point for improving the experiences of 
PWMCI and their advocates with healthcare services: 
Guidance for the management of PWMCI could cover areas such as: 
• Provision of information in the clinic booking letter about what will happen at the 
appointment 
• Open acknowledgment of concerns about the nature of the PWMCI’s memory 
problems  
• Provision of a clear explanation of the cognitive tests that are to be used  
• Provision of appropriate verbal and written information on the topics discussed in this 
thesis 
• Ensuring that the PWMCI feels sufficiently involved with decisions being made about 
their care 
• Use of ‘signposting’ to direct PWMCI to alternatives to the memory clinic for 
information and support  
 
Guidance for the management of advocates of PWMCI could cover areas such as: 
• Provision of a clear explanation of the cognitive tests that are to be used for the 
PWMCI and any assessments that are to be completed by the advocate.  
• Provision of information on the topics discussed in this thesis, both verbally and in 
writing  
• Facilitation of  communication between the PWMCI and advocate regarding the 
memory problems  
• Use of ‘signposting’ to direct advocates to alternatives to the memory clinic for 
information and support  
5.3 Conclusion 
As per the aim of this study, information about the experiences of PWMCI and their 
advocates, with particular reference to their involvement with healthcare services has been 
gathered – both from in-depth interviews and surveys of a larger sample. The findings 
confirm some of those from the existing literature in this area regarding the challenges faced 
by PWMCI and their advocates in daily life and they also shed new light on issues specific to 
contact with healthcare services for these groups. The information gathered was used to 
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develop a PROM to assess health related quality of life in PWMCI (the MCQ) and an 
equivalent measure for advocates (the MCQ-Carer); both have good psychometric 
properties and therefore have the potential for use to assess outcomes in these groups 
within clinical practice. A detailed picture of the experiences of PWMCI and their advocates 
within healthcare services was obtained and, on the basis of this, suggestions for 
improvements to services have been made. It is hoped that the findings described here will 
improve the experiences of these, up to now somewhat neglected, groups within healthcare 
services.  
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Appendices 
Appendix 1 – Interview Topic Guides 
Interview Topic Guide for People With Mild Cognitive Impairment 
• Tell me a bit about your background….. 
• Looking back what do you think the first signs were that there was a problem? 
• Tell me about daily life with your memory problem 
• Reasons for initial presentation to primary care 
• Experience of consultation with primary care physician 
• Experience of consultation in memory service including  
 understanding of reasons for referral 
 process of assessment including cognitive testing 
 receiving the diagnosis of mild cognitive impairment (MCI) 
 understanding of the diagnosis (the meaning and implications of the 
diagnosis of MCI)  
 information provided by healthcare professionals at each stage 
• Other sources of information accessed 
• Practical strategies adopted to aid memory 
• Impact of the problems described on relationship with spouse / family members / 
social contacts 
• Perceptions about the future 
• How the process of consultation, diagnosis and support might be different 
• Day to day issues caused by memory problems 
• Do you think you have more or less problems than others of your age 
• Influence of their experiences of other people with memory problems on their 
perceptions of their own problem 
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• Is there anything else I haven’t covered? 
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Interview Topic Guide for Advocates 
• Tell me a bit about your background…. 
• Looking back what were the first signs that something might be amiss? 
• Tell me about daily life with the person with MCI (PWMCI) 
• Experience of consultation with general practitioner (GP) (if advocate was present) – 
their role 
• Experience of consultation in memory service including (if advocate was present) – 
their role 
• Information given by primary care / Memory service specific to their needs as an 
advocate 
• Other sources of information accessed 
• Communication with the PWMCI about their memory problems 
• Impact on their relationship with the PWMCI / other family members / friends 
• Impact / burden on them, coping strategies 
• Experience of other people with memory problems and how this influences their 
perceptions of the patients problems 
• Perceptions about the future 
• How the process of consultation, diagnosis and support might be different 
• Anything I haven’t covered? 
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Appendix 2 – Examples of Study Literature from Interview Stage 
Initial Information Sheet – Person With Mild Cognitive Impairment - 
Interview 
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Full Information Sheet – Person With Mild Cognitive Impairment - 
Interview 
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Full Information Sheet – Advocate - Interview 
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Consent Form – Person With Mild Cognitive Impairment– Interview 
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Consent Form – Advocate – Interview 
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Appendix 3 – Details of Revisions to Questionnaires Following 
Focus Group Feedback 
Modifications to Questionnaires for the Mild Cognitive Impairment 
Group 
General 
• Minor alterations to the wording and formatting were made to make the 
questionnaires easier to read and complete. 
• The wording of the final ‘white space’ question was simplified from ‘If there is 
anything else you would like to tell us about how your memory problems affect you, 
or your experiences of healthcare services, please do so here’ to ‘If there is anything 
else you would like to tell us please do so here’. 
 
Your Background 
• The wording of the introduction was altered to make the explanation as to why 
demographic information was being collected clearer. 
• Question 4: ‘When was your last appointment with the memory clinic / service’, an 
option to answer ‘Not Sure’ was added to allow for lack of recall regarding this matter 
 
How Your Memory Problems Affect You 
• The wording of the introduction was altered to ask about the last ‘four weeks’ rather 
than the last ‘month’ for clarity   
• Question 11: The wording of the item ‘Worry about feeling generally ‘slowed down’ in 
both mind and body’ was altered to ‘Worry about feeling generally ‘slowed down’ in 
order to avoid asking about two separate concepts in one question. 
• Question 13: The wording of the item ‘Feeling unable to talk to friends or relatives 
about your memory problems’ was altered to ‘Feeling unable to talk to friends or 
relatives about your memory problems because it is upsetting or embarrassing’ to 
ensure that subjects answering this in the affirmative were describing a limitation with 
an emotional rather than practical basis 
• Question 14: The wording of the item ‘Feeling you have had to cover your memory 
problems up to hide them from someone else’ was altered to ‘Feeling you have had 
to cover your memory problems up to avoid upsetting someone’ again, to ensure that 
the limitation described had an emotional basis. 
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Your Experiences at the GP and Memory Clinic 
• Question 22: ‘What made you discuss your memory problems with your GP initially?’ 
an option for ‘If you have not discussed your memory problems with the GP’ was 
added as a small number of subjects may have been referred to memory services 
from a source other than their GP. 
• Question 23:‘The following questions are about what it was like when you discussed 
your memory problems with your GP for the first time’ and Question 24: ‘The 
following questions are about what it was like when you went to the memory clinic’ 
options to answer ‘Not Sure’ and ‘To Some Extent’  were added to allow for lack of 
recall and some nuance in responses respectively 
• Question 23c: ‘Did the GP suggest that your memory problems were ‘just due to 
age?’, the wording was altered to ‘Do you think that your GP took your memory 
problems seriously’? to ensure that the concept of the GP being ‘dismissive’, rather 
than reassuring, was conveyed 
• Question 25: ‘From whom do you currently receive practical help and / or emotional 
support for any difficulties caused by your memory problems?’,  an option to answer 
‘I don’t feel I need any help or support’ was added as this was a common response in 
the interviews with the MCI group 
•  Question 27: ‘The following questions are about possible changes you would like to 
see made to the memory clinic in light of your experiences: 
o Question 27e: ‘Would you have liked to have been assessed using tests that 
seemed more appropriate for mild memory problems?’, wording was altered 
to ‘Would you have liked to have been assessed using tests that seemed 
more appropriate to the nature of your memory problems?’ to avoid the need 
for subjects to define ‘mild’ memory problems in order to answer the question 
o Question 27g: A question about improved coordination of services was added 
to reflect a common topic from the interviews and focus group 
o Question 27i ‘Do you feel that there’s not much more anyone can do for you 
at present?’, wording was altered to ‘Do you feel that it is possible for the 
memory clinic to give you extra help or support at moment?’ for clarity 
• Question 28: ‘The format of this question, regarding whether a relative or friend was 
present during assessment of the PWMCI, was altered to make it simpler to progress 
through the questionnaire 
SF-12v2 
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• An introductory statement was included prior to the SF-12v2 to explain the rationale 
for collecting the information and to encourage participants to complete it even if it 
did not appear directly relevant to them. 
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Modifications to Advocate Questionnaires 
General 
• Minor alterations to the formatting and wording were made to make the 
questionnaires easier to read and complete. 
• The wording of the questionnaire introduction and supporting literature for the 
PWMCI and advocates was altered to state that the linked PWMCI had been 
requested to pass on the questionnaire to ‘a relative or friend who they think has 
been affected by their memory problems and who they are in contact with at least 
twice a week’ in order to ensure that the advocate receiving the questionnaire had 
sufficient knowledge of the PWMCI to complete it accurately 
• The wording of the final ‘white space’ question was simplified from ‘If there is 
anything else you would like to tell us about how your relative or friend’s memory 
problems affect you, or your experiences of healthcare services, please do so here’ 
to ‘If there is anything else you would like to tell us please do so here’ 
 
Your Background 
• The wording of the introduction was altered to make the explanation as to why 
demographic information was being collected clearer. 
• Question 5: ‘When was your relative / friend’s last appointment with the memory 
clinic / service’, an option to answer ‘Not Sure’ was added to allow for lack of recall or 
knowledge regarding this matter 
 
How Your Relative or Friend’s Memory Problems Affect You 
• The wording of the introduction was altered to ask about the last ‘four weeks’ rather 
than the last ‘month’ for clarity   
• Question 23: An item about ‘loss of the person you used to know’ was added to 
incorporate a concept that was raised in both the interviews and focus group 
 
Your Experiences at the GP and Memory Clinic 
• Question 24 ‘What made your relative or friend discuss their memory problems with 
their GP initially?’  
o The wording was altered to ‘What do you think made your relative or friend 
discuss their memory problems with their GP initially?’ to ensure that the 
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advocate’s opinion is recorded and to avoid appearing to be attempting to 
verify the linked PWMCI’s response  
o An option for ‘If your relative or friend has not discussed their memory 
problems with the GP’ was added as a small number of subjects may have 
been referred to memory services from a source other than their GP 
• Question 26: ‘The following questions are about what it was like when your relative / 
friend discussed their memory problems with their GP for the first time’ and Question 
28‘The following questions are about what it was like when you went to the memory 
clinic’  
o The wording was altered to ‘The following questions are about what you 
thought it was like when your relative / friend discussed their memory 
problems with their GP for the first time’ and ‘The following questions are 
about what you thought it was like  when your relative / friend went to the 
memory clinic’ to emphasise the fact that it was the advocate’s experience, 
rather than the PWMCI’s, which was the subject of the questions 
o Options to answer ‘Not Sure’ and ‘To Some Extent’  were added to allow for 
some nuance in responses and provide parity with the MCI group 
questionnaire 
• Question 26 ‘The following questions are about what you thought it was like when 
your relative / friend discussed their memory problems with their GP for the first time’ 
o Question 26c: ‘Did the GP suggest that your relative or friend’s memory 
problems were ‘just due to age?’, wording was altered to ‘Do you think that 
your GP took your relative or friend’s memory problems seriously’? to ensure 
that the concept of the GP being ‘dismissive’, rather than reassuring, was 
conveyed 
o Question 26e: ‘Did you feel like you were given the right amount of time with 
the GP’, wording was altered to ‘Did you feel like your relative or friend was 
given the right amount of time with the GP’ for clarification 
• Question 28 ‘The following questions are about what you thought it was like when 
your relative / friend went to the memory clinic’  
o Emphasis was placed on the term ‘you’ in several of the answer options to 
make it clear that opinions on the advocate’s experience were being sought 
o Question 28j: A question about the length of wait for a follow-up appointment 
to receive feedback was added to reflect a concern raised in the interviews 
and focus group 
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• Question 29: ‘From whom do you currently receive practical help and / or emotional 
support for any difficulties caused by your relative or friend’s memory problems?’ 
o For the answer options ‘your husband / wife / partner’, ‘other family members’ 
and ‘friends or social groups’ the explanation that ‘this may include the person 
with memory problems’ was added for clarity 
o  An option to answer ‘I don’t feel I need any help or support’ was added as 
this was a common response in the advocate interviews 
• Question 30 ‘Which of the following have been helpful sources of information about 
memory problems?’, wording was altered to ‘Which of the following have you found 
to be helpful sources of information about memory problems?’ again to place the 
emphasis on the advocate’s opinions 
• Question 31: ‘If you were present when your relative / friend attended the memory 
clinic please answer the following questions about possible changes you would like 
to see made to the memory clinic in light of your experiences’ 
o Question 31g: A question about improved coordination of services was added 
to reflect a common topic from the interviews and focus group 
• Question 32: The format of this question, regarding whether the relative or friend with 
memory problems was present during the part(s) of the assessment which the 
advocate took part in, was altered to make it simpler to progress through the 
questionnaire 
 
SF-12v2 
• An introductory statement was included prior to the SF-12v2 to explain the rationale 
for collecting the information and to encourage participants to complete it even if it 
did not appear directly relevant to them. Particular emphasis was placed on the fact 
that the questions referred to the health of the advocate rather than the PWMCI.  
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Appendix 4 – Final Versions of Questionnaires 
Questionnaire for People With Mild Cognitive Impairment 
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NB. At this point, the survey pack also included a copy of the SF-12v2. Due to copyright 
protection this cannot be reproduced in this thesis. However, the SF-12v2 may be viewed 
online at this URL http://www.qualitymetric.com/tabid/238/Default.aspx (URL published with 
permission from Optimuminsight Life Sciences Inc, (f/k/a QualityMetric Incorporated) 
208 
 
 
 
 
209 
 
 
 
Questionnaire for Advocates 
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NB. At this point, the survey pack also included a copy of the SF-12v2. Due to copyright 
protection this cannot be reproduced in this thesis. However, the SF-12v2 may be viewed 
online at this URL http://www.qualitymetric.com/tabid/238/Default.aspx (URL published with 
permission from Optimuminsight Life Sciences Inc, (f/k/a QualityMetric Incorporated) 
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Appendix 5 – Medical Outcomes Study Short Form Health Survey, 
12 item version (version 2) Population Norms (Median) 
 
Scale Median 
PCS: general population 53.03 
PCS: 65 – 74 year olds 44.66 
PCS: over 75s 39.53 
MCS:  general population 51.83 
MCS: 65 – 74 year olds 54.12 
MCS: over 75s 50.87 
Table 16. SF-12v2 norms (median) for the 1998 U.S. Population, Standard (4-Week) Form 
 
220 
 
 
 
Appendix 6 – Final Version of the Mild Cognitive Impairment 
Questionnaire (MCQ) 
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Appendix 7 – Final Version of the Mild Cognitive Impairment 
Questionnaire for Carers (MCQ-Carer)
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Appendix 8 – Coefficients Generated by Regression Analyses of 
the Healthcare Experiences Survey Data  
Relationship Between Opinions About Improvements to Services 
and Mental Health 
Using SF-12 MCS as the dependent variable 
 
Variable Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
 (Constant) 39.924 9.132  4.372 .000 
Sex .919 1.967 .049 .467 .642 
Age .137 .121 .117 1.131 .262 
Would you have liked to have been given 
more information at the appointment? 
-3.939 2.704 -.211 -1.457 .149 
Would you like to have been given more 
time at the assessment? 
2.023 3.217 .080 .629 .531 
Would you have liked more warning of what 
was going to happen at the assessment? 
-3.755 2.533 -.194 -1.482 .142 
Would you have liked the process of 
assessment to have been shorter? 
.296 3.637 .009 .081 .935 
Would you have liked to have been 
assessed using tests that seemed more 
appropriate to the nature of your memory 
problems? 
2.877 2.685 .155 1.072 .287 
Would you have liked to have had more 
reassurance form the staff? 
2.846 3.426 .121 .831 .409 
Do you think that your healthcare should 
have been better coordinated? 
-7.098 3.057 -.322 -2.322 .023 
Do you feel that you need any extra help or 
support from the memory clinic at the 
moment? 
-5.672 3.400 -.252 -1.668 .099 
Do you feel that it is possible for the 
memory clinic to give you extra help or 
support at the moment? 
-1.504 2.987 -.073 -.504 .616 
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Relationship Between Opinions About Improvements to Services 
and Quality of Life 
Using MCQ ‘emotional effects’ scale score as the dependent variable 
 
Variable Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
 (Constant) 71.841 19.886  3.613 .001 
Sex .138 4.274 .003 .032 .974 
Age -.579 .263 -.220 -2.199 .031 
Would you have liked to have been given 
more information at the appointment? 
13.089 6.197 .315 2.112 .038 
Would you like to have been given more 
time at the assessment? 
-5.217 6.813 -.096 -.766 .446 
Would you have liked more warning of 
what was going to happen at the 
assessment? 
1.755 5.503 .041 .319 .751 
Would you have liked the process of 
assessment to have been shorter? 
-6.709 7.137 -.097 -.940 .350 
Would you have liked to have been 
assessed using tests that seemed more 
appropriate to the nature of your memory 
problems? 
3.797 5.924 .093 .641 .523 
Would you have liked to have had more 
reassurance form the staff? 
.644 6.858 .013 .094 .925 
Do you think that your healthcare should 
have been better coordinated? 
-1.447 6.535 -.030 -.221 .825 
Do you feel that you need any extra help 
or support from the memory clinic at the 
moment? 
.423 7.703 .008 .055 .956 
Do you feel that it is possible for the 
memory clinic to give you extra help or 
support at the moment? 
12.133 6.765 .259 1.794 .077 
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Using MCQ ‘practical concerns’ scale score as the dependent variable 
 
Variable Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
 (Constant) 66.332 16.126  4.113 .000 
Sex -4.403 3.443 -.130 -1.279 .205 
Age -.403 .214 -.189 -1.888 .063 
Would you have liked to have been given 
more information at the appointment? 
6.084 4.913 .184 1.238 .219 
Would you like to have been given more 
time at the assessment? 
-.598 5.375 -.014 -.111 .912 
Would you have liked more warning of 
what was going to happen at the 
assessment? 
2.464 4.461 .072 .552 .582 
Would you have liked the process of 
assessment to have been shorter? 
-5.717 5.807 -.103 -.985 .328 
Would you have liked to have been 
assessed using tests that seemed more 
appropriate to the nature of your memory 
problems? 
.616 4.944 .019 .125 .901 
Would you have liked to have had more 
reassurance form the staff? 
-4.650 5.580 -.116 -.833 .407 
Do you think that your healthcare should 
have been better coordinated? 
7.470 5.311 .193 1.406 .163 
Do you feel that you need any extra help 
or support from the memory clinic at the 
moment? 
1.885 5.971 .046 .316 .753 
Do you feel that it is possible for the 
memory clinic to give you extra help or 
support at the moment? 
7.228 5.313 .192 1.360 .177 
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Relationship Between Healthcare Experiences Summary Score and 
Experiences of Individual Aspects of Memory Clinic 
Using the ‘experiences of healthcare summary score as a dependent variable’ 
 
Variable 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
 (Constant) -.371 2.430  -.153 .879 
Sex -.485 .433 -.110 -1.121 .268 
Age .015 .030 .051 .498 .621 
Found tests stressful or upsetting .959 .485 .199 1.977 .054 
Wait for first appointment too long -.218 .494 -.047 -.442 .661 
Gap between clinic appointments too 
long 
.740 .522 .160 1.418 .163 
Given all the information wanted .781 .593 .171 1.317 .194 
Treated with dignity and respect .326 1.037 .033 .315 .755 
Worried before the appointment that 
problem was serious 
.700 .509 .133 1.376 .175 
Clinic well organised -.155 .821 -.020 -.189 .851 
Felt sufficiently involved in care 1.490 .615 .283 2.424 .019 
Test results explained in a 
comprehensible way 
1.380 .557 .291 2.480 .017 
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